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the original fibrillar network.ǳ 
French surgeon, Dr Jean-Claude Guimberteau, on fascia 
  ǲThe findings of fascia research show that the disregarded connective tissue includes the cause for inexplainable illnesses and pain, but also, an inexhaustible source of cure.ǳ  
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Breast cancer is the most commonly diagnosed cancer in women and surgery remains the primary 
treatment. Evaluation of tumour spread is done by axillary lymph node assessment by surgical 
excision. Such invasive treatments, in conjunction with adjuvant therapies such as chemotherapy, 
radiotherapy and hormonal therapy, may alter patient healing patterns giving rise to 
complications such as axillary web syndrome (AWS). 
 
AWS presents as a puckering web of axillary skin overlying a cord of tissue that tightens with 
shoulder abduction. It is painful, limits shoulder range of movement (ROM) and reduces the 
quality of life of the patients. The syndrome is elusive, does not occur in everyone and is thought 
to be self-limiting in nature with spontaneous cord resolution. Evidence, however, is pointing 
towards long-term morbidity in some patients. The cord itself has been hypothesised to be 
lymphatic or vascular in origin and damage during axillary surgery gives rise to the structure. 
 
Anatomically, the vascular structures are bound by the connective tissue network of fascia. The 
adhesive and puckering appearance of the cord on clinical examination and in limited biopsy 
studies could imply a possible role of damaged fascia in the syndrome. The fascia, as a three-
dimensional body-wide network, has been shown to be a functional unit with the musculoskeletal 
system and is important in coordinating movement. Furthermore, the fascia contains numerous 
receptors imperative for proprioceptive and nociceptive functioning. The fibroblast cells and 
fibres that it comprises are involved in tissue healing and scar tissue formation. Chronic 
inflammation upon fascial damage can lead to tissue adhesions and fibrosis, rendering a non-
functional scar.  
 
Ultrasonography (US) has been able to visualise fascial differences and has been used to examine 
fascial abnormalities including scars and adhesions. Physiotherapy treatment has been shown to 
aid in remobilising scar tissue and in being able to help improve morbidity in AWS patients. The 
authors therefore hypothesised that damaged fascia contributes to the symptomology of AWS. 
The present study set out to evaluate whether altered fascia plays a role in the syndrome using 
fascial explanations for risk factors in the AWS literature and US in patients with AWS to observe 
anatomical changes. Furthermore, the authors hypothesised that myofascial physiotherapy could 
aid in cord resolution and symptom improvement and that it would reflect in fascial changes on 
US.  
 
The current descriptive, observational, pilot, proof-of-concept case-series study focused on fascial 
changes before and after myofascial release physiotherapy in women presenting with AWS 
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following breast cancer treatment (n = 11). At the time points, US in the area of interest (the axilla) 
and MRI scans of a single patient were done pre-physiotherapy. Furthermore, patient variables of 
ROM, pain and disability using the SPADI questionnaire, and quality of life using the FACT-B 
questionnaire, were evaluated to relate to any fascial differences between affected and unaffected 
arms on US and compared to findings after physiotherapy to determine trends. To observe fascial 
continuity, alignment of US scans was attempted.  
 
The results from the case studies and overall trends indicated thickened fascia, reduced 
continuity, decreased gliding potential and increased adherence between the different fascial 
layers on US in the majority of patients on the affected arm in the area of interest suggesting that 
they are changes resulting from the treatment. The findings related to the external cord 
appearance. On MRI, a fibrous band of tissue was observed connecting to muscles and skin. The 
findings were found to descriptively show a trend with reduced ROM and increased SPADI scores. 
No descriptive relationship with FACT-B was noted.  
 
Several patients (n = 6) continued with physiotherapy for six treatments. The treatment proved 
beneficial for all patients, who improved on ROM and SPADI scores. However, not all their 
symptoms were completely resolved. The findings corroborate observations on US showing 
improved gliding, more regular and organised fascia, and less adhesions post-physiotherapy. Cord 
resolution or reduction occurred in half of the patients. 
 
Risk factors for AWS as identified in the literature and related to the patients, such as more 
invasive treatments and (neo)adjuvant therapies, were explained to cause more fibrosis and 
possibly contributed to the symptoms seen but could not be verified in the study due to the small, 
varied sample. Furthermore, due to the difficulty of finding suitable patients and the low sample 
size, the current study could not statistically corroborate many correlations and hence was limited 
to descriptive trend description. 
 
Using the fascial literature, restricted fascia and adhesions could be explained to lead to 
biomechanical limitations, explaining reduced ROM and nociceptor activation as seen in pain 
reported in the study. A fibrosed vessel damaged during axillary surgery as well as surrounding 
fascial changes, which occurred as the result of the healing response, could explain the varying 
appearances of the cord.  
 
The author concluded that the trends seen suggest a link for morbidity resulting from fascial 
damage and adds weight to the evidence of fascial involvement in AWS. Wider fascial involvement 
on US and MRI descriptively related to the presence of cording, limited shoulder ROM and pain 
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before and improvements and changes in the domains after physiotherapy, supported the 
hypotheses. The present study highlighted that myofascial release can be beneficial for patients 
suffering from AWS and suggests that US may be a feasible outcome measure to aid in evaluating 
fascia and fibrosis subsequent to physiotherapy, guide it and determine its efficacy. Furthermore, 
risk factors need to be identified to implement an early warning system for the sequelae of breast 
cancer so that patients at risk are identified timeously and receive the help they need to minimise 
the effect of the syndrome on their wellbeing in order to improve their quality of life.  
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Chapter 1: Introduction 
 
1.1.  Breast cancer and treatment 
Female breast cancer is a worldwide problem with more than one million new diagnoses per year 
(Parkin et al., 1999). In South Africa it is the most commonly diagnosed cancer with 1 in 29 women 
at risk of developing the disease (Cancer Association of South Africa, 2004). The mainstay of 
breast cancer treatment remains surgery with the focus of invasively removing the local tumour 
and the assessment of axillary lymph node spread. The assessment is by sentinel lymph node 
biopsy (SLNB) or axillary lymph node dissection (ALND) with the former being less destructive 
(Cheville & Tchou, 2007; Edge, 2004). Surgery may be used in conjunction with adjuvant or 
additional therapies such as radiotherapy and chemotherapy which may impact healing patterns 
(Cheville & Tchou, 2007). Despite that procedures have become more conservative, there are 
numerous complications that can arise from the treatments (Fourie & Robb, 2009). However, it is 
thought that clinicians often downplay the potentially debilitating effects the complications might have on a patientǯs life after they have already had to cope with cancer (Josenhans, 2007). As a 
result of the stance of the clinicians and the negligence of not assigning appropriate exercises, the 
patient may be wrongfully led to think that the symptoms they experience, such as limited range 
of movement (ROM) and pain, are normal. Normalisation often leads to worse complications and 
sometimes permanent morbidity (Kepics, 2007). The features mentioned are seen in a disorder 
called axillary web syndrome (AWS). 
 
1.2. Axillary web syndrome (AWS) Moskovitz and colleagues first described AWS in ʹͲͲͳ as ǲa visible web of axillary skin overlying 
[a] palpable [cord or] cords of tissue that are made taut by shoulder abductionǳ ȋMoskovitz et al., 
2001 p. 435). They further describe the webbed cording as extending from the axilla down the 
ipsilateral arm sometimes as far as the thumb (Figure 1.1). The tissue is described as painful and 
tender to the touch, causing tightness and pulling on both the skin and contents of the axilla 
(Moskovitz et al., 2001). Other symptoms include axillary pain that radiates down the arm and 
greatly reduced ROM of the arm itself (Moskovitz et al., 2001). Other authors describe AWS 
differently and include functional limitations and morbidity in their definitions (Lacomba et al., 
2009; Craythorne, Benton & Macfarlane, 2009). Practitioners in, especially, the manual therapies prefer to use the term ǲcordingǳ as the cord is often found not to be limited to the axilla ȋKepics, 
2007) and can form in a completely different place such as over the arm or on the chest wall 
(Rashtak et al., 2012). Most of the terms are often used interchangeably in the literature which 
leads to confusion as the term ǲcordingǳ could only refer to the physical cord structure without 
accompanying symptoms. The uncertainty of the terminology also results in difficulties 
establishing prevalence in AWS. 
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Figure 1.1. Schematic of axillary web syndrome (AWS). Adapted from Moskovitz et al. (2001). 
 
1.2.1.  Prevalence of AWS 
A very wide range of prevalence of 6-72% has been reported for AWS following axillary dissection, 
ALND and SLNB, after breast cancer surgery (Severeid, 2007; Lacomba et al., 2009; Bergmann et 
al., 2012). Leidenius and colleagues (2003) report a 20% prevalence of AWS after SNLD and a 
72% prevalence after complete clearance of the axilla, which Craythorne and colleagues (2009) 
corroborate. The discrepancy in the literature might come about because of the relatively small 
sample sizes (n < 100) of the studies, which may reduce their statistical power. Furthermore, the 
different contexts in which the studies have been done may relate to differences in surgical 
procedures. Alternatively, sometimes the cord(s) may not be visible or palpable on physical 
examination due to its/their extension into the trunk. It is also possible that the cord might go 
undetected due to an increased thickness of the adipose layer superficial to the cord in patients 
with raised BMI (> 25) or in patients with lymphoedema in whom the accumulated fluid might 
obstruct access and visibility to the cord (Leidenius et al., 2003; Koehler, 2013). Kepics (2007) 
describes that she observed patients who were thought to have lymphoedema but where the cord 
had actually deformed the skin giving it an oedematous appearance. An apparently higher 
prevalence of AWS is therefore plausible.  
 
Although more destructive surgery – such as complete axillary clearance in which all the 
connective tissue, adipose tissue and lymph nodes are removed – seems to predispose the patient 
to AWS development (Koehler, 2013), other research points towards even minor surgery and 
inflammation as possible causative factors for the development of the syndrome (Rashtak et al., 
2012). Other variables that have shown a correlation with AWS include a low BMI (BMI < 25) and 
having had a radical mastectomy (Bergmann et al., 2012). AWS also seems to be associated with 
lymphoedema development (Bergmann et al., 2012). Further exploration of the relationships 




- 3 - 
 
1.2.2.  Aetiology of AWS 
Moskovitz et al. (2001) hypothesised that the aetiology of AWS is the result of the disruption of 
superficial veins and/or lymphatics during axillary surgery. Histopathological findings in the 
literature showed the cord may represent thrombosis of a blood vessel (Shetty & Watson, 2001) 
or a fibrosed and stased lymph vessel (Josenhans, 2007). Marcus, Pawade and Vella (1990) 
described collagenous tissue on biopsy and most authors found fibrosis (Marcus, Pawade & Vella, 
1990; Reedijk et al., 2006; Villamiel Capos et al., 2008; Rashtak et al., 2012). Kepics (2007) 
hypothesises that stasis in lymphatics can lead to lymphoedema and leaking of protein-rich fluid 
into the interstitium which would lead to fibrosis, the increased deposition of collagen on the 
vessel wall and formation of the hardened cord.  
 AWS is sometimes also suggested to be a variant of Mondorǯs disease because of its similar 
presentation with a cord, but with occurrence in a different location – predominantly the chest 
wall and legs (Conant et al., ͳͻͻ͵Ȍ. Mondorǯs disease is described as superficial thrombophlebitis 
of the subcutaneous veins of the chest, showing a comparable cord on the chest wall (Conant et 
al., 1993). The majority of studies on AWS imply a link to the lymphatic rather than the vascular 
system (Leduc et al., 2009; Bergmann et al., 2012). Apart from blood vessels and lymphatics, one author posited that the cord in the case of Mondorǯs disease could be the result of twisted fascia 
(Salmon, Berry & Hamelin, 2009). However, there still remains much uncertainty around the topic 
as not much clear evidence, such as biopsies of the cord, exists to show its composition (Josenhans, 
2007). 
 Due to the cordǯs similar appearance in both disorders, the aetiological findings in Mondorǯs 
disease could be extrapolated to the anatomical pathology of AWS. The superficial lymphatics and 
vessels, which are suggested to make up the cord, are bound and anchored by superficial fascia. A 
fibrosed cord, as seen in both, could therefore be related and adhere to the surrounding fascial 
planes. Salmon and colleagues (2009) go as far as to hypothesise that the interplay of fascia might play a bigger role in the initiation of Mondorǯs disease than the lymphatic system does. Only Fourie 
& Robb (2009) suggest a possible link of damaged fasciae to AWS symptoms. Other research 
denies observing any involvement of fascia using imaging modalities (Leduc et al., 2009, 2014; 
Koehler, 2013; Koehler et al., 2014). 
 
1.2.3. Imaging of AWS 
Medical imaging modalities allow observation of internal structures in patients. Most AWS studies 
have, however, focused on physical examinations of the anatomy of the syndrome (Leduc et al., 
2009; Fourie & Robb, 2009). In total, there have been four studies that have used ultrasound (US) imaging as an attempt to observe the cordǯs anatomy in AWS. OǯToole and colleagues ȋʹͲͳͷȌ 
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showed linear, continuous structures which extended into the biceps brachii muscle in 
longitudinal direction to the cord with a ǲhoneycombǳ appearance in transverse direction, but 
concluded not to be able to find consistent indicators of the cord on US.  
 
Koehler et al. (2013, 2014) came to a similar conclusion, as the cord could not be observed and 
showed no significant differences in skin thickness or echo density of the affected versus the non-affected arm in patients with AWS. A comparison to findings on Mondorǯs disease were made 
where a tubular, reduced echoic structures was observed with no flow on Doppler US (Yanik et 
al., 2003). Although a high-frequency probe was used for increased visibility, only transverse 
scans were taken, giving a limited and discontinuous view.  
 
Wei and colleagues (2013) showed a hyperechogenic tube on longitudinal B-type US which was 
revealed to be a blood vessel on Doppler ultrasound and thought to be the cord. Unfortunately, 
the findings of the study were not well explained, and the observed structure could be a regular 
blood vessel instead of the cord.  
 
Leduc and colleagues (2014) provide the only study that reports the ability to visualise the cord 
and relating US and MRI findings, using a specific method to maintain the cord in a stretched 
position. Their findings show an anechoic appearance with hyperechogenic edge superficial to, or 
at, the hypodermis-deep fascia junction. The authors report that there was, however, no evidence 
of fascia involvement or focal fascial thickening.  
 
Imaging of the cord, its contents and its relationship to the surrounding structures has thus not 
yet provided definitive answers about the anatomy of AWS but requires further investigation and 
may explain symptom onset and resolutions. 
 
1.2.4.  Onset and resolution of the symptoms of AWS 
The onset of the symptoms of AWS has been found to occur between one and five weeks after the 
surgical procedure (Lacomba et al., 2009; Leduc et al., 2009; Cheville & Tchou, 2007; Fourie & 
Robb, 2009). The medical literature asserts that AWS is self-limiting and spontaneously resolves 
within three months (Moskovitz et al., 2001; Leidenius et al., 2003). Physiotherapists, on the 
contrary, suggest that when AWS is left untreated, morbidity and pain can persist for years 
(Kepics, 2007). In agreement with Kepics (2007), the current study notes that the same original 
information is reproduced and original sources are referred to in the literature without critical 
appraisal. Perpetuated long term-effects of AWS may thus occur when the symptoms have gone 
unnoticed. Long-term complications might include altered shoulder dynamics as found in many 
other breast cancer patients (Shamley et al., 2007) as well as posture problems, muscle 
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imbalances and chronic pain (Koehler, 2013). Cheville and Tchou (2007) assert that it is the 
prolonged symptoms that are the biggest threat for AWS sufferers.  
 
More studies find that patients may present with the symptoms of AWS after the three month ǲcut-offǳ suggested by the medical research and that some patients even present with symptoms three 
years post-surgery (Kepics, 2007; Wyrick, Waltke & Ng, 2006). Furthermore, some symptoms 
might disappear naturally while others require physical treatment to resolve.  
 
1.2.5. Treatment of AWS 
Several case studies have shown that manual therapies that target the soft tissues including the 
fasciae are beneficial in treating the symptoms of AWS (Kepics, 2007; Moreau et al., 2010; Fourie 
& Robb, 2009; Tilley, Thomas-MacLean & Kwan, 2009). Pain and shoulder ROM are found to be 
often be returned to premorbid states and the cord can be resolved. The therapies, however, differ 
substantially from each other. Whereas Fourie & Robb (2009) used tissue gliding, mobilisation 
and stretching as primary techniques, Kepics (2007) used cord stretching and heating and cooling 
techniques to work on the limited movement of the shoulder. Fourie & Robb (2009) described a ǲpoppingǳ sound when the cord gave way after stretching it in a longitudinal direction. The stretch 
led to an immediate improvement of the ROM in, especially, abduction of the arm and did not 
appear to have any negative consequences.  
 
Moreau et al. (2010) attempted to test the efficacy of two different treatments: one focused on 
light work with prevention of pain; the other was more painful and utilised more stretching. They 
came to the conclusion that there was no statistically significant difference between the two 
treatments. AWS treatments in the literature seem to have some overlap focusing predominantly 
on the myofasciae, but the effectiveness of particular treatments and which are the most effective 
remains unclear. Davies & Logan (2010), for example, observed reoccurrences of the cord in two 
of their patients after their treatment protocol. The ambiguous results of the treatments reported 
in the literature show that a more standardised and generalised treatment plan is needed for 
patients suffering from AWS. 
 
1.2.6. Gap in the AWS literature 
The burden of AWS is often underestimated by health professionals (Josenhans, 2007) but it is 
unknown whether they undervalue the problem because of (i) the unclear definition of what 
constitutes the disorder, (ii) belief that it is self-limiting or (iii) uncertainty regarding its aetiology. 
Education and improved knowledge of the disorder are essential. Current research lacks a focus 
on the anatomical structures associated with the symptoms as the functional anatomy may 
explain more about the aetiology of the syndrome.  
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A possible role of fascia in the development of the cord and other symptoms is likely because of 
the cordǯs adhesive presentation, its likelihood to be a superficial vascular structure and hence its 
continuity with the surrounding fascia. Fascia, as a previously unexplored area in AWS imaging 
research, may thus provide new insights into the aetiology of the disorder. US imaging was shown 
to reveal fascial differences clearly (Paulssen & Shamley, 2012 [unpublished academic mini-
dissertation]). Manual treatments have been used to treat the symptoms of patients but require 
standardisation and need to be guided by anatomical evidence. Monitoring manual treatment and 
the observation of the structural changes via imaging modalities may thus help determine the role 
of the different anatomical structures, including the fasciae, in relation to the syndrome.  
 
1.3.  Study relevance 
The relevance of the current research project lies with its contribution to the literature on AWS 
that is generally very limited, unclear and that can be contradictory, and that contains little 
previous research on establishing the occurrence of the syndrome in the South African context. 
The current study builds on existing research but adds new perspectives to a field that has confined itself to understanding the cordǯs origins rather than understanding the source of the 
symptomology experienced by the patients. The present study is one of the first studies to 
consider fascia as a contributing factor to the symptoms in AWS and one of very few studies that 
uses both an internal and external approach to determine the anatomical characteristics of the 
syndrome. By using ultrasound imaging before and after physiotherapy that focuses on the 
fasciae, observed changes in symptomology may be explained by changes on the scans. 
Furthermore, a more complete picture of the syndrome is created because of the increased 
number of clinical and demographic variables that are analysed compared to recent studies and 
because of imaging data which give information on the structures involved and could help guide 
future treatments (Wyrick, Waltke & Ng, 2006; Moskovitz et al., 2001; Davies & Logan, 2010).  
 
1.4. Purpose of the study 
From the literature, a flow diagram on how fascia could contribute to AWS symptomology was 
constructed that aided in the design of the current project (see Appendix A). To investigate the 
relationship between fascia and AWS symptoms, the study attempts to address two hypotheses 
and three aims: 
 
Hypothesis 1 
Altered fascia plays a role in the restriction of upper limb movement, the perpetuation of pain and 
the fibrosis and formation of the cord in axillary web syndrome (AWS). 
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Aim 1 
To descriptively relate variables that were found to be (risk) factors in AWS literature to our study 
and the fascia literature to determine fascial involvement.  
I. To obtain demographic and clinical variables from patient records. 
II. To descriptively correlate and describe the outcome measures described under the Aim 2. 
 
Aim 2 
To test the use of ultrasound (US) as an imaging technique for fascia in AWS in patients after 
treatment for breast cancer and to observe whether findings on the ultrasonographs relate to the 
presenting symptoms complex. 
 
Objectives 
I. To determine the anatomical structures involved in AWS through:  
• External observation, i.e. photography of the cord, measurement of the cord length 
and localisation of the cord. 
• Internal observation, i.e. ultrasound (US) and magnetic resonance imaging (MRI). 
II. To measure the range of movement (ROM) manually via a goniometer. 
III. To measure shoulder pain and disability using the Shoulder Pain and Disability Index 
(SPADI) and determine more localised tissue tightness and pain. 
IV. To determine quality of life using the FACT-B questionnaire. 
V. To descriptively correlate and describe the outcome measures described above.  
VI. To compare and contrast the observed morphological characteristics between the 
different patients in the area of interest (the axilla). 
VII. To determine cord presentation in terms of patterns and variations. 
 
Hypothesis 2 
Changes on US images of the cord, fascia and surrounding structures will be evident when the 
cord resolves, or symptoms improve.  
 
Aim 3 
To determine whether changes in fascia on US images can be seen after manual therapy and to 
descriptively relate the US findings to possible changes in the other outcome measures.  
 
Objectives 
I. To evaluate and obtain outcome measures as described for the first aim over time at two 
specific points: before and after the manual treatment.  
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Chapter 2: Literature Review 
 
To understand the possible involvement of fascia to the symptomology of the patients in axillary 
web syndrome (AWS), an overview of the general fascia literature and the fasciae and structures 
in the anatomical area of interest, the axilla, are described in the following chapter.  
 
2.1. Introduction 
Although recent human anatomical research has largely focused on applied anatomy, the fasciae 
as a connective tissue network still remains to be described in detail (Schleip, 2006). Its omission 
from most anatomy atlases shows that the tissues that the fascia encompasses, of which still little 
is known, have not been considered as vitally important (Schleip, 2009). In both educational and 
research spaces the tendency has been to remove the fascia in order to uncover the muscles or 
the organs being investigated, possibly because it was thought not to have a clear function, but 
also because it can be a difficult tissue to understand and research (Guimberteau & Armstrong, 
2015). New technologies such as ultrasound (US), magnetic resonance imaging (MRI) and 
endoscopy make researching the fasciae easier (Langevin & Kawakami, 2012; Guimberteau & 
Armstrong, 2015). Current efforts by numerous researchers to explore the fasciae are adding to 
an expanding field that may aid in understanding diseases that before could not be explained (Van 
der Wal, 2012; Stecco, 2015,). AWS may be one such disorder, and to understand the underlying 
structural changes that have occurred in the syndrome, the basic anatomy of the axilla and its 
contents are described. 
 
2.2.  The anatomy of the axilla  
Stecco (2015) describes the axilla as a pyramidal-shaped cavity that lies between the upper limb 
and the upper part of the lateral thoracic wall. Due to its central position between the two parts, 
it plays an important role in upper limb movement. Many force lines extend through it from the 
different muscles forming its borders and that act on the shoulder joint. The anterior border of 
the cavity is shaped by pectoralis major and minor and the posterior wall by subscapularis 
superiorly and latissimus dorsi and teres major inferiorly. A medial border is lined by the 
intercostals of ribs 1-4 and serratus anterior forming an arched wall with the lateral wall being 
shaped by the conjoining of the anterior and posterior wall. Its inlet is continuous with the neck 
superiorly and allows for passage of major vessels and nerves through it to and from the upper 
limb. Its contents include the infraclavicular part of the brachial plexus that supplies the upper 
limb, numerous lymph nodes important in cancer metastases, and vessels such as the axillary 
artery and vein, fibrofatty tissue and it may contain the axillary tail of the breast (a continuation 
of the mammary glandular tissue) entering it (Standring, 2008). Enveloping and connecting all the 
structures is the fascia.  
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2.3. Fascia  The fascia, or ǲbandǳ in Latin, is described in Gray’s Anatomy as ǲmasses of connective tissue that are large enough to be visible to the unaided eyeǳ ȋStandring, ʹ ͲͲͺȌ. The Terminologica Anatomica describes it as a ǲsheath, sheet or any dissectible aggregate of connective tissueǳ (Stecco, 2015). A 
more recent definition was proposed at one of the first Fascia Research Congresses to incorporate all connective tissue structures and avoid excluding some due to ǲdissectiveǳ anatomical 
terminology (Findley, 2007) as the fascia is a continuous structure rather than comprising 
independent parts. Fascia was described as the ǲsoft tissue component of the connective tissue system that permeates the human bodyǳ ȋSchleip, Jäger & Klinger, 2012). It includes not only the 
fascia underneath the skin (superficial fascia) or enveloping muscles (deep fascia) and organs 
(visceral fascia), but extends to incorporate ligaments, tendons and regionally specialised tissues such as the ǲflat tendonsǳ or aponeuroses. The fascia is seen as a three-dimensional network that 
spreads throughout the whole body, connects to all tissues and has different macroscopic and 
microscopic features depending on the location in which it is found (Abu-Hijleh et al., 2006; Stecco 
& Stecco, 2012).  
 
2.3.1. Components 
Microscopically, fascia consists of fibroblast cells, collagen and elastic fibres and extracellular 
matrix (ECM) (Stecco, 2015). The fibroblast cells allow the tissue to be metabolically active 
whereas the fibres are responsible for the mechanics and the ECM provides malleability (Stecco, 
2015). The ECM forms the scaffold for cells and contains ground substance containing water, 
extracellular proteins, glycosaminoglycans, proteoglycans and collagen and elastic fibres 
(Williams, Holleman & Simel, 1995). Collagen has the highest tensile strength whereas elastic 
fibres provide distensibility (Stecco, 2015). The fibres form fascial fibrils with irregular 
microvacuolar polyhedral shapes which differ in appearance depending on the different types of 
fascia (Figure 2.1) (Guimberteau & Armstrong, 2015). 
 
 
Figure 2.1. The fibril composition of the fasciae. Photo courtesy of Jean-Claude Guimberteau, 2015. 
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2.3.2. Classifications  
The fasciae are of the subtype connective tissue proper and can be found to be loose or dense.  
 
Loose connective tissue, sometimes called areolar tissue, is the most abundant in the body with 
an increased amount of ECM and the preponderance of adipocytes (Benjamin, 2009). The collagen 
in loose connective tissue is dispersed multi-directionally, offering a framework in which the 
adipocytes are interspersed (Stecco, 2015). Its components make it a gel-like tissue (Day, Stecco 
& Stecco, 2009). It is found in the hypodermis of the skin but also between muscles and organs, 
and allows for independent movement by providing a gliding surface to reduce friction between 
neighbouring planes (Stecco et al., 2006; Stecco et al., 2011). 
 
The dense connective tissue contains much stronger and organised collagen and is packed very 
densely with few cells (Stecco, 2015). Dense connective tissue, due to its highly structured 
architecture, is able to resist mechanical stressors put on it (Day, Stecco & Stecco, 2009; Huijing, 
2003). Several different types are classified: dense irregular connective tissue is found within the 
dermis and as part of the superficial fascia, and dense regular connective tissue that makes up the 
deep fascia, visceral fascia, tendons and ligaments (Schleip, Jäger & Klinger, 2012).  
 
It is important to note that, contrary to anatomical thinking, the fascial tissues are not distinct 
entities but more regional specialisations and are continuous with one another throughout the 
body (Guimberteau & Armstrong, 2015). Figure 2.2 illustrates the body-wide three-dimensional 
connective tissue network of the fasciae connecting skin to bone. The different subsections of 














Figure 2.2. A cross-sectional schematic of the fasciae from epidermis to cancellous bone. The independent 
components of the superficial fascia are not shown but are instead highlighted. DAT=deep adipose tissue, 
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2.3.3. Superficial fascia 
The first clear layer of the fascial system, called the superficial fascia (SF) or hypodermis, is located 
below the dermis and epidermis, which contains a dense network of connective tissue, and 
comprises different sublayers with a clear structure (Lancerotto et al., 2011).  
 
Anatomical research using cadaveric dissections revealed that the superficial fascia has a 
membranous layer with sometimes multiple lamina, which may be found within the tissue with a 
layer of adipose tissue superficial to it (superficial adipose tissue or SAT) and below it (deep 
adipose tissue or DAT) (Figures 2.2 and 2.3a) (Stecco et al., 2009; Chopra et al., 2011). The 
membranous layer sprouts off different fibrous septa or skin ligaments that connect to the dermis 
(retinaculum cutis superficialis) and to the deep fascia of the muscle (retinaculum cutis profundis) 
providing a physical link (Figure 2.3b) (Stecco & Stecco, 2012). Surgically, however, it appears to 
blend with its skin ligaments and may not be a distinct layer (Guimberteau & Armstrong, 2015). 
Guimberteau and Armstrong (2015) suggest that the layer should rather be seen as a 
reinforcement of the fascia fibrils. The discrepancy between the views may arise from the 
methodology of dissecting an embalmed and dehydrated structure in cadavers versus observation 
in vivo during surgery (Guimberteau & Armstrong, 2015), making the tissues appear more dense 
than they are in a living body. 
 
The membranous layer was previously thought to be confined to the abdominal wall exclusively, 
but has since recently been shown by several authors to be present all around in the body (Abu-
Hijleh et al., 2006; Chopra et al., 2011) in different appearances. The thickness of the layer is 
dependent on the location within the body (thicker in the lower limb than upper limb), the 
anatomical position (posteriorly thicker than anteriorly) and on the sex of the individual (thicker 
in women than in men) (Huerta & García, 2007). The adipose content of the SF depends on climate 
(higher in colder climates), body habitus (increased in obese individuals) and sex (increased in 
women) (Standring, 2008). The skin ligaments themselves can be absent or very prominent or a 
more fibrous or fatty appearance may be found (Stecco & Stecco, 2012). The appearance relates 
to the functional mobility the tissues require – fewer and longer skin ligaments are found in areas 
that require increased mobility, for example, providing the ability of the dermis and SF to move 
independently over the muscle (Stecco & Stecco, 2012). 
 
Functionally, as the SF layers comprise mainly elastic fibres it allows, together with its extensions 
to the dermis, for continuous endogenous tension onto the dermis (Standring, 2008). The so-called Langerǯs lines or skin tension lines provide tissue memory permitting the skin upon stretch 
to return to its original shape (Crumpler & Ghaudhry, 2001; Borges & Alexander, 1962). Aging 
decreases the elastic abilities of the tissues which is a proposed reason for the development of 
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wrinkles (Abu-Hijleh, Dharap & Harris, 2012). SF also provides a framework for vessels (Figure 
2.3c), lymphatic vessels (Figure 2.3d) and nerves which it invests in (Standring, 2008). The 
















Figure 2.3. Fascia investing in different tissues. (a) The framework of the superficial fascia investing into the 
adipose tissue, (b) the close connection of the superficial fascia to the deep fascia, (c) investing fascia into the 
wall of a vein, (d) fascia surrounding the lymphatic vessels, shown on the blue paper. AT=adipose tissue, 
DF=deep fascia, LV=lymphatic vessel, SF=superficial fascia, V=vein. Photos courtesy of Jean-Claude 
Guimberteau, 2015. 
 
The vessels and nerves are located in different parts of the SF as explained by Stecco (2015). The 
arteries run both perpendicularly and longitudinally to the dermis forming networks or plexi in 
the SAT and membranous layer. Communicating veins that transverse the different layers are 
predominantly present in the SAT and DAT connecting to horizontal veins in the membranous 
layer. The lymphatic veins form plexi close to the skin and send off shoots along the skin ligaments 
as they have thin walls and require support, then anastomose within the membranous layer to the 
bigger vessels running in the DAT where lymph glands are also located. Nerves form small plexi 
close to the skin which connect to Ruffini and Pacini corpuscles in the SAT and membranous layer 
of the SF and respond to stretch and compression respectively. They connect to bigger nerves in 
the DAT which run obliquely to reduce shearing force on them, preventing damage. The different 
layers also contain many free nerve endings responsible for sensing pain (Myers & Frederick, 
2012).  
 
The general features described above are more specifically adapted in the fascia of the breast, 
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2.3.3.1.  The superficial fascia of the breast, axilla, upper limb and shoulder 
The superficial fascia (SF) of the thorax is continuous with the superficial fasciae of the breast, 
axilla, upper limb and shoulder (Stecco & Stecco, 2012). Dissection of the breast in a woman 
highlights a continuous layer of membranous fascia within the superficial fascia encompassing the 
mammary gland (Stecco, 2015). The axillary fascia results from the junction of the superficial fascia of the thorax, upper limb and back and unites with the surrounding musclesǯ deep fasciae 
(Stecco & Stecco, 2012). The SF in the axilla contains holes that contain fibrofatty tissue which 
allow vessels and nerves to pass through (Standring, 2008). The DAT lying within the cone of the 
axilla is especially clear in patients with higher BMIs (Stecco, 2015). Stecco and Stecco (2012) 
furthermore describes that the SAT and DAT of the upper limb and shoulder have less adipose 
tissue making the SF a thinner structure there. At bony points and others, such as at the inferior 
border of the deltoid muscle, the superficial fascia also merges with the deep fascia forming 
anatomical compartments (Stecco, 2015).  
 
2.3.4.  Deep fascia 
Compared to its superficial counterpart, the deep fascia is closely connected to the musculature 
which is called myofascial continuity (Gautschi, 2012) (Figure 2.4a). The deep fascia is described 
as consisting of organised, dense layers (Benetazzo et al., 2011). The deep fascia also includes the 
aponeurotic fasciae that forms thickened sheaths into which muscles can insert via myofascial 
expansions and shape anatomical compartments (Figure 2.5a), and is related to providing 
strength and resisting force (Stecco, 2015). It also includes the epimysial fascia which envelops 
individual muscles and interacts with their fascicles closely (Stecco, 2015) (Figure 2.4b). The close 
connections to muscular tissue highlights an important role of the tissue in the biomechanics of 
the musculoskeletal system (Fourie, 2012), comprising the bones, muscles and fasciae extending 









Figure 2.4. Fascia investing in muscle. (a) The deep fascia investing closely to the muscle, (b) the deep fascia 
extending between the muscle fibres forming the perimysium. SF=superficial fascia, DF=deep fascia, 
M=muscle. Photos courtesy of Jean-Claude Guimberteau, 2015. 
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On a smaller level, the perimysium separates the different muscle bundles or fascicles (Figure 2.4) 
which connect to the endomysium, which in turn, divides each bundle into muscle fibres (Stecco, 
2015; Guimberteau & Armstrong, 2015). Whereas the endomysium is thought to be more involved 
with metabolic control and smooth gliding, the perimysium is involved with force transmission 
and is part of the epimysial fascia (Purslow, 2010; Stecco, 2015). 
 
The mechanical abilities of the deep fascia are dependent on the stiffness of the tissue. The 
stiffness, resulting from ECM composition, leads to other biomechanical properties such as force 
resistance to force and load (Schleip, Jäger & Klinger, 2012). Increased collagen content makes the 
tissue more resilient to forces (Guimberteau, 2012). How the fascia may adapt to force load is also 
subject to the smooth gliding between different layers and the collagen alignment (Oschman, 
2012). Depending on the location in the body, the tissues present with different layering (Stecco, 
2015). Aponeuroses, consisting of multiple layers that are aligned in different directions, appear 
to be able to resist force in multiple directions (Langevin et al., 2009). Between each layer one can 
find areolar tissue or a layer of hyaluronan, a lubricant produced by hyaluronan-producing cells 
of fibroblast lineage, both of which allow for smooth movement and reduced friction (McCombe, 
2012). The lubricated layer is also present between the muscle and the epimysial layer and 
between each collagen fibre.  
 
Smooth limb movement is an interplay of muscle contraction and relaxation which is regulated by 
deep fascia receptors called muscle spindles (Fourie, 2012). The muscles spindles provide 
proprioceptive information to the central nervous system on the state of muscle contraction and 
positioning of the body (Stecco, 2015). Activation of the muscle spindles due to the stretching of 
the epimysial fascia and DAT results in reduced muscle activation to prevent overexertion (Stecco 
et al., 2009a). The fascia is then able to modulate muscle activity responsible for controlling 
quality of movement (Fourie, 2012). As muscles or portions of muscles are activated, specific 
areas of the deep fascia are stretched which together with nerve receptors allow for mutual 
feedback between the two tissues (Stecco, 2015).  
 
2.3.4.1. The deep fascia of the breast, axilla, upper limb and shoulder 
The deep fascia of the trunk consists of three laminae of connective tissue that provide 
independent gliding planes for the different muscles they envelop, but form an anatomical 
continuity (Figure 2.5) (Stecco, 2015). The myofascial layers are: the thickest, superficial lamina 
that surrounds pectoralis major below the mammary gland, latissimus dorsi and surrounds 
sternocleidomastoid and trapezius posteriorly; the middle layer that envelops the pectoralis 
minor, serratus anterior and extends to the back and abdomen; and the deep layer which 
incorporates mostly intercostal and abdominal muscles before it extends to the back. 
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The superficial lamina over the pectoralis major is its fascia, which is sometimes removed but 
most often damaged during mastectomies (Lacomba et al., 2010; Fourie, 2008), and sends 
multiple fibrous septa into the muscle between the different muscular fibres (Stecco et al., 2009a). 
Stecco (2015) describes that the pectoralis major fascia consists of two layers and attaches 
laterally to the deltoid fascia and axillary fascia after it continues to become brachial fascia. Over 
serratus anterior the double-layered structure becomes one, but remains bilayered to encompass 
latissimus dorsi posteriorly where it also envelops deltoid. Medially, the superficial layer is 
continuous with the contralateral pectoralis fascia whereas the deep layer invests into the 
sternum. The superficial layer has expansions that extend towards the brachial fascia and form 
lines of force.  
 
The axillary fascia connects to the superficial lamina and has a cone shape (Stecco, 2015; 
Standring, 2008). It is continuous with the brachial fascia towards the upper limb, serratus 
anterior medially and posteriorly with the latissimus dorsi. Multiple connections exist between 
the shoulder girdle and axillary fascia, resulting in many different force lines acting on it, forming 
the oval window (see Figure 2.5c) (Stecco, 2015).  
 
The middle lamina of the deep fascia of the trunk forms the clavipectoral fascia that envelops 
predominantly pectoralis minor but becomes the axillary suspensory ligament (Figure 2.5d). The 
structure allows the axillary contents to be lifted up upon arm movement (Stecco, 2015). It also 
forms a costocoracoid ligament that isolates the axillary cavity from the thorax anteriorly.  
 
The deep lamina incorporates serratus anterior, subscapularis and subclavius. At the shoulder 
joint the three lamina join with the subdeltoid bursa and posterior part of glenohumeral joint 
(Stecco, 2015).  
 
2.4.  Biotensegrity and fibrillar chaos 
To understand the global biomechanical consequences of a continuous system in the mobile axilla 
highlighted in the sections above, one can refer to the concept of biotensegrity. Biotensegrity applies the architectural term ǲtensegrityǳ to the human body (Chaitow, 2014). Tensegrity, a 
combination of the words tension and integrity, has the premise that a structure consisting of 
separate elements can exist with the elements not touching one another due to their connection 
to elastic continuously tensed elements (Levin & Martin, 2012). The link provides a tension- 
compression system that can resist forces by transmitting and redistributing the forces (Levin & 
Martin, 2012). In the context of the human body, tensegrity explains that the skeleton is not the 
main scaffold but rather is suspended within the fascia (Chaitow, 2014). 
 






















Figure 2.5. Fascial anatomy of the shoulder girdle and axilla. (a) The continuity of the fascia and the 
myofascial insertions into the muscles (see arrows). (b) The posterior aspect of the arm and the continuity of 
the fascia overlying the muscles (see arrow). (c) The oval window in the axilla formed by the different fasciae 
meeting there and the fibrofatty tissue inside the axilla. The arrows denote the different fascial directions 
forming the window. (d) The undissected axilla with the clavipectoral fascia extending towards it forming the 
suspensory ligament (see arrow). Note the continuation of the fascia over coracobrachialis. AF=axillary 
fascia, BB=biceps brachii, BF=brachial fascia, CB=coracobrachialis, CF=clavipectoral fascia, DF=deltoid 
fascia, IS=intermuscular septum, LDF=lattismus dorsi fascia, OW=oval window, Pm=pectoralis minor, 
PmF=pectoralis minor fascia, PM=pectoralis major, TMF=teres major fascia.  
Photos courtesy of Carla Stecco, 2015. 
 
Further evidence for the biotensegrity system in the human body is highlighted by Guimberteau 
and Armstrongǯs visualisation of the fascia on a mesoscopic level.  
 
Using endoscopic intratissular videophotography, the fascia is highlighted as a chaos of fibrils that 
are able, due to their dynamic ability, to split from one another and re-attach, with its web-like 
architecture to act as a shock-absorber (Guimberteau, 2015). Furthermore, they can resist forces 
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2.5.  Remodelling and the inflammatory response 
Tensional forces across the tissue not only provide it its shape, but also aid in remodelling and 
restoring the tissue to its original mould when damaged (Fourie, 2012; Guimberteau, 2015). The 
fibroblasts that produce the ECM and fibres are involved with remodelling the tissues in response 
to physical demands (Purslow, 2010). According to Wolffǯs law, bone is remodelled in the 
direction of force put on it (Oschman, 2012). The remodelling reaction is also observed in fascia 
where collagen fibres are realigned in the direction of force (Oschman, 2012). Remodelling avoids 
a compressive load on the fascia and strengthens the fascia in that direction (Levin & Martin, 
2012), dynamically adapting to the situation. 
 
Upon tissue injury, i.e. when tissue integrity is lost, a wound-healing cascade is activated in which 
inflammatory cytokines are released and inflammation occurs (Van den Berg, 2012). More fibre-
producing fibroblasts then enter the tissues to produce granulation tissue and changes to the ECM 
occur. Granulation tissue consists of a weaker form of collagen (type III) but which gets replaced 
with a stronger type I collagen as the scar matures (Van den Berg, 2012). Some fibroblasts then 
specialise to myofibroblasts which can contract and aid in closure of the wound (Van den Berg, 
2012) in response to the tension force lines on the tissue. The ability of the skin to restore integrity 
under non-pathological circumstances via the wound-healing cascade is important for it to regain 
its original form and tension, although the tissue quality will be reduced (Fourie, 2008). 
 
Chronic inflammation can, however, occur as a result of too much damage or if the tissue is 
irritated continuously during the healing process. Fibrosis, or the excessive deposition of collagen 
under the influence of TGF-B, is laid down haphazardly as a means to restore tissue integrity in 
the form of a scar (Fourie, 2012). Furthermore, neighbouring tissues can also become affected due 
to the widespread cytokine release leading to changes beyond the original insult. 
 
2.6.  Pathology and functional consequences 
The consequences of chronic inflammation are manifold and can result in both structural changes 
and functional limitations. In terms of structural alterations, Stecco (2015) makes a differentiation 
between fibrosis and densification. Fibrosis is the laying down of excess collagen in a haphazard 
way in a pathological situation as a result of chronic wound-healing such as in a scar. Fibrosis may 
be visualised on imaging by an increase in echogenicity on US (Langevin et al., 2009). On the other 
hand, densification is explained as any change in the composition of the loose connective tissue 
components including adipose tissue, glycosaminoglycans and hyularonan (Stecco, 2015). 
 
Structural changes such as those resulting from repetitive stress injuries, strain and over-use can 
lead to alterations in the viscosity of the fascia. ECM is replaced, making the tissue stiffer and the 
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ability of the fascia to absorb stressors is diminished (Stecco & Stecco, 2012). Fibrosis, when ECM 
has become replaced by rigid collagenous tissue, may show a similar effect. Furthermore, a stiffer 
tissue does not permit regular stretch of the spindles, which has been hypothesised to lead to an 
inability of certain muscle parts to be activated, affecting joint movement and causing pain 
(Stecco, 2015). Conversely, stretching of the myofascial expansions linking to a thickened 
epimysial fascia can lead to chronic activation of the spindles and subsequent muscles which are 
in a continuously contracted state leading to joint impairments and pain (Stecco, 2015). 
Furthermore, chronic contraction can lead to antagonistic and synergistic imbalances in 
movement and proprioception (Stecco et al., 2009b). 
 
Adhesions, or the adhering of two planes of tissue, may occur when damaged tissue is further 
irritated after initial healing (Fourie, 2008). Adhesions may cause pathological force lines in the 
fasciae and affecting strain on other tissues. Due to the continuity of the system explained by 
biotensegrity (Gautschi, 2012), adhesions may have body-wide consequences. Myofascial trigger 
points (MTPs) are localised areas of muscle tightening, with fascial shortening and adhesive cross-
links (Gautschi, 2012). Any fibrotic change, as seen in MTPs to fascial layers, has been 
hypothesised to lead to ischeamia (Distler, 2007). As a result, fascial scars and taut bands develop 
within the deep fascia that lead to restricted movement (Gautshi, 2012). Restricted mobility can 
lead to poor posture and resultant strain on muscles and joints via force lines in the affected area. 
 
Furthermore, adhesion between multiple fascial layers can prevent smooth movement upon 
normal stretch or muscle contraction and lead to the overactivation of nociceptors and resultant 
pathological symptoms such as pain (Gautshi, 2012). Abnormal changes, such as adhesions, may 
be visualised using imaging modalities.  
 
2.7.  Fascial imaging 
Many different imaging techniques have been used to visualise fascia. However, fasciae are not 
typically examined by radiologists and hence there is limited research that describes normal and 
abnormal fasciae on imaging modalities (Langevin & Kawakami, 2012). Normal fascia on CT scans 
shows hyperdense layers and hypodense adipose tissue (Ozturk et al., 2012). On MRI, normal 
fascia shows both hypodense signals on T1- and T2-weighted imaging (Langevin & Kawakami, 
2012) and adipose tissue is enhanced (Stecco et al., 2014). On ultrasound (US), the fascia presents 
as echogenic lines and fractions with hypoechoic layers of adipose tissue (Langevin et al., 2009). 
Although CT and MRI can show the location of the different planes more easily, US gives more 
structural detail permitting the researcher to measure structural features (Langevin & Kawakami, 
2012). Furthermore, US is cost-effective and is able to show tissues moving dynamically (Leduc et 
al., 2014). Dynamic observation allows the analysis of tissue glide as shown in a study by Langevin 
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and colleagues (2011). Some researchers favour US over MRI because of the ability of US to 
distinguish better between tissues containing a fibrous component such as in fibromas (McNally 
& Shetty, ʹͲͳͲȌ. The major limitation of US imaging is the operatorǯs skill and experience in 
utilising the technique (Luomala et al., 2014). In addition, a requirement to analyse fascia is a full 
understanding of its structure and any abnormalities related to it (Stecco, 2015).  
 
2.8.  Fascial abnormalities on US imaging 
Several studies that use US have shown fascia abnormalities to be implicated in pathology. Findley 
(2012) describes a case where fascia continuity was disrupted in the abdominal fascia in a car 
accident with continued pain in the area years later. Langevin and colleagues (2009; 2011) 
showed in two subsequent studies fascial thickening on US and, using gliding potential analysis, 
that there was less shear strain, indicating an inability for smooth fascial glide in patients with 
lower back pain, possibly leading to the symptoms. Wearing (2012) describes thickened plantar 
facia in plantar fasciitis, correlating to collagen degeneration and fibre disorientation. Chronic 
contraction of muscle can lead to all the findings (Myers & Frederick, 2012).  
 
Day and colleagues (2009) found in their study of chronic neck pain that there was increased 
fascial thickness which correlated to reduced smooth movement, affecting ROM of the muscles 
and pain. The authors hypothesised that the symptoms are caused by an increase in the density 
of the hyaluronic acid which results in stiffness. Axillary fascia has been thought to become 
densified in overuse syndromes of the shoulder (Stecco, 2015). Changes in hyaluronic acid in 
another study were found to possibly contribute to pain, inflammation and loss of function (Lee 
& Spicer, 2000).  
 
Apart from visualising the structural and functional anatomy, the non-invasive imaging modalities 
are able to give specific direction to treatment but can also monitor tissue changes during 
treatment (Findley, 2012). Physiotherapy treatment has been particularly effective in treating 
some individuals with fascial-related pathology. 
 
2.9.  Physiotherapy 
Immobility and pain due to scar tissues and adhesions can be very debilitating and are often seen 
by physiotherapists. Furthermore, long-term immobilisation can lead to permanent movement 
morbidity and an inability to return to prior level of mobility (Van den Berg, 2012), e.g. as a result 
of shoulder joint stiffening (Schultheis et al., 2012).  
 
Tissue stiffness and mobility of the joints appear to be alleviated by manual therapies and fascial 
stretching. Stretching has been suggested to lead to functional changes in the abnormal tissues, 
causing the increased remodelling of collagen and allowing the structure to modify according to 
new demands (Myers & Frederick, 2012).  
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Another proposed mechanism to explain how the fascia becomes more fluid upon stretching is by 
the release of water from the ground substance changing the matrix, making the tissue more 
pliable and possibly altering fibroblasts and their production of collagen (Schleip, 2012; Meert, 
2012). Bouffard and colleagues (2008) found that stretching scar tissue induced in mice for ten 
minutes twice a day, for one week, caused a decrease in both TGF-B and collagen. Other 
suggestions include skilful activation of mechanoreceptors that stimulates receptors that might 
have been stuck in fibrotic tissue in order to ǲre-educateǳ and loosen the receptors (Schleip, 2003). 
Deep friction, on the other hand, has been thought to improve perfusion and healing (Van den 
Berg, 2012). A study by Yang and colleagues (2005) showed that regular stretching of tendons 
had an anti-inflammatory response which also improved homeostasis of the tissues.  
 
Adhesions and MTPs can be identified by manual palpation by a physiotherapist. Using a 
myofascial release technique was found to restore independent muscle gliding, improve 
coordination between neighbouring myofascial structures and improve fluidity of the tissues 
(Fourie & Robb, 2009). It also allows the therapist to break membranes that have become 
adherent (Bouffard et al., 2008; Myers, 2012) by using shear stress on one layer to move it relative 
to the other. One of the few studies looking at fascia with imaging post-treatment highlighted a 
reduction in fascial thickness to normal levels and was shown to reduce pain and disability (Stecco 
et al., 2014). Manual treatment may thus be effective in modifying fascia. 
 
From the literature one can observe that damaged, fibrotic or densified fasciae may be related to 
symptoms of pain and impaired movement due to anatomical or physiological restrictions. Few 
studies have looked at the link between symptomology and anatomy in detail and have noted 
specific characteristics that one can extrapolate to other diseases in which injured fascia may be 
implicated. Only one study used imaging to observe changes after physiotherapy treatment 
(Stecco & Stecco, 2012). The current studyǯs approach to AWS, which has an obvious puckering 
and adhesive presentation, will describe US features and relate pre- and post-physiotherapy and 
affected and unaffected arm ultrasonographs. US alignment will be used to observe wider fascial 
involvement and to relate the patientǯs symptoms through methodical and limited statistical 
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Chapter 3: Materials and Methods 
 
The findings of the study are reported using the Equator Standards for Reporting (Equator, 2013). 
The current study complied with the Helsinki Declaration (World Medical Association, 2008). 
 
3.1.  Study design 
The present study is both qualitative and quantitative in nature. It is a predominantly descriptive, 
observational, pilot, proof-of-concept study with a case-series design that focused on the use of 
ultrasonography (US) to detect the fasciae in the axillae of women presenting with axillary web 
syndrome (AWS). The study adhered to the guidelines for the Development and Evaluation of 
Randomised Control Trials for Complex Interventions to Improve Health and was a Phase 1 study 
(Medical Research Council, 2000). The current  study attempts to develop a greater understanding 
of the underlying clinical syndrome of AWS and, specifically, the anatomical structures focusing 
on the fasciae present on US images of the cord and surrounding tissue. Furthermore, evidence 
that is generated may contribute to knowledge of the therapeutic intervention in relation to the 
disorder (Medical Research Council, 2000).  
 
3.2. Researcher training and consultations 
The researcher obtained training to operate the US machine during his Honours degree from a 
doctor of anatomy who was skilled and experienced at performing US. Furthermore, training 
exercises to understand the anatomy of the axilla were done on peers and self to familiarise the 
researcher with the observations before scanning and analysis. The researcher also consulted 
with researchers in the field of AWS, the team physiotherapist, a radiologist regarding radiology 
treatment, obtained surgical advice from a professor in surgery and was guided by his supervisors 
who are anatomists. Furthermore, to improve insight into the treatment procedure, the 
researcher observed a unilateral and bilateral mastectomy with axillary clearance done in an 
oncology theatre at Groote Schuur Hospital.  
 
3.3. Characteristics of the study population 
The study included patients treated for breast cancer who presented with AWS (n = 11 patients). 






- 22 - 
 
Table 3.1. Inclusion and exclusion criteria for patients during recruitment. 
Inclusion criteria Exclusion criteria 
Age 18 years or older Unable or unwilling to consent 
Afrikaans/English speaking 
Surgical treatment for breast cancer (uni- or bilaterally) 
with/without adjuvant treatment 
Presence of cording with/without pain and reduced ROM 
 
 
3.3.1. Study sites 
The research study sites were the Department of Radiation Oncology at Groote Schuur Hospital 
(GSH) at six-month oncology check-up appointments at which patients were screened for AWS 
after breast cancer treatment for a total of six months, the GSH Ultrasound Unit (C10) for the first 
and second measurement cycle of the study and at our team physiotherapistǯs private 
physiotherapy clinic where the patients received their physiotherapy treatments. 
 
3.4. Recruitment and enrolment 
Following ethics approval from the University of Cape Town Faculty of Health Sciences Human 
Research Ethics Committee (HREC: 423/2013), active recruitment took place in the GSH 
Department of Radiation Oncology. The patients who presented for their follow-up appointment 
were approached by the researchers to ask if they were experiencing any problems after breast 
cancer treatment. Probing and selective questions (Table 2) were used to screen whether the 
patient was experiencing the problems that might indicate AWS. The primary diagnostic criterion 
was a web of axillary skin with a palpable cord(s) that tensed up with abduction of the shoulder 
and extended along the ipsilateral arm towards the thumb. The cord or web could be accompanied 
by secondary symptoms of decreased ROM of the upper limb and pain in the arm and around the 
area of surgery.  
 
Table 3.2. A list of questions used to identify potential patients with AWS. 
Sample probing questions asked of patients during recruitment  
Do you speak Afrikaans or English? YES NO 
Are you here for a breast cancer check-up? YES NO 
Have you received surgery for breast cancer? YES NO 
Are you having any problems that came about after the treatments? YES NO 
Are you feeling any pain in the shoulder and/or armpit?  YES NO 
Are you having problems in moving your shoulder on the treated side? YES NO 
Do you feel any pulling in the armpit? YES NO 
Do you feel a cord or tight structure when lifting your arm? YES NO 
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If the patient was identified as experiencing the clinical symptoms of reduced ROM, pain and 
axillary tightness, a clinical exam was carried out by the supervisor in a private room for 
inspection of the axilla for the presence of cording. After positive identification, the researcher 
would sit down with the patient to go through the study information leaflet (see Appendix B) and, 
if the patient was interested in participating, the researcher would ask the patient to fill out their 
contact details and name on a reply slip (see Appendix B) so she could be contacted for the first 
appointment of the study.  
 
Due to the difficulty of recruiting patients via the manner described above, patients that presented 
with AWS during recruitment for a second study by the supervisor were also approached for 
participation after presenting with the required symptoms during a questionnaire.  
 
During the patient sampling stage (Diagram 3.1), the researcher identified 156 potential patients 
that were screened for AWS. Of the potential patients, 35 patients were experiencing the 
symptoms indicative of the syndrome of which only 21 patients actually presented with one or 
multiple axillary cords. The patients with the cording were then approached for further 
participation, of which only eleven patients were willing or able to enter the study.  
 
Diagram 3.1. Patient sampling procedure. 
 
Total breast cancer 
patient sample GSH 







Included patients with 
cording after 
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After the first US appointment, four patients dropped out due to socioeconomic pressures (one), 
cord resolution before the physiotherapy appointment (two) and one who did not respond to 
phone calls for physiotherapy. Seven out of eleven patients received up to six physiotherapy 
treatments after which six took part in the second measurement cycle. One patient was too ill to 
continue with her physiotherapy treatment and had to withdraw. After recruitment the drop-out 
rate of the study was five patients. 
 
3.5. Research procedure 
3.5.1. Patient consent and first measurement cycle  
At the first appointment in the Ultrasound Unit (C10) of GSH, the participant was informed about 
the aims and objectives of the study. A full explanation of the study procedure, the risks and the 
benefits of participation were given to the patient at the first appointment. Patients were given 
the opportunity to discuss anything that was unclear. The participant was also notified that any 
transport fees to commute to the research locations would be reimbursed. 
 
When the patient had read the consent form for the study (see Appendix B), which was drawn up 
in accordance to the Standard Operating Procedures provided by the UCT Faculty of Health 
Sciences Human Ethics Committee, she was asked to sign the consent form that was co-signed by 
a member of the research team for proof of acceptance. By giving consent, the patient agreed to 
participate in the study and allowed the researchers permission to obtain clinical and 
demographic information from her healthcare professionals and the hospital files (see Appendix 
E). 
 
Once the patient consented, data collection occurred in the following measurement sequence. 
First, the SPADI (Shoulder Pain and Disability Index) questionnaire and the FACT-B (Functional 
Assessment of Cancer Treatment-Breast) questionnaire to measure quality of life were filled out. 
After the questionnaires, ROM (range of movement) of both her shoulders was measured and the 
cord was photographed, documented and measured (see Appendix C+D; Collection Sheet A (i) and 
(ii)). Lastly, the participant underwent US scans on both affected and unaffected sides. The data 
collection measures are detailed below.  
 
3.5.2. Patient physiotherapy treatment  
After the first measurement cycle, the patient underwent treatment by a physiotherapist on the 
team. The treatment focus and goals were determined by the standard norm of the therapist for 
the treatment of AWS. An impairment-based treatment approach (Fourie & Robb, 2009) was used 
to address the personal needs of the patients but set within limits to maintain standardisation 
across all participants.  
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The literature suggested that approximately six to thirteen treatments of 30 minutes each spread 
over one to two months was sufficient for resolution of all the symptoms of AWS (Josenhans, 2007; 
Moreau et al. 2010; Fourie & Robb 2009). The number of treatments for each individual patient 
was established by the physiotherapist depending on the severity of the symptoms, but a limit of 
no more than six treatments was given due to time constraints of the study. Each treatment 
session lasted about an hour and a homework programme was issued to all patients tailored to 
their specific needs. The physiotherapist assessed patients independently and prescribed 
treatment accordingly. The specifics of each treatment and the patient symptomology and 
improvements were documented by the physiotherapist (see Appendix F and G; Data Collection 
Sheet C and physiotherapist notes). 
 
3.5.3. Second measurement cycle 
When the physiotherapist had decided on the last physiotherapy session (treatment six or fewer, 
depending on how much improvement could still be made), the participant was asked to return 
within a week of her last appointment for a second measurement cycle. The second cycle entailed 
the same procedure as the first measurement cycle.  
  
3.5.4. Patient-reported outcome measures and data collection methods  
3.5.4.1. Shoulder pain and disability index (SPADI) The SPADI is a reliable and sensitive patient reported outcome measure of patientsǯ experience of 
pain and disability (Williams, Holleman & Simel, 1995). The questionnaire gives independent 
scores for pain and disability which were used for data analysis. The questionnaire contains two 
domains: pain and disability. The pain domain contains five items and the disability domain 
contains eight items. All of the items are questions relating to how much pain and how much 
disability the patient experiences. The items are answered by using a scale from 0-10 with 0 
indicating ǲno painǳ and 10 ǲthe worst pain imaginableǳ. For each domain the scores are made up 
of the addition of all individuals item scores giving a maximum score of 130 for the whole 
questionnaire. A total SPADI score is given as a percentage of the maximum score. The higher the 
score the more disability and pain the patient experiences. The patient filled in the questionnaire 
by herself but, in case anything was unclear, the researcher would assist in answering the 
questions, avoiding any bias in their answering.  
 
3.5.4.2. Functional assessment of cancer treatment – breast (FACT-B) 
The FACT-B is a well-validated, multi-dimensional patient self-report questionnaire which 
measures physical, social, emotional and functional well-being and additional breast cancer 
concerns in separate subscales (Fallowfield et al., 1999). Its psychometric properties show high 
reliability and internal consistency and is simple and quick to fill out (Fallowfield et al., 1999). The 
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patient filled in the FACT-B questionnaire by herself after the SPADI. If she needed any 
clarification, the researcher would help but made sure to avoid any bias. The questionnaire is 
divided into five sections: Physical, Social, Emotional, Functional and Additional, with questions 
in each around those themes. Each question is worth 4 marks with a total score of 140. The higher 
the score, the better the quality of life measure. 
 
3.5.4.3. Shoulder range of movement (ROM) 
Active shoulder ROM of the patient was measured using a standard goniometer, which has high 
inter-observer reliability (Johansson et al., 2001). Only active movements were measured as they 
were considered to be the best representation of the patientsǯ dysfunction and debilitation. The 
patient was asked to stand with her back towards a wall so that bony landmark points at which 
the goniometer would be positioned could be marked on the patient with a washable pen (Figure 
3.1). The patient was then asked to abduct and forward flex her arm. After that she was asked to 
move with her face towards the wall and extend her arms as far as possible within her levels of 
pain and discomfort. Lastly, the patient was asked to lie on her stomach on the plinth for 














Figure 3.1. Locating the bony landmark and marking it with a ballpoint pen.  
Permission was obtained from the model. 
 
For abduction, the goniometer axis was placed at the anterior aspect of the glenohumeral joint, 
1.3 cm inferior and lateral to the coracoid process. The stationary arm was held parallel to the 
sternum and the moveable arm parallel to the longitudinal access of the humerus (Clarkson & 
Gilewich, 1989) (Figure 3.2). 
 











Figure 3.2. Goniometric measurement of abduction. Permission was obtained from the model.  
 
For forward flexion and extension, the goniometer was placed at the lateral aspect of the centre 
of the humeral head, 2.5 cm inferior to the lateral aspect of the acromion process. The stationary 
arm of the device was held parallel to the lateral midline of the trunk, whereas the moveable arm 













Figure 3.3. Goniometric measurement of extension (left) and forward flexion (right).  
Permission was obtained from the model. 
 
 
For internal and external rotation, the patient was asked to lie in prone position on the plinth 
with her elbow in a 90° angle. The bony point of interest was marked and the patient was asked 
to move the lower arm as far back as she could for internal rotation of the shoulder and forward 
for external rotation. Measurements were taken at the highest and furthest points the patient 
could move within pain and discomfort levels. For internal and external rotation, the goniometer 
axis was placed on the olecranon process of the ulna, with the stationary arm perpendicular to the 
floor and the moveable arm to the longitudinal axis of the ulna towards the ulnar styloid process 
(Clarkson & Gilewich, 1989) (Figure 3.4). 
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Figure 3.4. Goniometric measurement of external (left) and internal (right) rotation.  
Permission was obtained from the model. 
 
3.5.4.4. Cord length 
Whilst lying on the plinth in supine position, the participant was asked to abduct and externally 
rotate her arm to her maximum within levels of pain and discomfort, which would allow for full 
exposure of the cord. The length of the cord was then determined using digital callipers from the 
points of visual and palpable tethering (Figure 3.5). Cord length was measured with a measuring 
tape in a previous study (Leduc et al., 2009). There is, however, little information on the validity 
and reliability of using the measuring tape method. Digital callipers are widely used in other 
clinical measurements due to it being a valid and reliable measurement tool (Ebaugh, Spinelli & 
Schmitz, 2011); therefore, it was chosen as the measurement tool of choice. To make sure the 
measurement was accurate, the researcher always verified the points of tethering with the 
research assistant. In addition, photographic record of the cord was taken ȋexcluding the patientǯs 












Figure 3.5. Measurement of a hypothetical cord (dotted line) with a digital calliper.  
Permission was obtained from the model. 
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3.5.4.5. Ultrasonography (US) 
3.5.4.5.1. Machine details and location 
The present study utilised a Toshiba Xario™ Diagnostic Ultrasound System (Model SSA 660A) with 
a Toshiba Linear Array transducer (Model PLT 120-4BT; 12 MHz frequency). Located in the 
Ultrasonography and X-Ray Department of Radiology, Groote Schuur Hospital, the new and 
recently calibrated machine is used for clinics during the day and access was granted for use after 
hours in the present study. It was the most modern machine available and had the highest 
frequency probe available (12 MHz) to allow for the increased detail needed in the scans. For all 
the scans the ultrasound system was put in a pre-programmed musculoskeletal setting (MSK) 
with a frequency of 12 MHz and a penetration depth of 5 cm. Advice on the workings of the 














Figure 3.6. Ultrasound procedure with the patient in the ABER position.  
Permission was obtained from the model. 
 
3.5.4.5.2. Procedure 
The patient was asked to undress to her bra and asked to lie down in the supine position on the 
plinth. For full disclosure of the cord, the patient was asked to hold her arm in abduction-external 
rotation with her hand behind her neck but within patient level of pain and discomfort.  
 
The US procedure always commenced on the right arm with the same researcher doing the 
scanning. Gel was applied to the probe after which it was placed on the most inferior point of 
tethering of the cord in the axilla in longitudinal orientation, in line with the main cord. The cord 
was followed systematically externally starting from the inferior point of tethering moving to the 
most visible point of tethering superiorly. In the case of multiple cords, only the most obvious one 
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was followed to minimise the time and discomfort for the patient. The transducer was held 
directly superior to it and was placed lightly onto the skin to avoid much indentation on the scans 
(Figure 3.6). After agreement was reached between the researcher and the researcherǯs assistant 
on the best and most clear scans, the assistant pressed the button to save the scan.  
 
To show the fascia continuity below the cord, static snapshots were taken during real-time 
dynamic scans of the cord following its trajectory moving from one probe head-width superior 
and inferior to the cord in longitudinal probe positions, and were aligned to show wider fascial 
continuity. At the midway point of the cord, one transverse scan was taken to show a cross-
sectional view. Furthermore, a video of the arm in movement (neutral – abduction-external 
rotation) was taken at the midpoint of the cord in longitudinal probe position to highlight the 
tension on the fasciae and fascial gliding (Diagram 3.2).  
 
The described procedure was replicated on the unaffected side or, in the case of a double 















Diagram 3.2. Diagram detailing the ultrasonography procedure. The inset highlights the cord and the 
positioning of the ultrasound probe (as depicted by the rectangles) to obtain a longitudinal (blue) and cross-
sectional/transverse (yellow) view of the cord on the ultrasonographs. The longitudinal graphs were 
obtained along the midline of the full visible cord whereas the transverse ultrasound was obtained at the 
midpoint of the structure. The longitudinal ultrasounds were consecutively aligned to show a more 
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3.5.4.6. Photographs Detailed photographs were taken of the patientsǯ cords. Depending on where the cords reached, the photographs depict the axilla, arm, forearm and chest of the patient. The patientǯs face was 
never photographed, or her face was concealed, for anonymity reasons. The pictures were taken 
using a standard Canon PC1677 Digital Camera in auto-mode. 
 
3.5.4.7. Magnetic resonance imaging (MRI) 
For the exploration of alternative imaging methods to improve our knowledge of the anatomical 
structures in and surrounding the cord, MRI was chosen. After additional ethics clearance was 
obtained (HREC: 098/2014), only a single patient was chosen to participate because of the 
expense of the method. Due to the discomfort of lying still within the MRI machine for an extended 
period of time, the patient would need to be able to hold her arm in the ABER position for which 
Patient FS/2013/11 qualified. The patient was imaged using a Philips Ingenia 3.0T MRI machine 
and was scanned in long axis STIR PDFS T1, as well as short axis STIR T1 to get a dual view as well 















Figure 3.7. MRI set-up with patient in the ABER position. Permission was obtained from the model. 
 
3.5.5. Patient folder information 
Clinical and demographic details of the patients were collected from the General Hospital and 
Radiology patient folders at Groote Schuur Hospital. The supervisors assisted in obtaining the 
chosen information and included diagnosis (type of breast cancer, tumour variables), treatment 
information (type: surgery, adjuvant therapies; side, area, frequency and history) and 
physiotherapy information (treatments, dates, frequency). For a full list of items, refer to 
Appendix E; Data Collection Sheet B. 
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3.6. Data analysis 
3.6.1. Numerical data 
Numerical data from all the measurements were analysed using the programme STATISTICA 12 
(StatSoft®, 2013). Normality was assessed using the Shapiro-Wilk test. As the sample was not 
normally distributed, non-parametric Kruskal-Wallis and Spearman rank tests were done to 
observe any significant differences and relationships between the data before and after 
physiotherapy and between arms. The statistical data were used to establish possible trends in 
the data, and supporting established trends, not for generalising to a larger cohort due to the 
limitations of the study. 
 
Due to the small and non-normal sample, medians were used as the non-parametric equivalent of 
average and percentage change, and differences were used to observe how much patients 
improved after physiotherapy and how much the affected arm differed from the unaffected arm. 
Furthermore, percentage contribution to total score in the SPADI and FACT-B questionnaire were 
used to establish which item contributed most to the overall score as an indicator of which specific 
behaviour most affected patients pre- and post-physiotherapy. 
 
A Bonferroni correction controlled for inflated familywise error associated with multiple pairwise 
comparisons and are reported in the appropriate sections of the results.  
 
3.6.2. Categorical data 
The categorical data that arose from the clinical patient records was attributed a number and was 
analysed with the numerical data as described above. Categorical variables were submitted to chi-
squared testing to assess whether the variables are associated with differences between and 
within patients in the larger GSH cohort. 
 
3.6.3. Qualitative data  
Being the main focus of the study, data from the description and explanation of the fascial 
continuity, fascial and cord changes and fibrotic development were compared within and between 
the participants, before and after physiotherapy treatment. Furthermore, trends that were visible 
within the numerical data were discussed with the qualitative and physiotherapy data in mind.  
 
3.6.3.1. US analysis  
Static US analysis was done by means of a summary table as shown in Leduc et al. (2014) to 
identify which patients showed which features on the US scans (see Appendix H). The current 
study used descriptors that were described in the fascia and AWS literature (Stecco, 2015; 
Langevin et al., 2011; Leduc et al., 2014; Koehler, 2013) (Table 3.3). Dynamic ultrasound analysis 
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was done comparing the tissue glide and movement between unaffected and affected arms, before 
and after physiotherapy. The videos can be accessed via https://drive.google.com/open?id=1-
o4EHuPy-IcsQBk1X-fVroPXviPruJlg  
 
3.6.3.2. MRI analysis 
MRI analysis was provided by the radiologist at the site of the scan and was rewritten in line with 
the descriptor definitions used in US analysis. 
 
3.6.3.3. Descriptor definitions 
Standardised definitions to describe the features on US and MRI were used to prevent confusion 
due to the different interpretations of the same terms used in the literature (Table 3.3). The 
definitions were adapted from the literature (Stecco, 2015; Langevin et al., 2011; Leduc et al., 
2014; Koehler, 2013). 
 
Table 3.3. The definitions used to describe features on the ultrasound and MRI scans. 
Descriptor definitions  
Adhesions: vertical connections between parallel planes 
Densification: impaired gliding potential between layers 
Echogenicity: the intensity of the signal on ultrasound; hyper=increased, hypo=decreased 
*Echotexture: an overall appearance of speckles, haziness; can be either smooth (homogenous) or 
coarse (heterogenous) 
Fascial continuity: no disruption in the fascial planes, continuous lines 
Fibrosis: thickening of the individual fascial layers and/or increased echogenicity 
Heterogeneity: a varied overall appearance  
Homogeneity: a similar overall appearance 
Honeycomb structure: resembling a hexagonal structure 
Reduced gliding potential: reduced gliding on dynamic ultrasound videos  
Superficial fascia: the multiple echogenous layers on ultrasound in the hypodermis  
* The term was borrowed from the ultrasound terminology describing fibrosis in liver and lungs (Perez et al. 2007). 
 
3.7. Data safety and monitoring 
All the information that was gathered during the data collection appointments was noted on Data 
Collection Sheet A which was divided into two parts for the two separate appointments (see 
Appendix C + D). The data which were obtained from the medical records and the health 
professionals were compiled on Data Collection Sheet B (see Appendix E). Physiotherapy-related 
data were compiled on Data Collection Sheet C (see Appendix F). Whenever new data were 
acquired, they were saved electronically on the computer the same day after which the physical 
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copy was securely stored in the supervisorǯs research office. Back-ups were stored on a separate 
hard drive which was stored safely and separately from the physical data. 
 
The study ran according to the Protection of Personal Information Bill (2009). All the data obtained 
in the study was coded with study numbers (FS/2013/participant#), on both the computer and 
on physical copies. The master key was kept in a secure location ȋthe supervisorǯs research officeȌ 
and held separate from the data to maintain anonymity and protection of privacy. Only the 
principal investigator and the postgraduate student involved knew the location and had access to 
it.  
 
3.8. Research procedure limitations  
US is an operator-dependent modality. Because of the patientsǯ inability to maintain the same 
position for an extended period of time, measurements and scans could not be repeated to 
establish reliability. The current study attempted to ensure the reliability of the findings by 
including the following: 
1. The anatomical location of each patientǯs cord in the axilla was provided as the cord 
positions differed per person, which indicated the location where US scans were taken.  
2. US scans were analysed using anatomical atlases (Standring, 2008; Stecco, 2015) to determine more accurately the anatomical structures at the cordǯs location and guided by 
the anatomical knowledge of the supervisors. 
3. A description of the US settings and analysis method was given. 
4. The same observer carried out all US scans and other measurements. The researcher that 
conducted the scanning has experience using US, was adequately trained and was 
supervised by a senior staff member when necessary. 
5. There were always at least two researchers present: one of the team and an assistant who 
was familiarised with the protocol. A consensus between the two researchers  during the 
measurement cycle was reached to obtain the best representation of the area of interest 
on US and the most correct measurements. In case of illness, another team member (who 
had been updated about previous sessions and was able to replicate the procedures) 
would take over. 
6. For full transparency, most of the data including US scans are provided and US videos may 





- 35 - 
 
Chapter 4: Results 
 
4.1. Introduction 
The results chapter is set out in accordance with the aims and objectives described in Chapter 1 
and describes the general findings and trends of the study. The sections include patient 
demographics and clinical data, statistical analyses, patient outcome measure exploration and 
summaries of imaging findings in relation to outcome measures. Detailed case analyses can be 
found in Chapter 7 – Supplementary Information. 
 
4.2.  Patient demographic and cancer profile 
A summary of the patient demographics and clinical cancer data of the study sample is listed in 
Table 4.1. Of the study sample (n = 11), 81% was over 40 years of age and 27% was over the age 
of 60 years. Two patients received bilateral mastectomies. One received a sentinel lymph node 
biopsy, whereas all patients had axillary clearances. Over 90% of individuals had more than six 
nodes removed, with 58.3% of the sample having between 0-5 positive nodes. The most common 
tumour size was found within the 20-39 mm range (36.6%).  
 
Two patients received radiation therapy before surgery and seven after surgery, with one person 
receiving two doses after surgery. Five patients received chemotherapy pre-surgical treatment 
and eight post-surgical treatment, whereas two patients received hormonal treatment before 
surgery and seven after surgery. 
 
4.3.  Patient AWS symptomology and study outcome measures 
Table 4.2 shows that there is a very wide range of number of days from surgery to the first 
measurement time with patients presenting with AWS from 57 to 1 455 days (± four years) after 
surgery. Six out of eleven patients presented more than a year with cording before physiotherapy. 
Three out of six patients continued to have a cord after physiotherapy of which two had surgery 
more than a year ago.  
 
Nine out of eleven patients who participated in the study self-reported pain over the shoulder or 
axilla and eight reported limited movement of the upper limb. After physiotherapy, the fraction 
decreased to one out of six who continued to have pain and three still had a remainder of the cord 
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Table 4.1. Summary of patient demographics and clinical data. 
Demographics and cancer profile 
 Patient  Patient 
Characteristic % Frequency Characteristic % Frequency 
Age   Neoadjuvant treatments   
 <40 18.2 2  Radiation therapy   
 40-49 27.3 3  1 course 9.1 1 
 50-59 27.3 3  2 courses 9.1 1 
 >59 27.3 3  Chemotherapy   
Breast surgery    1 course 36.3 4 
 Single mastectomy 81.8 9  2 courses 9.1 1 
 Double mastectomy 18.2 2  Hormonal therapy   
Axillary surgery*    2 courses 9.1 1 
 SLND (<4 nodes) 9.1 1**  3 courses 9.1 1 
 ANC 90.9 11# Adjuvant treatments   
Number of resected nodes*    Radiation therapy   
 <5 8.3 1  1 course 54.5 6 
 6-15 58.3 7##  2 courses 9.1 1 
 16-25 33.3 4##  Chemotherapy   
Number of positive nodes*    1 course 45.5 5 
 0-5 58.3 7  2 courses 27.3 3 
 10-15 42.7 5#  Hormonal therapy   
Tumour size    1 course 36.3 4 
 <19 18.2 2  2 courses 27.3 3 
 20-39 36.3 4    
 40-59 9.1 1    
 60-79 18.2 2    
 >80 18.2 2#    
Histological type      
 Invasive ductal 81.8 9    
 Lobular 18.2 2    
Stage      
 II 18.2 2    
 III 45.5 5    
 IV 36.3 4    
Grade^      
 I 9.1 1    
 II 45.5 5    
 III 36.3 4    
Lymphovascular invasion 36.3 4    
Multifocality 54.5 6    
Receptorial status      
 PR-positive 27.3 3    
 ER-positive 72.7 8    
 HER-2-positive 54.5 6    
 
* The number of patients in the category add up to more than 11 as one patient had a lymph node resection bilaterally 
** The individual received SLND on only one side but had a bilateral mastectomy 
# The category examined the same individual twice for each side that treatment was received 
## The categories contained the same individual but for which each side differed 
^ For one individual no tumour grading could be extracted from the patient folder 
/ The category contained patients who received the same type of neoadjuvant treatment as adjuvant treatment 
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The other three patients experienced full relief of all symptoms. Nine out of eleven patients had 
one cord, whereas two patients had a true axillary web with two dominant cords. Just less than 
half of patients (46.2%) showed a cord of between 90-109 mm with two patients presenting with 
a longer cord. After physiotherapy, the cord resolved in 50% of the sample with only one patient 
still presenting with a cord that was over 89 mm, one between 70-89 mm and one with a cord that 
was between 50-69 mm in length.  
 
Table 4.2. Symptomology of patients in percentages and number of patients per category. 
Signs and symptoms 
 Patient 
Characteristic % Frequency 
Time from surgery to Observation Point 1*   
 < 3 months 18.1 2 
 3 months – 1 year 23.0 3 
 > 1 year 54.5 6 
Time from surgery to Observation Point 2   
 3 months – 1 year 33.3 2 
 > 1 year 66.7 4 
Symptomology present before physiotherapy**   
 Pain present 81.8 9 
 Reduced ROM present 72.7 8 
 Cording present 100 11 
Symptomology present after physiotherapy**   
 Pain present 14.2 1 
 Cording present 42.9 3 
 Full resolution of symptoms 42.9 3 
Cord side   
 Left  36.3 4 
 Right  45.3 5 
 Bilateral  18.1 2 
Number of cords   
 1 81.9 9 
 2 18.1 2 
Cord length before physiotherapy (mm)   
 50-69 15.4 2 
 70-89 23.0 3 
 90-109 46.2 6 
 >110 15.4 2 
Cord length after physiotherapy (mm)   
 50-69 33.3 1 
 70-89 33.3 1 
 90-109 33.3 1 
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4.4. Statistical analysis of the numerical data 
4.4.1. Normality testing 
A Shapiro-Wilks test was performed to evaluate the normality of the study data distribution. The 
test showed that the majority of the variables were not normally distributed. Normalisation of the 
data was attempted by log or square-root transformations which did not yield normal data, and 
hence non-parametric tests were used in the subsequent report. 
 
4.4.2. Spearman rank correlations 
Spearman rank correlation tests were performed to assess the relationship between cord length, 
ROM measures, time from surgery until Observation Point 1, FACT-B Functional and Physical 
domain scores and total score, SPADI total and domain scores, age, and number of resected nodes 
before and after on the affected side (Association Matrix 4.1) and unaffected side (Association 
Matrix 4.2).  
 
In the affected arm, at the Bonferroni-corrected level of significance, before physiotherapy there 
was a significant positive association between cord length and internal rotation (r = 0.791). After 
physiotherapy, there was a significant negative association between cord length and SPADI Pain 
(r = -0.895). The number of resected nodes was significantly positively associated with age (r = 
0.847). 
 
In the unaffected arm there was a significant negative association of flexion with age (r = -0.900) 
after physiotherapy, but no significant associations before physiotherapy.  
- 39 - 
 
Association matrix 4.1. The Spearman rank associations for outcome measures of cord length, ROM, time from surgery to the first observation point (Surg-Obs 1), FACT-B, SPADI, age and 
number of resected nodes (number of nodes) for the affected side. The darker red part of the matrix indicates before physiotherapy, the lighter part after physiotherapy. The numbers in red 
are significant associations, while the numbers in blue are significant associations after the Bonferroni correction (p < 0.001).
VARIABLE Cord 
length 
























 0.348 -0.050 0.633 0.152 0.791 -0.444 -0.069 0.033 -0.041 -0.221 -0.240 -0.223 -0.494 -0.419 
Abduction -0.434  0.017 0.354 0.158 0.202 -0.219 0.025 -0.073 -0.263 -0.295 -0.330 -0.271 -0.224 0.033 
Extension -0.783 0.382  -0.163 -0.559 0.211 0.626 0.379 0.289 0.311 -0.151 0.057 0.044 0.094 0.156 
Flexion -0.149 0.775 0.275  0.283 0.328 -0.145 0.213 0.172 -0.007 -0.528 -0.447 -0.517 -0.510 -0.215 
External 
rotation 
-0.729 0.214 0.764 0.234  0.106 -0.140 -0.117 -0.159 -0.352 0.072 -0.180 -0.094 -0.424 -0.395 
Internal 
rotation 
-0.236 0.107 0.218 0.270 0.464  -0.269 -0.108 -0.024 -0.029 -0.035 -0.130 -0.062 -0.298 -0.373 
Surg-Obs 1 0.497 -0.739 -0.028 -0.346 -0.090 0.018  0.755 0.598 0.492 -0.358 -0.257 -0.286 0.358 0.203 
Total 
Physical 
0.266 -0.111 0.113 -0.019 -0.371 -0.741 0.411  0.909 0.702 -0.724 -0.763 -0.792 0.348 0.304 
Total 
Functional 
0.164 -0.259 0.396 0.019 0.000 -0.259 0.748 0.  0.894 -0.717 -0.677 -0.727 0.311 0.490 
Total 
FACT-B 
-0.060 0.018 0.358 0.036 -0.090 -0.739 0.236 0.935 0.748  -0.619 -0.376 -0.473 0.400 0.634 
SPADI 
Pain 
-0.895 0.306 0.688 0.300 0.721 0.360 -0.346 -0.262 -0.075 0.036  0.738 0.848 -0.059 -0.366 
SPADI 
Disability 
0.079 -0.679 -0.436 -0.739 -0.393 -0.143 0.126 -0.074 -0.185 -0.126 0.000  0.975 -0.164 -0.087 
Total 
SPADI 
-0.378 -0.324 -0.138 -0.482 -0.036 -0.180 -0.282 -0.168 -0.355 -0.027 0.436 0.829  -0.155 -0.177 
Age -0.020 -0.306 0.413 -0.164 0.054 0.342 0.673 0.262 0.673 0.164 0.073 0.090 -0.209  0.256 
No. of 
nodes 
0.039 -0.536 0.327 -0.505 -0.071 -0.143 0.739 0.556 0.778 0.487 -0.072 0.286 0.000 0.847  
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Association matrix 4.2. The Spearman rank associations for outcome measures of ROM, time from surgery 
to the first Observation Point (Surg-Obs 1) and age for the unaffected side. The darker blue part of the matrix 
indicates before physiotherapy, the lighter part after physiotherapy. The number in blue is the significant 
association after the Bonferroni correction (p < 0.005). 
 
 
4.4.3. Kruskal-Wallis difference testing 
Kruskal-Wallis tests were performed to determine statistical differences before and after 
physiotherapy within the outcome measures of ROM (affected, unaffected), SPADI domain scores, 
FACT-B scores and cord length.  
 
4.4.3.1. ROM  
For the affected side, statistically significant (Bonferroni-corrected p-value < 0.01) results were 
observed for abduction (p = 0.0078) and flexion (p = 0.0062) , which all showed a significantly 
higher ROM post-physiotherapy. On the unaffected side, no statistically significant differences 


















Surg-Obs 1 Age 
Abduction  0.517 0.383 -0.300 0.350 0.183 -0.293 
Extension 0.667  0.150 -0.067 0.300 0.283 -0.552 
Flexion 0.200 -0.359  0.100 0.500 -0.367 -0.628 
External 
rotation 
-0.900 -0.821 0.100  0.667 0.217 0.000 
Internal 
rotation 
0.300 0.821 -0.200 -0.400  0.350 -0.351 
Surg-Obs 1 -0.500 -0.103 -0.300 0.600 0.300  0.234 
Age -0.100 0.616 -0.900 -0.200 0.600 0.400  
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4.4.3.2. SPADI, FACT-B and cord length 
There was a statistically significant reduction noted for SPADI Pain (p = 0.0003), SPADI Disability 
(p = 0.0055) and SPADI Total (p = 0.0008) after physiotherapy (Table 4.3). No significant 
differences were observed for cord length or FACT-B scores. 
 
Table 4.3. A summary of the descriptive statistics (median, min and max) and p-values of 
Kruskal-Wallis tests done on cord length, SPADI domain scores and FACT-B domain scores 
before (B) versus after (A) for the affected side. The number in red shows significant differences.  





Outcome measure Median 
p-value 
B vs A 
SPADI Pain before 33.00  
SPADI Pain after 6.00 0.0003 
SPADI Disability before 39.00  
SPADI Disability after 10.00 0.0055 
Total SPADI before 71.00  
Total SPADI after 20.00 0.0008 
FACT-B Physical total before 16.00  
FACT-B Physical total after 14.50 0.8424 
FACT-B Functional total before 21.00  
FACT-B Functional total after 23.50 0.5727 
Total FACT-B score before 95.00  
Total FACT-B score after 102.17 0.6626 
Cord length before 92.64  
Cord length after 79.04 0.0097 
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4.4.4. Cohort results for SPADI and FACT-B 
A chi-squared test was performed to observe whether baseline data for the current study sample 
was representative of the larger GSH breast cancer treated patient cohort. The before (n = 13) 
and after data (n = 7) of FACT-B and SPADI answers for individual items were compared to the 
cohort consisting of three other study samples taken in previous years (Shamley et al., 2012-
2014 [unpublished raw data]) (n = 119). The test showed no significant difference between the 
scores and groups (p > 0.057) with the exception of SPADI item Ǯlying on the involved sideǯ ȋp = 
0.ͲͲ͵Ȍ, SPADI item Ǯreaching highǯ ȋp = 0.036) and the FACT-B item ǮI am close to my friendsǯ ȋp 
= 0.020) before physiotherapy. 
 
Further analysis showed a higher percentage of patients that scored 7 or higher for SPADI item Ǯlying on the involved sideǯ ȋͶ͸% of individuals in the current study compared to ʹ ͺ% in the total groupȌ and SPADI item Ǯreaching highǯ ȋ͹͹% of individuals in the current study compared to 
36% in the total group) in our sample group before physiotherapy compared to the larger 
patient group or after physiotherapy. Furthermore, there was a higher percentage of patients 
who scored a 1 or 0 for FACT-B item ǮI am close to my friendsǯ for our sample group at baseline 
before physiotherapy compared to the larger population (36% in the current study compared to 
21% in the total group).  
 
Overall, apart from the abovementioned items, there were no statistical differences in the other 
46 items (p > 0.057) between the samples of the present study before and after physiotherapy 
and the larger population sample; thus the current study sample was used here as 
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4.5. General ROM, SPADI, FACT-B  
4.5.1. Ranges of scores 
 
Table 4.4. Different ranges of different outcome measures before and after physiotherapy. 
 
Outcome measure  Range before Range after 
ROM (affected) (°)   
 Abduction  65-139 112-171 
 Extension 24-85 55-66 
 Flexion 37-132 113-162 
 Internal Rotation 41-95 50-127 
 External Rotation 8-92 52-84 
SPADI   
 Pain (/50) 20-39 0-14 
 Disability (/80) 8-71 4-22 
 Total (/130) 22-107 4-26 
FACT-B    
 Physical (/28) 5-24 9-25 
 Functional (/28) 13-27 12-27 
 Total (/140) 80-125 113-162 
 
 
The scores in Table 4.4 give an overview of the measures of ROM on the affected side, SPADI and 
FACT-B findings in the patient groups. Comparing the before and after data, and lower and 
higher limits, the biggest changes appear in ROM (especially abduction and flexion) and SPADI, 
with FACT-B scores remaining almost the same. Further analysis of the data is presented in the 
subsequent sections. 
 
4.5.2. ROM change: affected vs unaffected arms 
Figures 4.1 and 4.2 show the differences in median percentage change for the affected and 
unaffected arm after physiotherapy treatment. On the affected arm (Figure 4.1) there was an 
improvement noted for all movements, with the actions with the highest improvement seen in 
abduction (48.9%) and flexion (28.3%), followed closely by external rotation (27.4%) and 
internal rotation (26.3%). Extension was least improved on the affected side with 8% 
improvement, and showed no change on the unaffected side. However, only the improvements 
for abduction (p = 0.0078) and flexion (p = 0.0062) reached statistical significance. Similar to the 
affected side, abduction on the unaffected side showed the most improvement (31.4%) and 
external rotation improved by 21%. Internal rotation showed a decrease of approximately 8% 
after physiotherapy on the unaffected arm (Figure 4.2) and flexion showed only a very slight 
improvement (3%). None of the changes reached statistical significance.  
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Figure 4.1. The median improvement of the different movements on the affected arm after physiotherapy.  
* indicates a significant change of p < 0.01 at the Bonferroni-corrected level of significance. 
 
Figure 4.2. The median change in movement in the unaffected arm after physiotherapy.  























Percentage change in ROM (affected arm) 


























Percentage change in ROM (unaffected arm) 
after physiotherapy treatment 
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4.5.3. SPADI 
4.5.3.1. Total SPADI and domain scores 
The total median SPADI and component scores are shown in Figure 4.3. The median total SPADI 
score of 72, which equated to a 55% score is broken down into a 39 = 48.8% disability score and 
a moderate 33 = 66% pain score. After physiotherapy, the total SPADI score had markedly 
decreased by 42.7% to 12.3%. The total pain score significantly decreased to 6 = 12% and the 
disability score significantly decreased to 10 = 13% total disability score.  
 
 
Figure 4.3. The change in median total SPADI score, before versus after physiotherapy, out of 130. The 
numbers inside the different subsections refer to the median percentage score for that section, i.e. for pain 
out of 50 and for disability out of 80. * indicates a significant change of p < 0.007 at the Bonferroni-
corrected level of significance (see Table 4.3). 
 
4.5.3.2. SPADI total score – domain contribution to total score 
Figure 4.4 depicts the percentage contribution of the score of each SPADI subcategory to the 
total median SPADI score before and after physiotherapy. The disability category, which 
contributes 62% (80/130) to the SPADI score in terms of total score, is shown to contribute only 
55% to the total before physiotherapy. The remainder of 45% is thus a higher contribution for 
pain. The pain category contributes the remainder 38% (50/130) to the total SPADI score and 
is shown as a slightly lower percentage (36%) after physiotherapy with a little elevated 
disability contribution of 64%. The distribution difference indicates an improved pain score 
































Total score: 72 (55.3%) 
Total score: 16 (12.3%*) 
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Figure 4.4. The contribution of the SPADI subcategories to the median total SPADI score  
before and after physiotherapy. 
 
 
4.5.3.3. SPADI pain – item contribution to total score 
In Figure 4.5, the differences in contribution of each item to the total median domain score are 
shown. In the SPADI questionnaire, each item contributed 20% to the overall score. Before 
physiotherapy, it was observed that the items Ǯtouching the back of the neckǯ and Ǯlying on the involved sideǯ contributed most to the score, with the former contributing the greatest (25%). After physiotherapy, the distribution changed with Ǯat worstǯ or Ǯpushing with involved armǯ not 
contributing to the total score, indicating a notable reduction. 
 
4.5.3.4. SPADI disability – item contribution to total score 
Figure 4.6 highlights the item contribution distribution for the disability total component of the 
SPADI. Here the items contributed 12.5% in terms of its items to the total score. Before the 
physiotherapy treatment it was observed, however, that Ǯobject on high shelfǯ or Ǯcarrying a heavy objectǯ ȋboth ʹͷ.͸%Ȍ contributed the most to the median overall score. The item Ǯputting 
on pantsǯ yielded only a ʹ.͸% contribution. After physiotherapy, the items Ǯfrom back pocketǯ, Ǯputting on pantsǯ and Ǯwashing hairǯ no longer appeared, meaning that they yielded a median 
















Total SPADI before Total SPADI after
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Figure 4.6. The contribution of each item in the disability SPADI category to the 
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Pain SPADI domain item contribution to 
median total score 
AT WORST
PUSHING WITH INVOLVED ARM
TOUCHING BACK OF NECK
REACHING HIGH
























Disability before Disability after
Disability SPADI domain item contribution to 
median total score 
FROM BACK POCKET
CARRYING HEAVY OBJECT
OBJECT ON HIGH SHELF
PUTTING ON PANTS
BUTTONED SHIRT AFTER
PUTTING ON A VEST
WASHING BACK
WASHING HAIR
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4.5.4. FACT-B 
4.5.4.1. Total FACT-B and domain scores 
Figure 4.7 highlights the differences in median total FACT-B and component scores. The higher 
the total scores, the better the quality of life measure. The total scores were very similar with a 
score of 113 before physiotherapy and 112.25 after physiotherapy. Comparable scores were also 
evident in the subsection scores with only slight decreases in Emotional (2.5 points) and Social 
(1.75 points). Additional Concerns increased by 2.5 points and Functional increased by 1 point. 














Figure 4.7. The change in median total FACT-B score before versus after physiotherapy. The numbers 
inside the different subsections refer to the median score for that section. No statistically significant results 
were obtained (see Table 4.3). 
 
 
4.5.4.2. Percentage improvement Total FACT-B 
Figure 4.8 shows the majority of patients having an improved FACT-B score except for 
FS/2013/08 with a reduction of 16.8%. 
17 = 60.7% 17 = 60.7%



























Median FACT-B domain scores to 






Total score: 113 = 78.5% Total score: 112.25 = 77.8% 










Figure 4.8. Percentage individual improvement on the Total FACT-B score. 
 
4.6. General cord characteristics The cord was fully exposed within the axilla with the patientǯs arm in abduction whilst standing 
or in the ABER position whilst lying down.  
 
4.6.1. Cord position in axilla 
Within the patient sample there was a variance in the cord location. The cordǯs trajectory did not 
perfectly follow the mid-axillary line as sometimes depicted, but also fell within the grooves 
between the musculature. The cord locations could be divided into three categories: (1) superior 
to coracobrachialis, (2) within the groove for axillary vessels, or (3) in the mid-axillary line 




    
 









Figure 4.9. Variance in cord location (arrows) corresponding to the anatomical diagram: (1) superficial to 
coracobrachialis, (2) in the axillary vessel groove, (3) in the mid-axillary line. Diagram adapted from 
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4.6.2. Cord trajectory 
In the current studyǯs sample group, the cordǯs trajectory ranged from originating from the chest 
wall, the scar on the breast and the axilla, and ending in the axilla or upper limb, or extending 








Two patients had a second cord that was palpable but not clearly visible. 
 
4.6.4. Cord thickness 
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4.6.5. Length  
The length of the cords was variable within our sample size and was defined as the length of the 
structure between its palpable and visible confines. It ranged from 57.96 mm to 139.52 mm 
before physiotherapy, and between 0 mm to 97.1 mm after physiotherapy. 
 
4.6.6. Side 
The cord appeared six times on the left side and seven times on the right side but was, on 
average, longer on the left side (median left: 100.3 mm versus median right: 81.9 mm) and both 
cord duplications appeared on the left side. 
 
4.6.7. Appearance 
Within the sample, two different presentations of the cord – both visible and palpable – were observed when the patientǯs upper limb was in the ABER position before physiotherapy: 
indenting (Figure 4.12a) and protruding (Figure 4.12b) cords. After physiotherapy cord 






Figure 4.12. Different cord appearances before physiotherapy: (a) indenting, (b) protruding. 
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4.7. General imaging findings 
On the individual ultrasound (US) scans (Tables 4.5 and 4.6 per patient case; see Chapter 7 for 
more detail), a number of characteristics were observed to be present on the affected side 
compared to the unaffected side (Figure 4.14). Surprisingly,  a clear cord structure was not noted 
in any of the patients. The characteristics observed were a thickened superficial fascia and deep 
fascia (Figure 4.14a), increased connections between the dermis and hypodermis as well as 
between the SF and DF (Figure 4.14a), (areas of) coarse homogeneity in the hypodermis or 
heterogeneity in echotexture (Figure 4.14b), general disorganisation in the hypodermis 
compared to the unaffected side (Figure 4.14c), reduced number of SF layers, the presence of a 
fibrous scar (Figure 4.14d), densification of the present layers, discontinuity of the layers, and 
















Figure 4.14. Typical US findings in the present study: (a) highlights a thickened, dense, hyperechogenic 
superficial fascia (SF) with numerous extensions/adhesions to the skin; (b) highlights increased 
heterogenous echotexture (circle); (c) highlights tissue disruption and honeycomb structures (arrow); (d) 
highlights a fibrous scar extending to the tissue surrounding it and discontinuity of SF. 
 
The MRI scans of the single patient corroborate the US findings with the presence of adhesions 
arising from a fibrous conglomeration within the hypodermis stretching along the axillary wall, 
admixture of the fibrous tissue with adipose tissue in the hypodermis and connectivity of the 



















Figure 4.15. Example MRI scan from patient 11. Long axis STIR PDFS T1 in parasagittal view showing fat 
admixture, fibrous bands indicated by the red arrow. For more MRI scans and a more detailed description, 
see Chapter 7. Orientation indicators: S=superior, I=inferior, P=posterior, A=anterior, L=lateral, M=medial. 
Within the scans: HH=humeral head, BB=biceps brachii, Dt=deltoid, CB=coracobrachialis, TM=teres major, 
LD=latissimus dorsi, PM=pectoralis major, Pm=pectoralis minor. 
 
 
4.8. General links between outcome measures and imaging  
Tables 4.5 and 4.6 highlight each caseǯs outcome measures and imaging findings as well as some 
demographic detail. A full analysis of each case and their individual differences, depending on 
the location of the cord, tightness and other symptomology, can be found in Chapter 7. 
 
The case analyses show that the fascial differences as noticed on US imaging between affected 
and unaffected arms, and changes that presented after physiotherapy, agree with the findings in 
the other outcome measures. Improvements after physiotherapy generally showed decreased 
or absent cord length, improved ROM and reduced SPADI scores from baseline with decreased 
thickening of the fascial layers, decreased fascial connections between layers, decreased 
hyperechogenicity and freer and more fluid gliding on dynamic ultrasound scans. Descriptive 
correlation between the two imaging modalities in patient FS/2013/11 showed a concurrence 
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Table 4.5. Summarised case histories of six patients with AWS who received physiotherapy, listing age, the side affected, treatments, time until recruitment, symptoms  
and confounding factors noted, ultrasound features, and ROM, SPADI and FACT-B scores. 
Cases with physiotherapy  

















(% change after physiotherapy) 
SPADI  
and FACT-B  
(% change after 
physiotherapy) 
FS/2013/01 48 Both Surgery: bilateral 




Hormonal therapy: no 
Physiotherapy: x5 
70 Before: cording, 




Before: thicker and more dense 
homogeneous SF (L), honeycomb 
structures (R) 
After: more regularity, more fluid 
independent fascial gliding 




Internal rot.: +24.2(L)/+31(R) 




FACT-B total: +5.1 
 
  
FS/2013/02 38 Right Surgery: mastectomy, 
axillary clearance  
Chemotherapy: yes 
Radiotherapy: yes 
Hormonal therapy: no 
Physiotherapy: x8 
149 Before: cording, scar 
tightness, reduced 
ROM 
After: cord remnant 
(-65.4%) 
Before: heterogenenous 
echotexture, hyperechoic bands in 
SF 
After: fewer clear connections SF to 
skin, coarser echotexture, improved 
gliding 




Internal rot.: -33.3  
External rot.: -8.8 
SPADI total: 
-75 
FACT-B total: +9.5 
 
  
FS/2013/04 69 Right Surgery: mastectomy, 
axillary clearance  
Chemotherapy: yes 
Radiotherapy: yes 
Hormonal therapy: yes 
Physiotherapy: x6 
368 Before: cording, 





Before: increased disruption, 
thickened bands in SF 
After: more regularity and 
organisation, improved gliding 




Internal rot.: +40.4 
External rot.: -5.9 
SPADI total: 
-36.8 
FACT-B total: +3.3 
 
  
FS/2013/07 63 Right Surgery: mastectomy, 
axillary clearance  
Chemotherapy: yes 
Radiotherapy: yes 
Hormonal therapy: yes 
Physiotherapy: x5 
798 Before: cording, 




thoracic kyphosis  
Before: thicker SF, disregularity, 
coarse echotexture 
After: more linearity and continuity 
of SF, decreased adhesions to 




Internal rot.: +44.3 






FS/2013/08 68 Right Surgery: mastectomy, 
axillary clearance  
Chemotherapy: yes 
Radiotherapy: no 
Hormonal therapy: yes 
Physiotherapy: x6 




time, fibromyalgia, no 
motivation for 
homework exercises, 
lower back pain 
 
Before: disorganisation in SF, 
increased thickening dermal-
hypodermal junction 





Internal rot.: +27.4 






FS/2013/11 51 Left Surgery: mastectomy, 
axillary clearance  
Chemotherapy: yes 
Radiotherapy: yes 
Hormonal therapy: yes 
Physiotherapy: x5 
601 Before: cording 
After: cording 
(-69.7%) 
Before: increased coarse 
echotexture, broken bands, 
increased connections to dermis 
After: more regularity and 
multilayering of SF, focal thickening 
still present 
Abduction: +10.1 
Extension: -11.3  
Flexion: +16.7 
Internal rot.: -24.2 
External rot.: -11.8 
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Table 4.6. Summarised case histories of five patients with AWS who did not receive physiotherapy, listing age, the side affected, treatments, time until recruitment, symptoms 
and reason for drop-out from the study, ultrasound features, and ROM, SPADI and FACT-B scores. 
Cases without physiotherapy  














(% difference compared to unaffected) 
SPADI  
and FACT-B# 
(% of total possible 
score) 




Hormonal therapy: no 





Thickened and hyperechoic SF, 
layer adherence with reduced 
gliding, better continuity on 
unaffected side 




Internal rot.: -1.6 











Hormonal therapy: yes 
 






Thickened and hyperechoic SF, 
adherence to muscles, greater 
organisation on unaffected side, 
fibrotic scar on both arms 




Internal rot.: 23.4 











Hormonal therapy: yes 
 






Thickened SF, increased 
adherence to dermis, less 
organisation, adhesions between 
most layers, more defined and 
continuous on unaffected side 




Internal rot.: -53.7 











Hormonal therapy: yes 
 






Thickened and denser SF, 
reduced continuity, adherence to 
dermis, better organisation and 
regularity on unaffected side 




Internal rot.: +33.3 











Hormonal therapy: yes 
 
1133 Cording, pain, reduced 
ROM 
 
Drop-out: no response 
to call for physiotherapy 
Thickened and closely adherent 
SF, reduced continuity, better 
organisation on unaffected side 




Internal rot.: -19.6 









* The patient was affected on both arms and thus the ROM percentage difference is how much difference there was between the two affected arms. 
# Note that a high SPADI score indicates more severe pain and disability, whereas a high FACT-B indicates better quality of life.
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Chapter 5: Discussion 
 
To facilitate an effective discussion, the discussion chapter will follow the structure of the 
hypotheses presented in the introduction.  
 
The first hypothesis states that, ǲAltered fascia plays a role in the restriction of upper limb 
movement, the perpetuation of pain and the fibrosis and formation of the cord in axillary web syndrome ȋAWSȌǳ. The first aim of the first hypothesis was to descriptively relate variables that 
were found to be (risk) factors in the AWS literature to our study and the fascia literature to 
determine fascial involvement. The risk factor variables will be focused on in the subsections of 
Section 5.1 and in the cord characteristics in Section 5.2.2. The second aim was to test the use of 
ultrasound (US) as an imaging technique for fascia in AWS in patients after treatment for breast 
cancer and to observe whether findings on the ultrasonographs relate to the presenting 
symptoms complex.  
 
The second aim as well as the second hypothesis, ǲChanges on US images of the cord, fascia and surrounding structures will be evident when the cord resolves, or symptoms improveǳ, will be 
addressed in sections 5.2. and 5.3. when deliberating imaging and pre- and post-physiotherapy 
results. 
 
Each topic and its link to fascia will be discussed using the characteristics found on imaging and 
with what is already known from the literature. Considering the relationship will aid in 
understanding the fascia from an anatomical and pathological point of view that may aid in 
explaining the relevant symptom complex and other variables in AWS. The sections that are 
discussed in the present chapter are demographic and treatment variables (Section 5.1.), AWS 
variables (Section 5.2.), physiotherapy (Section 5.3.) and limitations (Section 5.4.). The specific 
section from the results chapter to which a topic pertains is highlighted in the title. 
 
5.1. Demographic and treatment variables 
In the AWS literature, a number of demographic and treatment variables have been associated 
with symptom development and resolution. They are age (Section 5.1.1.), body fat and BMI 
(Section 5.1.2.), surgical treatment with cord formation, imaging findings, number of nodes 
removed, patient-dependent variables, time since surgery, cord resolution and definition of cord 
resolution (Section 5.1.3.), tumour variables (Section 5.1.4.) and (neo)adjuvant treatments 
(Section 5.1.5.).  
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5.1.1. Age (Results Section 4.2.) 
Several authors have reported a relationship between age and AWS occurrence (Bergmann et 
al., 2012; Koehler, 2013). The current study showed presentation over a wide age range (35 to 
69 years) with a propensity towards those below 60 years (73% of the sample) which concurs 
with the literature (Bergmann et al., 2012; Koehler, 2013). Although breast cancer occurrence 
and hence treatment tends to increase with age (McPherson, Steel & Dixon, 2000), an 
explanation for the phenomenon may be found in understanding the fascia and its healing. 
 
Ageing affects the elastic fibres in the fasciae (Kirk & Chieffie, 1962). Changes that arise with age 
are a decreased number of fibroblasts and fewer collagen fibres that become disorganised, 
resulting in the skin losing its tension and becoming misshapen resulting in, for example, 
wrinkles (Abu-Hijleh, Dharap & Harris, 2012). A reduction in fibroblasts and fibres results in a 
reduced healing response and delayed scar tissue formation in the elderly (Engeland & 
Gajendrareddy, 2011), possibly making it less likely to develop cording.  
 
Increased age has also been linked to a more rapid stiffening of the joints upon immobility 
(Findley, 2012) and there is evidence for range of movement (ROM) to be age-dependent 
(Barnes et al., 2001) both possibly contributing to shoulder pain and reduced ROM in the older 
patients in the present study. Statistical analysis in the present study only showed a significant 
relationship between flexion and age after physiotherapy (r = -0.900) on the unaffected arm. The 
relationship indicates a reduced flexion in older patients which is supported by other studies 
(Doriot & Wang, 2006). That there was no relationship found on the affected arm could be 
explained by the altered dynamics due to the fascial changes having occurred (as will be 
discussed in Section 5.2.3.2.) possibly affecting both arms via direct connectivity and 
biotensegrity (see Section 5.2.3.2.1.) and after physiotherapy the unaffected arm having restored 
to more normal ROM. The lack of other correlations could be due to the small sample size of the 
current  study and further studies would be required to examine the relationship between age, 
ROM and fascia in detail. 
 
5.1.2. Body fat and BMI (Chapter 7 – Ultrasonography Section 4 per patient) 
A relationship between a lower-normal body fat percentage and BMI has previously been 
correlated with the occurrence of cording (Lacomba et al., 2009; Koehler, 2013). In the present 
study, BMI was not calculated; however, the thickness of the axillary hypodermis, which includes 
the SAT, SF and DAT, was measured on the US scans. Measuring the hypodermal thickness may 
be a better way to determine the adipose layer thickness in a localised area as BMI is an indirect 
measure of body fat and provides an average over the whole body (Rothman, 2008). The 
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measurements showed a variety of hypodermal thickness from 0.1 cm to 2 cm in the axilla, 
ranging from thin to larger individuals with no clear descriptive propensity towards either.  
 
The literature shows a mean BMI of 25.1 (Lacomba et al., 2009) and a mean of 24.8 (Koehler, 
2013) in patients with cording. Bergmann and colleagues (2012) describe a decreased risk of 
15% in obese patients. Leidenius and colleagues (2003) found that patients with AWS that do 
not have any symptoms are more likely to be obese (mean BMI = 26). OǯToole and colleagues 
(2013) and Leduc and colleagues (2009), on the contrary, did not observe a relationship 
between body fat or BMI and cording.  
 
Lacomba and colleagues (2009) propose that the relationship might be related to increased 
adipose tissue decreasing the inflammatory reaction of the severed vessel, preventing fibrosis 
and cord formation. Koehler (2013) similarly hypothesises that the prevention of adhesion 
formation could be related to increased adipose tissue in the tissue healing response. Lacomba 
and colleagues (2009) relate their findings to age, in which they describe that older people are 
more likely to gain weight which could explain why AWS appears in younger and thinner 
women.  
 
However, Leidenius and colleagues (2003) suggest a reason for the relationship could be that a 
cord might just not be observed or palpated easily in patients with higher BMI (>25) due to the 
thicker subcutaneous adipose layer. Additionally, Koehler (2013) suggests that in patients with 
lymphoedema the accumulated fluid might obstruct access and visibility to the cord, indicating 
a false relationship rather than a true one between BMI and cording. In the present study, an 
increased adipose layer did appear to mask symptoms of cording in patients with increased 
adiposity, making it difficult to clearly measure the extent of the cord or to discern it initially. 
Imaging modalities being able to visualise cording may be able to help identify cords in those 
patients with increased BMI. 
 
5.1.3. Surgical treatment (Results Section 4.2. + 4.3.) 
In the current sample, all patients underwent a mastectomy and received axillary surgery on the 
involved side and developed AWS symptoms on that side. The only exception was Patient 
FS/2013/05 who received a bilateral mastectomy and developed bilateral cording. The axillary 
surgery for the patients involved a full axillary clearance (ANC), except for patient FS/2013/01 
who received a left mastectomy and sentinel lymph node dissection (SLND) and a prophylactic 
right mastectomy. Her right side, however, was also affected with AWS symptoms and showed a 
cord structure, although less obvious than on the left side. 
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In the literature, most studies describe axillary surgery as the main risk factor for developing 
AWS. In their seminal paper, Moskovitz and colleagues (2001) described that no patient in their 
sample developed cording with only a breast procedure without axillary surgery, only with 
axillary node clearance or sentinel lymph node dissection - which was mirrored by several others 
(Koehler, 2013; Lacomba et al., ʹ ͲͲͻȌ. OǯToole et al. (2013), however, also reported four patients 
that had developed cords and had received breast procedures, but not axillary dissection.  
 
Remarkably, other cases of AWS without axillary dissection were observed in the literature. A 
patient was described who developed axillary cording after a transaxillary thyroidectomy (Kim, 
Park & Gong, 2014) and one after an insect bite with secondary fungal infection (Friberg et al., ʹͲͳ͵Ȍ. In Moskovitz and colleaguesǯ study (2001), one patient developed a cord on the side on 
which she developed stage IV fixed nodal disease. It was explained by the authors as tumour 
cells having occluded the lymphatic pathways and therefore giving rise to the cord.  
 
An interesting observation is that, physiologically, the body forms fibrosed cords from occluded 
vessels; for example, to make redundant vessels non-functional. After birth the ductus 
arteriosus, which connects the aorta to the pulmonary trunk to shunt blood away from the lungs 
into the aorta during foetal development, constricts and fibroses in response to inflammatory 
markers to become the ligamentum arteriosum (Standring, 2008). To understand the formation 
of the cord in AWS, further research could focus on whether a similar process to that of the 
ductus is followed with similar biochemical markers. All the mentioned examples do point 
towards injury, dysfunctionality and inflammation of the axilla as the major factors involved in 
cord formation. 
 
5.1.3.1. Cord formation 
Moskovitz and colleagues (2001), in addition to others, propose that the webbed cord forms as 
a result of axillary surgery, hemisection of a vessel, extravasation of fluid and subsequent stasis 
and occlusion and fibrosis (Koehler, 2013; Lacomba et al., 2009). Cord formation can be 
explained through the wound-healing process as a consequence of the surgical insult and the 
removal of the axillary tissues.  
 
An axillary clearance results in the removal of lymph nodes, axillary tissue and remnants of 
vasculature. The resulting cavity in the body undergoes a large inflammatory response and is 
initially filled with fluids but subsequently is reorganised (Panieri, personal communication, 
2014). Guimberteau and Armstrong (2015) mention that the body works to avoid any 
unintentional cavities. The fibroblasts in the remaining fasciae aid in restoration and start 
depositing granulation tissue haphazardly to fill the cavity and re-establish tissue integrity 
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(Fourie, 2012). Adhesion formation as a consequence of cell breakdown and tissue 
reorganisation occurs within the deposited tissue and between other tissues (Fourie, 2014). In 
addition, the removal of lymph nodes causes the disruption of lymphatic and possibly other 
vessels and can lead to insufficient lymph drainage and lymphedema (Fumiere et al., 2007) with 
a backing up of lymph fluid. The protein-rich fluid leaks into the interstitium and leads to fibrosis 
of the tissue and a damaged vessel wall to form the cord (Kepics, 2007). It  may result in chronic 
inflammation and definitive fibrosis of surrounding tissues (Fumiere et al., 2007). The 
inflammatory response that ensues after major surgery can thus explain the fibrosing of a 
damaged vessel forming a cord as well as the presence of generalised fibrotic tissue changes 
surrounding the cord.  
 
Figures 5.1 and 5.2 show how tissue fibroses as a response to surgery. Figure 5.1 highlights the 
fibrosis that can occur post-injury and the destruction of the normal anatomy and functionality 
of the tissue. Figure 5.2 shows small vessels in fibrotic planes and adhesions as a result of long-
term inflammation. The examples highlight how invasive surgical procedures may lead to the 
fibrotic tissue seen and felt in the AWS patients in the current study on clinical examination and 
can explain the arching of the skin (and different layers on the US) as a result of increased tension 
by pulling on the fibrotic fasciae upon movement. The puckered skin appearance can be 
explained by the SF that has elastic fibres, normally contributing to continuous endogenous 










Figure 5.1. Scar tissue after one year of injury showing the disrupted tissue, adhesions and fibrotic tissue 







Figure 5.2. The scar shows adhesions from the skin to the underlying aponeuroses with neovascularisation 
as a result of inflammation, highlighting the chronic inflammatory response responsible for the outcome. 
Photo courtesy of Jean-Claude Guimberteau, 2015. 
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5.1.3.1.1. Imaging findings (Results Section 4.7.) 
The fibrotic and adhesive features seen on imaging in the present study support the wound-
healing explanation of cord formation. On US there was a reduced number of SF layers, general 
disorganisation in the hypodermis and loss of fascial continuity which may be explained by the 
disruption and removal of the axillary tissue following surgery as well as the resulting fibrotic 
response (Stecco, 2015). The irregular deposition of fibrotic tissue may explain adhesion 
formations between the dermis and SF as well as between the SF and DF on US and MRI (also 
observed by Fourie, 2012), and may explain the fascial thickening observed in the different 
layers. Leduc and colleagues (2014) also describe connections from the hyperechogenic fibrotic 
structure visualised on US to surrounding fascia and dermis. A fibrous scar as highlighted in 
some individuals in the current study was also highlighted on US by Fourie (2012).  
 
Areas of coarse echotexture in the hypodermis as found in the present study were also described 
by Fumiere et al. (2007) as diffuse hypoechogenecity or localised hyperechogenicity in patients 
with lymphoedema. The authors explain that the appearance reflects water accumulation or 
diffuse fibrosclerosis, indicating a fibrosing response occurring. They found a good 
topographical correlation between hyperechogenic findings on US, hyposignal on MRI and 
invasive fibrosis on histology between and within adipocytes, similar to the US and MRI 
correlation of the present study. The histological fibrotic findings are reinforced by biopsy 
studies of the cord in AWS (Marcus, Pawade & Vella, 1990; Reedijk et al., 2006; Josenhans, 2007; 
Villamiel Capos et al., 2008; Rashtak et al., 2012). Coarse echotexture can be explained due to 
the admixture of adipose tissue which attenuates US and possibly masks or highlights the 
hyperechoic tissues and was also seen on MRI in the present study.  Furthermore, the haphazard 
laying down of the tissue in the fibrotic response could also explain the hazy impression which 
has been described on US images of liver fibrosis (Perez et al., 2007). 
 
Lastly, a honeycomb structure was found in the present study on US on the affected side of 
patients with cording, which was corroborated by a study by OǯToole and colleagues ȋʹͲͳͷȌ. 
Although the structure of the axilla with its fibrofatty plugs and network of connective tissue 
surrounding the plugs could represent a honeycomb appearance (Stecco, 2015), the observed 
structure was especially evident in thickened tissues in the study. The structure also 
corresponds with the irregular microvacuolar polyhedral shapes forming microvolumes 
visualised by Guimberteau and Armstrong (2015) on intratissular endoscopy but were larger. 
The honeycomb appearance could be the result of normal fascial tissue having become 
congested with either fat, fibrotic tissue or fluid deposited during in the inflammatory process. 
Fumiere and colleagues (2007) suggest that the appearance may represent oedema as it 
appeared in patients with lymphoedema.  
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5.1.3.2. Number of nodes removed (Results Section 4.2.) 
The number of nodes removed has been used by a number of authors as an indication of the 
invasiveness and extent of the axillary surgery and related to AWS development (Moskovitz et 
al., 2001; Koehler, 2013; Bergmann et al., 2012). In the present study, only one patient received 
an SLND, and the remainder full axillary clearances consisting of a median 12 nodes or more 
(over 90% of individuals had more than six nodes removed). When analysing the number of 
resected nodes, the number of resected nodes was significantly positively associated with age (r 
= 0.847). The correlation may be due to more nodes being removed prophylactically in older 
people and less conservative treatment, but was most likely coincidental due to the small sample 
size. The literature advices contrarily more conservative treatment for older patients with 
breast cancer as they do not benefit in terms of breast cancer mortality from axillary dissection 
(Martelli et al., 2011). There was no statistically significant correlation with any of the AWS 
symptoms or descriptively with changes and differences seen on the ultrasonographs.   
 
In the literature, both an increase in the number of nodes removed and more destructive surgery 
were found to predispose patients to AWS development, as increased tissue damage results in 
increased tissue fibrosis (Koehler, 2013). Leidenius and colleagues (2003) found that when 
patients underwent an axillary node clearance (> 5 nodes removed), there was a higher 
incidence of cording developing in 72% of patients, compared to 20% of patients after a more 
limited sentinel lymph node biopsy (SLNB). Moskovitz and colleagues (2001) reported a 6% 
incidence after ANC with preliminary results showing cord development after SLND, but no 
incidence was provided for the latter group. Koehler (2013) described a 4.8 times higher chance 
of developing cording with having 15 nodes removed compared to only two. Bergmann et al. 
(2012) describe an increased risk of 1% per node removed and in 2011 showed a reduced risk 
of 68% after SLND.  
 
Using the number of resected nodes in the present study as the basis of extent of lymphatic 
disruption or invasion may not be a clear indicator of the true damage done. Panieri (personal 
communication, 2014) mentions that the number of lymph nodes counted is fully dependent on 
the skill and meticulousness of the anatomical pathologist. Since the lymph nodes vary in size 
from 1-2 cm to 2-3 mm the pathologist may sometimes quote the wrong number of nodes 
because nodes may be missed in the fibrofatty tissue. Determining the correct nodes is 
particularly important in a SLNB where one attempts to be as minimally invasive as possible and 
only remove the sentinel lymph nodes.  
 
As mentioned before, the removal of more tissue leads to a worsened inflammatory response 
and a poorer outcome as tissues are less re-established to their original configuration if there is 
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greater destruction (Guimberteau & Armstrong, 2015). Leidenius and colleagues (2003) point 
out that with current radiomarkers used to identify the sentinel lymph nodes, the colloid marker 
may leak out into the neighbouring nodes which could lead to unnecessary removal of too many 
nodes. Increased damage could predispose the patient to an increased inflammatory response 
and possible cording and should thus be addressed with future research on improved lymphatic 
markers (Leidenius et al., 2003). A better way to determine the extent of tissue damage may be 
to record the surgery procedure, the tissue removed and to follow the subsequent healing 
process. 
 
5.1.3.3. Patient-dependent variables 
A reason for the different rates of patients being affected with cord formation throughout the 
literature after breast cancer treatment could be related to patient-dependent variables that 
inform the surgical procedure. Panieri (personal communication, 2014) mentioned in an 
interview that, even though there might not be a formal axillary dissection done, the breast 
procedure often extends into the axilla to remove the full extent of the breast tissue which 
includes the axillary tail (Stecco, 2015). Furthermore, as the vasculature of the breast and 
axillary tissue share a common embryological origin and hence are closely connected (Moskovitz 
et al., 2001), disruption and fibrosis of the vasculature inferior to the axilla could possibly result 
in cording as seen in the present study in the patient who did not undergo formal axillary 
surgery.  
 
Although surgery aims to follow a structured protocol and hence remain consistent in the 
removal of tissue, factors such as where incisions are made, how much tissue is removed (for 
example, the number of lymph nodesȌ and which tissues are damaged are reliant on the patientǯs 
body habitus and anatomical variation of the tissues to avoid and the tissue to remove (Panieri, 
personal communication, 2014). The present study showed that formal axillary dissection itself 
thus does not need to be a prerequisite for cord development. The current study was not able to 
investigate the exact anatomical details of which tissues were removed. 
 
Additionally, depending on the stressors put on the injured tissue during the wound-healing 
process, a scar matures as a result of internal factors (inflammatory mediators) and external 
factors (functional strain) (Stecco & Stecco, 2012). Patient-specific variables may thus also alter 
the healing response (Van den Berg, 2012) and are further discussed in Section 5.1.3.4. In the 
present study, both types of factors may aid in explaining the differences found in cord 
presentation and appearance, and the variances found on US, even though all patients received 
a similar surgical treatment. 
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5.1.3.4. Time since surgery and cord resolution (Results Section 4.3.) 
Several authors have proposed that AWS is a self-limiting disease that resolves within three 
months after symptom development and presentation (Moskovitz et al., 2001; Rashtak et al., 
2012; Moreau et al., 2008; Lacomba et al., 2009). In the present study, all patients presented with 
cording at the first observation point past the three-month cut-off time. There was a very wide 
range of number of days from surgery to the first measurement time with patients presenting 
with AWS from 57 days (±three months after surgery) to 1 455 days (± four years after surgery), 
of which six patients presented with cording more than a year post-surgery before 
physiotherapy. The syndrome did not appear to be self-limiting in the patients participating in 
the current study, highlighting that spontaneous resolution does not always occur. There are 
other studies that describe patients that do not follow the definitive timeline and present with 
symptoms more than three months and up to more than three years post-surgery (Johansson et 
al., 2001; Koehler, 2013; Leidenius et al., 2003; Fourie & Robb, 2009; Kepics, 2007; Wyrick, 
Waltke & Ng, 2006). If the syndrome is not self-limiting, the possible long-term effects of the 
syndrome are concerning and may be very debilitating (Cheville & Tchou, 2007). 
 
The cord resolution that follows the three-month timeframe may be explained by the time taken 
for the tissue healing pathway to go through the stages of remodelling and scar tissue formation 
(Van den Berg, 2012). Injured tissue heals and remodels according to a triphasic healing cascade 
that takes place at specific time intervals: (i) the inflammatory phase (days 1-5) that prepares 
the injured area to heal, (ii) the fibroblastic phase (days 5-28) in which a scaffolding of collagen 
type III tissue which does not have great mechanical stability is laid down, and subsequently (iii) 
the reconstruction phase (days 28-365) in which the type III collagen tissue network gets 
replaced by type I collagen tissue (Fourie, 2014; Van den Berg, 2012). In the fibroblastic phase, 
the healing tissue requires physiological tension to attain the structure most resembling pre-
injury condition (Cohen et al., 1992). However, scar tissue requires time to mature and if there 
are any irritating factors they may delay or disturb the maturation process and may lead to a 
chronic inflammatory process (Guimberteau & Armstrong, 2015) leading to non-functional scar 
tissue. The explained situation may explain the patients in whom cord resolution does not follow 
the three-month cut-off.  
 
A number of factors that can intervene with the maturation process have been noted such as 
foreign body inclusion in the tissue, nerve hemisection, functional tension that is put on the skin 
too early, or excessive repair as in certain scar tissue disorders (Fourie, 2014). Factors that may 
be responsible for the findings in the current study may be that patients start using their arms 
too early after surgery, for example due to socioeconomic requirements, introducing a 
secondary or prolonged inflammatory response. The patients may also be anxious to use their 
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arms for fear of hurting themselves and prolonged immobility could also lead to non-functional 
scar formation (Shultheis, Reichwein & Nebelung, 2012), to the extent that only surgery may 
then be able to release the tissues (Fourie, 2014). 
 
Another explanation of the longer time since surgery and cording in the current study may be 
that there was more invasive surgery or inadequate or no rehabilitation compared to other 
studies – as there is a long waiting list in the public system in South Africa for physiotherapy 
treatment – or a patientǯs symptoms may be normalised after breast cancer treatment 
(Josenhans, 2007; Kepics, 2007) possibly worsening the symptoms. Increased physiological 
stress levels, inadequate nutrients and inadequate perfusion of the tissues have also been 
suggested to lead to poor healing and regeneration (Van den Berg, 2012), especially in a 
resource-constrained and socioeconomically disparate settings. The use of anti-inflammatory 
medication affects the inflammatory response poorly and affects the connective tissues as well 
(Van den Berg, 2012). Lastly, the use of analgesics post-surgery to aid in pain relief also remove 
the natural pain signal which may lead to overuse of the arms and result in a prolonged 
inflammatory response (Van den Berg, 2012). Caution is thus required in the use of 
pharmacological treatment. 
 
5.1.3.5. Definition of cord resolution 
If cord formation may be linked to a worsened inflammatory and fibrotic response, cord 
resolution may be explained by resorption of the fibrotic tissues. Cord resolution has, however, 
never been explicitly defined in the literature. Moskovitz and colleagues (2001) make mention 
of resolution of the cord as the self-limiting factor of AWS and appears to entail a disappearance 
of the webbed cord and accompanying symptoms so that one cannot visually observe or palpate 
it. What happens to the physical cord structure upon resolution is unclear. 
 
The ligamentum arteriosum may be thought of as an example of a cord, exemplifying that a 
fibrotic vessel may not get completely resorbed (Standring, 2008). A different explanation for 
how the cord becomes unobservable is that the adhesions that keep the structure adherent to 
the skin and superficial tissues are resolved over time, or broken, allowing the fibrotic vessel to 
become buried within the surrounding tissue.  
 The breaking of the adhesions tethering the cord could explain the ǲpoppingǳ sound which is 
reported by our physiotherapist occurring in two patients in the current study during her 
treatment, and was previously reported by manual therapists to occur after myofascial release 
in other studies (Fourie & Robb, 2009; Lattanzi, Zimmerman & Marshall, 2012). In the current 
study, adhesions were visualised on the US and MRI scans between the skin and superficial 
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fasciae in most patients and were less obvious post-physiotherapy. The same patients presented 
with immediate improvement in pain and range of movement and reduced cord length after 
physiotherapy treatment. 
 
Furthermore, reports of recurrences of the cord can explain the adhesion hypothesis as well. 
After adjuvant, invasive treatment some patients re-presented with cords (Lacomba et al., 2009) 
which could be explained by a reignited inflammatory response and fibrotic tissue formation. In 
the current study, patient FS/2013/02, who received radiotherapy during the physiotherapy 
cycle, presented with worse cording and tighter and more adhesive skin afterwards. 
 
5.1.4.  Tumour variables (Results Section 4.2.) 
The size, type and location of the breast cancer tumour in AWS patients may have an additional 
impact on the healing process as recent discussions in the literature point out. Topical cancer 
biological studies highlight that the connective tissues play an important role in the immediate 
tumour environment (Stamenkovic, 2000). The tumour can cause tissue damage by releasing 
proteolytic enzymes (Stamenkovic, 2000), distorting the tissue anatomy (Laug, DeClerck & 
Jones, 1983) and causing the release of TGF-B and fibrinogen which leads to collagen deposition 
and fibrosis (Dvorak, 1986). The tumour can be seen as an inflammatory process and produces 
inflammatory responses to the surrounding tissues leading to the adhesive tissue that forms part 
of the tumour (Stone et al., 2003). The fasciae themselves also appear to contribute to cancer 
growth via the factors they release in fibrosis and inflammation (Langevin et al., 2016). The 
inflammatory response following the removal of the cancer may thus be exaggerated due to the 
presence of local inflammatory factors in especially larger and higher grade/stage cancers.  
 
In the AWS literature, the link between tumour size creating a pro-fibrotic environment and 
worse cording has not been explored but warrants future examination. Although there were 
clear fibrotic changes on US in the current study, no link could necessarily be made to the tumour 
size as being a determining factor as patients with the biggest tumour (> 80 mm) were not 
observed to have thicker, more disrupted fascia or more adhesions than those with smaller 
tumours. Statistical analysis did not show any correlation between other variables either. 
Furthermore, the variation in location (e.g. in the breast versus cancerous tissue in the axilla), 
and type of tumour, makes the relationship difficult to examine in our small sample. However, a 
contribution to the fibrotic findings and cord formation should not be ignored. A clearer effector 
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5.1.5. (Neo)adjuvant treatment (Results Section 4.2.) 
Radiotherapy, chemotherapy, hormonal therapy and other inflammatory inducing agents or 
triggers such as the cancer itself and infection lead to initiating a healing response (Fourie, 
2014), affecting the connective tissues. The healing response includes the production of 
cytokines such as TGF-B which has been shown to be involved in stimulating fibroblasts to 
produce collagen with over-activation resulting in fibrosis (Van den Berg, 2012). Furthermore, 
leakage of fibrin also encourages collagen production and deposition, further contributing to the 
fibrotic response (Stone et al., 2003). Table 5.1 indicates the different points in time at which the 
patients in the study received the different adjuvant therapies. The table highlights how many 
treatments each patient obtained which, together with the timing, could indicate an effect on the 
healing response that could explain the fibrotic findings and cording present.  
 
Multiple treatments appear to compromise healing due to the continued activation of the healing 
cascade (Stone et al., 2003). Stone and colleagues (2003) described that using chemotherapy 
and radiotherapy simultaneously could lead to a worse fibrotic response and that pre-surgery 
radiotherapy can initiate fibrosis and tissue breakdown more quickly after surgery (Stone et al., 
2003). Systemic treatments such as chemotherapy and hormonal therapy could thus affect and 
worsen local inflammatory responses resulting from surgery and radiotherapy. Furthermore, 
Lacomba and colleagues (2009) describe recurrences of AWS in patients for whom the cord had 
resolved but reappeared post-adjuvant therapy.  
 
In the present study, one patient received chemotherapy only, two patients received 
chemotherapy and radiotherapy, two patients received chemotherapy and hormonal therapy, 
and the other patients received all three treatment options. No correlation could, however, be 
found between having multiple treatments and having more reduced ROM or higher SPADI 
score. Also, due to the limited sample size of patients and that they received a myriad of different 
treatments at different times, prevented the authors from performing formal risk factor analysis 
(Table 5.1). Ranking was attempted to appreciate the effects of the different treatments but was 
inconclusive (Appendix I). Similarly, US findings could not be clearly attributed to the 
treatments; the US results, however, could have been worsened by the different treatments they 
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Table 5.1. Points in time of (neo)adjuvant therapy relative to the surgery 
 
5.1.5.1.  Radiotherapy 
Irradiation of tissues with ionising beams during radiotherapy leads to damage of both 
malignant and surrounding tissues and subsequent activation of the inflammatory cascade 
(Stone et al., 2003). How a tissue tolerates the ionising radiation depends on the functional 
reserve and structural organisation of the tissues (Stone et al., 2003). 
 
Radiation injury can be classified according to (i) immediate or acute effects where damage 
appears immediately, (ii) consequential after effects where there is persistent tissue damage and 
(iii) late effects which occur from approximately one-year post treatment (Stone et al., 2003). 
Acute effects are predominantly seen in rapidly-dividing cells and skin cells, for example, and 
get replaced, whereas late effects show more increased tissue damage and lead to a worse 
inflammatory response. Similarly, chronic damage due to continuous activation of the healing 
cascade results in consequential late effects. The consequential late effects are often observed in 
combination therapies which results in fibrosis, adhesions and lymphoedema in the skin due to 
fibrinous exudate and collagenous deposition, and highlight injury to connective and vascular 
tissues (Stone et al., 2003). 
 
Time of (neo)adjuvant treatments relative to surgery  
Participant # Radiation therapy Chemotherapy Hormonal therapy# 
FS/2013/01 - 2x Post (extending into physio) - 
FS/2013/02 1x Post (extending into 
physio) 
1x Post/ 1x Post (extending into 
physio) 
- 
FS/2013/03 1x Pre** 1x Pre*/ 1x Post - 
FS/2013/04 1x Post 1x Post (extending into physio) 2x Post 
FS/2013/05 - 2x Pre* 1x Pre**/ 1x Pre 
FS/2013/06 1x Pre*/ 1x Pre** 1x Pre*/1x Pre  1x Pre*/ 2x Pre**/1x Post 
FS/2013/07 1x Post 1x Post** 1x Post** 
FS/2013/08 1x Post^ 2x Post** 1x Post*/1x Post* 
FS/2013/09 1x Post*** 1x Pre** 1x Post** 
FS/2013/10 1x Post* 1x Post** 1x Post*/1x Post*** 
FS/2013/11 1x Post** 1x Post** 1x Post** 
Bolded participants are those that finished the study; the patients in red all had all three treatments 
# Due to an inability to extract the end-date of the hormonal therapies from the patient folders, we were unable to determine whether the patients 
were taking the medication during our study 
* Treatment occurred one year or longer (late effects) from the date of surgery and the first measurement cycle 
** Treatment occurred one year or longer (late effects) from the date of the first measurement cycle; less than one year to the date of surgery 
*** Treatment occurred one year or longer (late effects) from the date of surgery; less than one year to the date of the first measurement cycle 
^ The radiotherapy data for the patient could not be found in her patient file 
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Fractionating treatments determine some of the outcome of the effects. Larger dose fractions 
require less total dose but lead to more long-term effects; conversely, smaller fractions require 
a larger dose but have fewer long-term effects (Stone et al., 2003). All patients in the present 
study with smaller doses were shown to reduce late effects and have less severe outcomes. 
Patient FS/2013/02 received the largest dose per fraction of 3.2 Gy compared to 2.4-2.7 Gy for 
the other patients and received a second radiotherapy treatment during the physiotherapy 
treatment, which led to her having to stop the physiotherapy treatment and restart a few weeks 
later with worsened symptoms as described in the physiotherapy notes and patient cases.  
 
The worsened symptoms in patient FS/2013/02 could be the result of more severe 
consequential late effects to the fascia and other tissues, exacerbated by chemotherapy (Stone 
et al., 2003) and could also account for the reduced improvement after physiotherapy (< 20% 
improvement on ROM taking into account the baseline she had), limited changes on US (residual 
increased echotexture) and a cord remnant present. The specific patient example agrees with 
the literature on the effect of radiotherapy. Generally, a trend appeared that those treated with 
radiotherapy appeared to have a greater amount of fibrosis as visualised on US in the form of 
coarse echotexture and thickened fascial layers, which has been identified in the literature 
(Stone et al., 2003).  
 
 
5.1.5.2.  Chemotherapy 
Apart from having fibrotic effects, chemotherapy drugs have also been shown to increase 
radiosensitivity of certain tissues (Stone et al., 2003). Table 5.2 indicates the different 
treatments the current cohort of patients was exposed to and the evidence in the literature on 
whether they have been shown to be implicated in fibrosis or lead to increased sensitivity to 
injury and subsequent fibrosis after radiotherapy. All regimens and drugs used in the cohort 
appear to lead to increased sensitivity of certain anatomical tissues with direct evidence 
showing cyclophosphamide causing lung fibrosis (Yu et al., 2004). Little evidence could be found 
in the literature for the effects of chemotherapy on skin and subdermal tissues, except for 
paclitaxel and docetaxel which have been shown to be involved in cutaneous fibrosis (Cleveland, 
Ajaikumar & Reganti, 2000; Ostoros et al., 2006). 5-Fluoroacil, as part of most drug regimens 
given to patients in the current sample (Table 5.2), has been suggested to reduce proliferation 
of myofibroblasts (which have a contractile function in the fasciae), but this conjecture was not 
supported in experimental studies (Bulstrode et al., 2005). On the other hand, the same paper 
does point to lung fibrosis sharing a relationship with 5-fluoroacil treatment. 
 
In the current study, a direct contribution of chemotherapy was possibly only observed in 
patient FS/2013/02. She received one chemotherapy cycle (with CEF) and started a second 
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(with paclitaxel), as well as her radiotherapy treatment during physiotherapy, possibly affecting 
her outcomes of increased axillary fibrosis and adhesions as observed by the physiotherapist. 
 
Chemotherapy has also been linked to altered shoulder movement in a study done by Shamley 
and colleagues (2012) in which breast cancer patients showed decreased activity in pectoralis 
major and increased activity in serratus anterior. Decreased activity in the muscles leads to 
movement deviations and possible worsened outcomes, and may be a contributing factor to the 
results found in the current study.  
 
Table 5.2. A summary of the different chemotherapy drugs administered to the study participants and 
whether they have been shown to effect fibrosis, and their anatomical locations, with example studies. 
 
Chemotherapy drugs and fibrosis   
Name Constituents Fibrosis Anatomical location 
CAF  Cyclophosphamide* Y Pulmonary – pleura (Yu et al., 2004) 
Adriamycin#  (Lee & Harris, 2011) 
5-Fluoroacil#  (Bulstrode et al., 2005) 
CEF  Cyclophosphamide* Y Pulmonary – pleura (Yu et al., 2004) 
Epirubicin  - 
5-Fluoroacil#  (Bulstrode et al., 2005) 
Paclitaxel - Y Pulmonary – alveoli, interstitial; Cutaneous 
(Ostoros et al., 2006) 
Gemcitabine# - Y Pulmonary – alveoli, interstitial; liver (Shahrokni et 
al., 2007) 
CMF Cyclophosphamide* Y Pulmonary – pleura (Yu et al., 2004) 
Methotrexate# Y Pulmonary – alveoli, interstitial (Bedrossian et al., 
1979) 
5-Fluoroacil#  (Bulstrode et al., 2005) 
Vinorelbine# - Y Pulmonary – alveoli (Kirkbride et al., 2002) 
Taxotere/Docetaxel# - Y Diffuse scleroderma (Hassett et al., 2001) 
Cutaneous (Cleveland et al., 2000) 
# radiation-sensitizing agents 
* causes lung fibrosis 
Y = yes, N = no 
 
5.1.5.3.  Hormonal therapy 
Tamoxifen was the only hormonal therapy that was found in the literature to be related to 
fibrosis; in particular, enhancing the fibrotic effects of radiotherapy treatment to the lungs 
(Table 5.3), but could also have further reaching effects. As an aromatase inhibitor, it reduces 
the amount of oestrogen circulating in the body to reduce the growth of oestrogen-sensitive 
tumours (Fede et al., 2016). Recent discoveries have shown sex hormone receptors to be present 
on fascial tissue and that oestrogen has an anti-fibrotic effect on the receptors by reducing TGF-
B expression and collagen deposition (Fede et al., 2016). Less oestrogen, as a consequence of 
taking tamoxifen, could thus lead to more fibrosis. The finding has been used to explain the 
observation that women experience more fibrosis and myofascial pain than men (Fede et al., 
2016), and could explain a contribution of the drug to the fibrotic findings found in the current 
study.  
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Table 5.3. A summary of the different hormonal therapy drugs administered to the study participants and 
whether they have been shown to cause fibrosis, and their anatomical locations, with example studies. 
 
Hormonal therapy drug and fibrosis 
Name Fibrosis Anatomical location (study) 
Arimidex/Anastrasole N (Yavas et al., 2013) 
Tamoxifen Y Pulmonary – alveoli, interstitial; liver (Yu et al., 2004) 
Exemestane - - 
Provera - - 
 
5.2. AWS variables 
The majority of the sections in the previous section were able to be explained using fascial 
terminology – supporting the first hypothesis of the present study. The current section 
highlights general findings (Section 5.2.1) and findings regarding patient symptomology in AWS 
and fascial explanations where appropriate. In order of discussion are: pain (Section 5.2.3.1.), 
ROM (Section 5.2.3.2.) and FACT-B and quality of life (Section 5.2.3.3.) 
 
5.2.1. General (Results Section 4.3.) 
In the literature, the main symptom triad of AWS is described as cording, pain and reduced 
movement with a feeling of tightness. The symptomology presented by patients in the present 
study showed that not all patients complained of reduced ROM (n = 3) and two did not complain 
about having pain. The pathognomonic sign therefore appears to be the axillary cord, with which 
the literature agrees (Moskovitz et al., 2001; Tilley, Thomas-MacLean & Kwan, 2009; Rashtak et 
al., 2012; Craythorne, Benton & Macfarlane, 2009). The literature divides the cases into 
symptomatic or asymptomatic; why some patients remain without symptoms is not explained 
(Yeung, McPhail & Kuys, 2015). The differences in presentation in the literature could be due to 
individualising factors in treatment, as highlighted by the variability in cord and symptom 
presentation in the current study. 
 
Some studies include numbness as an additional symptom (Wei et al., 2013; Lattanzi, 
Zimmerman & Marshall, 2012) possibly because of intercostobrachial nerve involvement and 
damage either during surgery (Cheville & Tchou, 2007) or impingement subsequently.  
 
Symptom resolution did appear in most patients in the current study after physiotherapy 
(including cord resolution as described above), but some patients still reported continuing 
tightness and pain. The continued presence of some symptoms in our sample corresponds with 
the literature as especially limited shoulder ROM was still present in patients, even if the other 
symptoms resolved (Craythorne, Benton & Macfarlane, 2009; Wei et al., 2013). 
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5.2.2. Cord characteristics 
The present section highlights specific surface anatomical characteristics of the cord an factors 
influencing it. In the order they are discussed below are cord length (Section 5.2.2.1.), 
multiplicity (Section 5.2.2.2.), location and extension (Section 5.2.2.3.), size and grading (Section 
5.2.2.4.), and cord appearance (Section 5.2.2.5.). 
 
5.2.2.1. Cord length (Results Section 4.2. + 4.4.2. + 4.6.5.) 
The present study is one of few that has looked at cord length. In our current sample, the cords, 
as measured in the axillary space, ranged from 5.7 cm to 14.0 cm before physiotherapy and from 
0 cm to up to 9.7 cm in those in which the cord did not resolve after physiotherapy, which was 
not a statistically significant change. The cord did, however, resolve in 50% of the sample. 
Koehler (2013) describes that, in a sample of 17 patients, the cord length ranged between 0.3 
cm and 17.2 cm. Leduc and colleagues (2009) describe a longer cord length in his 15 patients 
with a range of 24 cm to 57 cm, but was able to follow it beyond the axillary space. The 
discrepancy between the studies might be because of different measuring methods and 
definitions, individual characteristics that may worsen the cord development and presentation 
such as anatomical variation of the affected vessels and tissues resected, adjuvant therapies 
used, an inability to measure the cord due to an inability to hold the arm open, or may be related 
to BMI, making the cord easier to observe beyond the axilla. 
 
Further analysis of the cord length and relating it to other outcome variables in the present study 
showed a single statistically significant relationship before physiotherapy between increased 
internal rotation and a longer cord length (r = 0.791). The relationship may be explained by the 
observation that the longer the cord length, the more exposed the cord is. In the majority of 
patients, the cord appears to be attached mostly in the midaxillary line impeding predominantly 
abduction movements as that is where the tension is placed, and tissue glide is therefore 
restricted (as seen in the current study). Internal rotation puts more tension medially, allowing 
the axilla to open up and the arm to move more easily, especially for a longer cord in which the 
attachments may be closer to the skin given the definition in the current study of cord length 
being the length between the outermost points of tethering.  
 
After physiotherapy, there was a significant negative association between cord length and SPADI 
Pain (r = -0.895). The relationship could be explained by hypothesising that, the longer the cord 
the more adhesive tissue will have formed, and hence the more fascial pathology will be present 
including the increased activation of nociceptors (also see Section 5.2.3.1.2.).  
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Generally, decreased cord length appeared to descriptively relate to better SPADI scores and 
ROM. Individual improvements, as seen in the case reports, highlighted the improvement in all 
domains after physiotherapy and cord length reduction or resolution. Better functioning is 
corroborated by the findings by Fourie & Robb (2009) which showed improvement in ROM and 
pain upon cord resolution.  
 
Cord length may not, however, be a good indicator of the true size of the full lesion as the cord is 
thought to be the area where the fibrosed vessel is adherent to the dermis via adhesions (Fourie, 
2014) and an external measure may thus not be clinically relevant. For example, in the current 
study, cord length after physiotherapy was found to be reduced and accompanied by reduced 
restriction, tightness and adhesions of several layers to the dermis on US. A study by Fourie & 
Robb (2009) found similar findings and explained it by their loosening of the cord from its skin 
adhesions using manual therapy. Furthermore, the full extent may not be visible due to the 
difficulty observing the cord on US (Leduc et al., 2014). The inability to visualise the cord fully 
indicates that it might be only visible and palpable cord disappearance and not real shortening 
of the lesion in the studies where the cords have resolved as has been discussed in Section 
5.1.3.5.  
 
5.2.2.2. Multiplicity (Results Section 4.6.3.) 
Multiple axillary cords, or webbing, is the reason for which AWS got its name. In the present 
study, only one patient described having two cords, the second of which was not very clearly 
observable. Numerous studies describe not one but multiple cords appearing in the axilla (Leduc 
et al., 2009; Koehler et al, 2014). If one observes that the cords are fibrosed vessels that were 
damaged during axillary surgery, the occurrence of multiple cords may be the result of either 
multiple vessels being damaged or an injury at a vessel that bifurcates leading to the multiple 
fibrosed strands. The superficial fascia in the axilla contains venous and lymphatic plexi that 
could be the target of the damage (Standring, 2008).  
 
5.2.2.3. Location and extent (Results Section 4.6.1. + 4.6.2.) 
The exact location of the cord in the axilla had not yet been documented in the literature prior 
to the current study. The present study found cords appearing either superficial to 
coracobrachialis, in the axillary vascular groove or in the mix-axillary line (Figure 4.27) and only 
one patient presented beyond the axilla reaching over the cubital fossa (FS/2013/01).  
 
Koehler (2013) described the cordǯs presence in predominantly the axilla, but also in the upper 
arm, elbow, forearm and chest wall. Leduc and colleagues (2009) described the cord as arising 
from the axilla and course via the epitrochlear area, via the anteromedian aspect of the forearm 
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to the base of the thumb in all the patients in his sample. The finding of Leduc and colleagues 
(2009) contrasts to our study, as they showed the majority of the cords originating from the 
lower axilla, often arising from the scar, and then disappearing in the proximal upper limb or 
axilla.  
 
The location of the cord may give an indication of the anatomical origin of the cord. A study by 
Leduc et al. (2009) attempted localisation of the cord to identify the anatomical structures 
involved, comparing the trajectory of the cord along the upper limb to cadaveric specimens of 
the superficial lymphatic pathways which overlapped. The present study was unable to localise 
the cords beyond the axilla due to most of the cordsǯ trajectories being limited to the axilla. The 
current study did show the majority of the fascial changes occurring close to the dermis on US, 
indicating that small lymphatic vessels or veins present in the SAT may be implicated as that is 
their anatomical location (Stecco, 2015). The small size of the vessels, however, does not 
necessarily corroborate the external appearance of some very large and thick cords, and some 
very thin, and will be discussed in the next section. Determining the anatomical origin of the cord 
was beyond the scope of the current study and future research using biopsy studies may be more 
successful.  
 
5.2.2.4. Size and grading (Results Section 4.6.4.) 
Grading the size of the axillary cord has not been done in a standardised fashion in the literature 
(Yeung, McPhail & Kuys, 2015). In the present study, it proved difficult to measure the cordǯs 
diameter due to its variable width along its length and the inability to measure accurately; hence, 
descriptive terms such as string-like and finger-thick were used and a variety of presentations 
were observed that were not able to be linked to findings on other domains per se. 
 
Other studies attempted to standardise measurement of the thickness by using different 
methods. Josenhans (2007) described the width of a cord using a scale that ranged from Ǯ+ǯ being 
a small cord and Ǯ+++ǯ indicating a thick cord. Koehler (2013) described it as 1 mm, bigger or 
smaller than that. She did, however, indicate the same difficulty of measurement with callipers 
due to the cords being too deep or not visible or having increased hypodermal thickness. 
 
A thickness measure, however, may be artificial as it will include surrounding tissues of the 
fibrosed vessel structure such as superficial adipose and fibrous tissue and may not be what, in 
the literature, is understood as the cord. The variable thicknesses along the length of a cord as 
observed in the study may corroborate that. As previously mentioned, a clear definition of 
exactly what the cord is has not been discussed; the definition needs to clarified in further 
studies. For the purposes of the present study, the cord includes the full extent of the fibrosity 
and is not limited to a fibrosed vessel.  
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5.2.2.5. Cord appearance (Results Section 4.6.7.) 
Cord appearance has been described in the literature on the basis of whether the cord was visible 
(protruding) and showed a clear bowstring appearance or whether it was only palpable – which 
presented almost 50% each in a study by Leidenius et al. (2003) – which adds to its elusive 
character and could be related to BMI or hypodermal thickness.  
 In Mondorǯs disease, where the cords appear similar to the cords in AWS but in a different 
location, a relationship in the appearance of the cord, which either indents or protrudes, and the 
hypodermal thickness, was observed (Bauerfeind, Himsl & Rueh, 2006). A patient with more 
adipose tissue would present with a furrow and can be explained by adipose tissue accumulating 
around the cord pulling the skin inwards. A number of cases with Mondorǯs disease presenting 
on the lateral side of, and superior to, the breast and on the chest wall exemplified the furrow 
appearance (Bauerfeind, Himsl & Ruehl, 2006). In our present sample, however, few patients 
exhibited a relationship to hypodermal thickness with some patients presenting with a 2 cm 
thick hypodermal layer showing a protruding cord (e.g. FS/2013/08) and a patient with < 0.5 
cm thickness showing an indenting cord (e.g. FS/2013/05). 
 
An additional explanation for the appearances observed beyond hypodermal thickness could 
relate to the adhesion of the cord to particular tissue layers. In the axilla, an indenting cord could 
be adherent to skin and underlying layers, showing as a furrow upon abduction. A protruding 
cord, on the other hand, would be more adherent to the skin, which would be tensed upon 
abduction producing the classical bowstring appearance in the axilla and is when the cord is 
most clearly observed. A cord that is merely palpable could then have a stronger connection to 
the underlying layers or looser connection to the skin, similar to an adherent scar as indicated 
in Figure 5.3. No clear differences between the presentations could, however, be observed on 
imaging in the different layers. After physiotherapy, cording became much less noticeable or was 









Figure 5.3. Skin invagination occurs not only in cording, but generally in scar tissue upon movement of the 
tissue here shown by flexion of the anterior surface of the forearm. Photo courtesy of Jean-Claude 
Guimberteau, 2015. 
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Table 5.4. Findings of imaging studies in AWS related to fascia and cord visualisation. 
Lead author 
and year 
Sample Findings Fascia Cord visualisation? 
Wei, 2013 n = 1 Doppler echo showed 
subcutaneous cords was a 
vessel 
No mention of 
fascia 
Yes 
Leduc, 2014 n = 15 Hyperechogenic structures at 
dermal-hypodermal junction 
on US; MRI showed 
hyperechogenic infiltration of 
general tissue 





OǯToole, ʹͲͳͷ n = 5 Striated linear appearance on 
longitudinal US; honeycomb 




No consistent or 
reliable indicator of the cordǯs presence 
Koehler, 2014 n = 17 No statistical differences 
occurred between affected 
and unaffected sides in terms 
of skin thickness, 






No consistent or 
reproducible 
identification of the 
cord 
 
5.2.2.6. Cord visualisation (Results Section 4.7. + Chapter 7) 
Cord visualisation is a contentious issue in the AWS literature. In the current study, there was 
no consistent structure on US that could describe the cord as seen on surface examination. Out 
of four studies (see Table 5.4) that used imaging to visualise the cord in AWS, only two were 
confident in finding a structure representing the cord. The reasons for the discrepancy 
mentioned were because of the cordǯs origin as a lymphatic vessel (Koehler et al., 2014) which 
is difficult to visualise on US; the cordǯs small size (Leduc et al., 2014); lymphedema fluid ȋOǯToole et al., 2015); or fibrotic and fatty tissue obscuring the cord (Koehler et al., 2014; Leduc 
et al., 2014). Leduc and colleagues (2014) noted that in an environment that is hyperechogenic 
such as the hypodermis, a hyperechogenic fibrotic cord would not be noticed.  
 
Although the cord could not be seen directly on the US scans in the current study, its superficial 
location could aid in understanding the aetiology of the disorder. As mentioned previousl,y 
according to Stecco (2015) the SAT contains predominantly veins and lymphatic tissues. The 
cord, being a small structure, possibly corroborates the hypothesis that the cord may be a 
superficial lymphatic or vein. Generally no vessels or fibrosed vessels could be identified in the 
current study. Leduc and colleagues (2014) mention that the cord is a very small structure and 
that their use of a higher frequency US probe (17 MHz vs 12 MHz in the current study), which 
increases the detail seen in more superficial layers, could explain why they were able to visualise 
the cord compared to the current and other, similar, studies. Although Wei and colleagues 
(2013) did not use a higher frequency probe, their use of Doppler imaging indicating flow 
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passing through the cord additionally highlighted a possible vessel as the structure representing 
the cord. Yanik and colleagues (2003) also showed a very small tubular reduced echoic structure in Mondorǯs disease but without flow on Doppler US. The radiologist analysing the MRI scans in 
the current study, however, suggested that the absence of a STIR hyperintensity in the cord 
indicates neither a patent vessel of either venous or lymphatic origin to be contributing to the 
cord. It does, however, not exclude a fibrosed vessel or fascial origin to the cord as hypothesised 
by Salmon and colleagues (2009) and only represented a single patient. More research is 
required. 
 
In the current study, findings of visualising the cord on MRI included multiple thinner linear 
fibrotic lines confluencing with subcutaneous adipose and fascial tissue of the upper limb and 
axilla forming the cord, supported fascial involvement. On MRI, the fibrotic tissue appeared to 
give a low signal on both T1 and T2, concurring with comparisons of hyperechogenic signals 
between US and MRI by Fumiere et al. (2007). The study by Leduc and colleagues (2014) 
produced similar findings on MRI. Their study with 15 patients highlighted the cord as being a 
conglomerate of multiple fibrous SF strands that connected at the skin. The structure appeared 
next to a lymphocoele, highlighting the cordǯs possible lymphatic aetiology.  
 
Although the present study showed features mentioned on US and MRI being indicative of fascial 
inflammation, adhesion formation, fibrosis and densification, most of the authors that used 
imaging to visualise the cords contents stipulate that there is no involvement of the fascia in 
their findings (Table 5.4). Koehler and colleagues (2014) mention that no abnormal fascia was noted by the radiologist. OǯToole ȋʹͲͳͷȌ mentions the fibrous honeycombed structures they 
observed were unrelated to fascia. Leduc and colleagues (2014) mention that no focal fascial 
thickening was observed on US or MRI, nor was there any evidence for scar adhesions or 
inflammation, although the structure they highlight as the cord consists (confusingly) of fibrous 
tissue. 
 
The differences in observations (and opinions) may be due to the different definitions of the 
cord, confusion surrounding what fascia actually is and its involvement in the healing response. 
Given the cordǯs adhesive, puckering and tight appearance on surface anatomy, the current study 
was interested in the fibrotic nature of the cord, fascial involvement and how the cord related to 
surrounding structures. US alignment, which had not previously been done, was used to attempt 
to appreciate the fascial continuity by giving a longitudinal and cross-sectional view of how the 
fasciae and surrounding anatomy are affected in AWS. Although US was used to visualise the cordǯs contents from a wider perspective, the present study found that MRI was better at 
visualising the full structure of the cord as it was better able to give an overview of the fibrotic 
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range of the cord and the structures it affected. US showed indicative features rather than a clear 
structure, possibly due to fat admixture or oedema as highlighted by echotexture changes. On 
the other hand, Leduc and colleagues (2014) concluded that US was better able to visualise the 
cord, based on their definition and ability to observe an actual vessel/structure to determine the 
cordǯs original aetiology, rather than observing the wider tissues involved which is the focus of 
the current study. Furthermore, fibrotic tissue as deposited material in the healing process may 
not be seen to be related to fascia, possibly explaining the conflicting message by Leduc and 
colleagues (2014) regarding fascial involvement. 
 
Another reason for the discrepancy in whether the fasciae are involved in the cord or not could 
be related to the limited knowledge regarding fascial anatomy and the subtle changes that can 
occur in fascial pathology. The present study utilised US terminology and fascial anatomical 
literature to identify the different structures on imaging and to describe the differences and 
changes seen in the fascia. US analysis of the fascia is, however, still in its infancy and many 
radiologists do not examine the tissue very often, if at all (Langevin & Kawakami, 2012). The 
radiologists used in the AWS imaging studies may thus not be focussed of fascial pathology and 
hence may miss or dismiss any changes to the fasciae, which could further explain why the cord 
or features related to it are not easily recognised on US.  
 
The explanations in the current section support the first and second hypotheses of the present 
study. In the subsequent sections specific US findings will be described in conjunction with the 
outcome measures . 
 
5.2.3. Outcome measures of SPADI, ROM and QOL 
The present section discusses the patient outcome measures in AWS: pain in general, as 
measured by SPADI and explained by fascial changes (Section 5.2.3.1), range of movement 
(ROM) changes with fascial explanations (Section 5.2.3.2), and quality of life (QOL) in the FACT-
B (Section 5.2.3.3). 
 
5.2.3.1. Pain in AWS (Results Section 4.3. + Chapter 7) 
Pain has been found to be associated with AWS patients in most studies (e.g. Lacombe et al., 
2009; Moskovitz et al., 2001; Koehler, 2013; Wei et al., 2013, Kepics, 2007; Johansson et al., 
2001). Not all patients, however, present with pain generally which appears to be an enigma in 
the literature in general post-breast cancer treatment (Shamley et al., 2007). In the current 
study, two patients did not self-report any pain upon initial questioning. The AWS literature 
suggests figures ranging from 5.4% of the sample in Bergmann et al. (2012) to 24.3% in Fabro 
et al. (2012) in terms of pain presence.  
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The pain experienced in AWS may be described as localised or spreading. Moskovitz and 
colleagues (2001) described the pain as arising in the affected axilla and radiating to the scar 
and up into the arm, predominantly upon movement and was described by most patients in the 
current study. Other studies report pain in the neck, superior to the clavicle and even spreading 
to the contralateral breast upon manual manipulation of the affected arm (Fourie & Robb, 2009). 
The pain could also be from other comorbid conditions. In the present study, patient 
FS/2013/04 experienced neck pain but was attributed to thoracic kyphosis rather than AWS. 
 
Pain has been measured using different scales. Some studies used a visual analogue scale to 
identify pain (Wei et al., 2013; Lacomba et al., 2009). To explore which actions affected the patientǯs functioning and possibly led to pain, the present study utilised the standardised SPADI 
questionnaire.  
 
5.2.3.1.1. SPADI (Results Section 4.4.3. + 4.4.4. + 4.5.3.) 
The present study was the first to use the SPADI as a specialised shoulder pain and disability 
questionnaire to measure pain and disability. The measure showed patients in the current study 
presented with moderate-to-high scores before physiotherapy ranging from 22-107 out of 130 
upon shoulder movement. Moderate-to-high pain intensity experienced by AWS patients was 
also reported in several other studies (Wei et al., 2013; Lacomba et al., 2009; Koehler, 2006).  
 
After physiotherapy, a significant reduction for SPADI Pain (p = 0.0003) or a median 54%, SPADI 
Disability (p = 0.0055) or a median 35.8%, and SPADI Total (p = 0.0008) or a median 42.7% were 
observed. Comparing the before and after score ranges showed the biggest minima and maxima 
shift after physiotherapy for both SPADI components and the total SPADI score. The reductions 
in pain and disability matched with similar findings in ROM (improvements especially on 
abduction and flexion) and changes observed on imaging (towards more regular, fluid fasciae). 
Although no statistical correlation between the other outcome measures was found, a general 
trend was observed and also corroborated by the literature. Fourie & Robb (2009) reported 
reduced pain after physiotherapy – although no formal measurement was taken – which 
corresponded to improved mobility.  
 
Further analysis, separating the two domains of the SPADI, showed the pain score being further 
reduced in its overall contribution to the total score, indicating that disability was the main 
contributing factor to the SPADI score after physiotherapy (Disability 63.6% vs Pain 36.4%). 
Disability domain items Ǯcarrying a heavy objectǯ, indicating strength, and Ǯputting an object on 
a high shelfǯ and Ǯwashing backǯ as well as pain domain items such as Ǯlying on the involved sideǯ, 
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showed highest morbidity as shown by the highest contribution to the total score suggestive of 
pain induced by stretching the affected arm, which is corroborated by long-term findings by 
Shamley et al. (2007), and with the same items affected statistically in comparison to the larger 
cohort (Section 4.4.4.). Fascial explanations for ROM disability will be discussed in section 
5.2.3.2. 
 
The larger cohort comparison highlights that, in the general pool of breast cancer patients, there 
may be significant debilitation post-breast cancer treatment regardless of whether cording was 
present. The findings require further research and attention.  
 
5.2.3.1.2. Fascial explanation for pain 
Damaged fasciae may explain the functional and pain difficulties experienced by the patients. As 
pain appears to arise mostly upon movement in AWS, the tension then placed upon injured 
tissues might be able to explain the pain activation.  
 
Traction on the skin as a result of skin adhesions and restrictions prevent smooth gliding of the 
fascial tissues and increase tension on the nociceptors causing pain, which can also lead to 
mechanical irritation and subsequent pain (Fourie, 2014). Adhesions are present in the present  studyǯs patients as visualised on US and MRI before physiotherapy as connections between the 
dermis, SF, DF and muscle. Reduced adhesions after physiotherapy could explain some of the 
reduced pain in the current study (Bouffard et al., 2008; Myers, 2012).  
 
An additional explanation for tension causing pain could be as a result of the disruption of the tensional network of the skin. The ǲrelaxed skin tension linesǳ, also called Langerǯs lines, or the 
lines of force in which the skin is held taut, have been used to instruct surgery where to cut to 
obtain the best cosmetic outcome (Crumpler & Ghaudhry, 2001; Borges & Alexander, 1962). 
When a scar crosses the lines, the tension that is put on the healing wound causes widening of 
the injury gap with resultant worse inflammation, scar tissue, adhesions and a higher risk for 
hypertrophic scars (Borges & Alexander, 1962; Fourie, 2014). In our AWS patients, the cord runs 
perpendicularly to skin tension lines in the axilla, possibly explaining some of the biomechanical 
limitation in ROM that is observed (Venkateswaran, Levy & Copeland, 2004). The skin tension 
line explanation with regard to movement restriction and pain is new in the AWS literature and 
could explain why some patients with different cord locations or appearances may suffer less 
pain but still experience a reduced ROM. 
 
Tension placed on the fascia may also explain pain arising in AWS patients. Recent literature has 
shown that the fascia is highly innervated with pain receptors that are activated upon stretching 
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(Schleip et al., 2006). The nociceptors are embedded within all fascia layers (Stecco, 2015). 
Damaged fascial tissue which has become adhesive and tense as a result of surgery and 
neoadjuvant treatments in AWS patients could thus explain some of the pain that the patients in 
the current study experience when stretching the fascial tissues upon movement (Shamley et al., 
2007; Fourie & Robb, 2009). Patients with a more radical surgery, resulting in more injured 
fascial tissue, furthermore appeared to suffer more pain (Shamley et al., 2012). Physiotherapy 
has been thought to aid in tissue restoration and remodelling, which may have aided in reduced 
pain after physiotherapy (Schleip, 2012; Meert, 2013). 
 
Specific pathological changes to the matrix of the fascia after injury have been linked to pain, 
inflammation and loss of function (Lee & Spicer, 2000; Stecco, 2015; Lee & Spiecer, 2000). Fascial 
fibrosis was especially noticed as thickening of the superficial fascia on US scans in the current 
study. Langevin and colleagues (2009) in their study found microinjuries in patients with 
chronic lower back pain and subsequent US analysis showed an increase of 25% in 
thoracolumbar fascia thickness and echogenicity. Johansson and colleagues (2001), in addition, 
mention that fibrotic changes apart from pain also appear to lead to reduced strength and fatigue 
as also seen in the current study analysing the SPADI results. Improvements in regularity of the 
fasciae, reduced thickness as well as improved continuity and layering after physiotherapy as 
seen on US in the current study, could explain some of the reductions in pain and may be the 
result of tissue modification encouraged by physiotherapy (Schleip, 2012; Meert, 2013). 
 
Stecco (2015) describes that, in fibrotic tissue, muscle spindles are not activated, leading to 
altered joint ROM and pain. Deising and colleagues (2012) observed that pain receptors in, 
especially, the deep fascia may become sensitised to altered movement patterns as a result of 
fibrotic tissue, explaining the development of long-term (muscular) pain found in the current 
study, with patients presenting years post-treatment with pain. The explanations are also 
supported by Shamley et al., 2007.  
 
Straining of the musculature and shoulder components upon altered shoulder movement as a 
result of myofascial restrictions, and under-activation of some and over-activation of other 
compensatory muscles, may also lead to muscular pain (Shamley et al., 2012). The axillary fascia 
has multiple fascial connections to the shoulder girdle, explaining movement alterations upon 
fascial damage. In the present study, compensatory scapular movement on the affected side 
showed increased internal rotation and was explained by the physiotherapist to be causing 
possible internal or external impingement leading to pain. An earlier study by Shamley and 
colleagues (2007) showed that, in breast cancer-treated patients, over-activation of upper 
trapezius and rhomboid, which are related to scapular movement and would cause altered 
- 82 - 
 
shoulder movements, were linked to an increased SPADI score. The authors commented that the 
omission of the connective tissues in their analysis might be able to explain pain and reduced 
ROM. Improved movement and functionality of the shoulder as shown in the current study after 
physiotherapy may thus also have led to improved pain measures due to reduced shoulder strain 
by removing adhesions and tension.  
 
Altered shoulder movements and resulting postural changes as well as an avoidance of 
particular actions (highlighted by the impaired movements in the SPADI disability section) may 
also explain the presence of pain. Lacomba and colleagues (2009) suggested that, in AWS 
patients, there is myofascial pain resulting from activation of the trigger points in latissimus 
dorsi, infraspinatus, pectoralis major and pronator teres. Myofascial trigger points are located 
in the muscles and are areas that can become contracted within the myofascia as a result of poor 
posture or damage, and that can cause local ischaemia which increases nociceptive signalling 
(Gautschi, 2012). The chronic inflammatory process prevents the unknotting of the trigger point, 
leading to a chronic myofascial pain syndrome. In the current study, physiotherapy may have 
aided in reducing the chronic inflammatory process by myofascial stretching. Stretching, as done 
in the present study, has been thought to remove inflammatory cytokines from the tissue, 
reducing the inflammatory response and leading to tissue restoration (Schleip, 2012; Meert, 
2013). Gradual guidance of remodelling and releasing the myofasciae could thus have aided in 
reduced pain post-physiotherapy (Fourie, 2014).  
 
The radiation of pain in our patient sample and the literature (Moskovitz et al., 2001) may be 
explained by the different nerves that transfer the pain signals. Pain within the superficial fascia 
appears to follow the dermatomal distribution whereas pain arising from deeper fascia follows 
motor nerves, due to the deep fasciaǯs myofascial continuity (Stecco, 2015). The idea of 
myofascial expansions from one muscle to another clarifies how different muscles involved in 
the same directional movement or action have anatomical continuity. Stecco (2015) explains 
that pain may be followed along the lines of force in the expansions, explaining the radiating 
pattern upon movement, and names the pattern a ǲfasciatomeǳ. The fasciatome can explain the 
resulting radiation of painful stimuli or distal parasthesia away from the primary insult over the 
arm upon particular movements. Stretching, as practised by the physiotherapist in the current 
study, is suggested to encourage remodelling of collagen in damaged tissue and may also aid in 
pain relief by releasing receptors which are activated by being confined in a fibrotic tissue and ǲre-educatingǳ them (Schleip, 2003; Myers & Frederick, 2012; Bouffard et al., 2008). 
 
The abovementioned explanations support the first and second hypotheses of the present study.  
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5.2.3.2. ROM (Results Section 4.4.3. + 4.5.) 
Range of movement (ROM) restriction occurs in a large number of patients that resent with 
axillary cords. All patients in the current study reported reduced shoulder ROM from their 
baseline. The literature reports a prevalence of 11.4% to 100% of patients having reduced ROM 
(see, for example, Moskovitz et al., 2001; Tilley, Thomas-MacLean & Kwan, 2009; Rashtak et al., 
2012; Davies & Logan, 2010; Johansson et al., 2001).  
 
The literature presents mostly data on abduction and flexion, even though the present study 
recorded extension, internal and external rotation as well for a better perspective on shoulder 
disability. Comparing the active shoulder movements between the current study and the 
literature showed concurrence in abduction and flexion: 37-132° versus 111-139° for flexion 
and 65-139° versus 90-132° for abduction (Lattanzi, Zimmerman & Marshall, 2012; Koehler, 
2013; Wyrick, Waltke & Ng, 2006). The minima of the ranges appeared lower in the present 
study, indicating that some patients in the current sample may be affected worse than others.  
 
To determine which are the worst affected movements, the ROM values were compared between 
affected and unaffected arms before and after physiotherapy, which ROM increased the most 
after physiotherapy using percentage improvement, as well as which movements showed a 
statistically significant difference on the affected arm after physiotherapy. From the case studies, 
one can observe that, after physiotherapy, the difference between affected and unaffected arms 
became smaller, indicating that the ROM values were closer to their baseline than before. 
Although all movements improved, abduction and flexion showed a statistically significant 
difference, showing to be the worst affected movements which is supported by the literature 
(amongst others, Lattanzi, Zimmerman & Marshall, 2012; Koehler, 2013; Wyrick, Waltke & Ng, 
2006). Abduction increased with 48.9% (p = 0.0078) and flexion showed a 28.3% (p = 0.0062) 
improvement. The changes were further supported by a comparison of the ROM values in the 
study (see Table 4.4) to the normal ROM values in Table 5.5.  
 
The evaluation showed predominantly the ranges of pre-physiotherapy abduction and flexion 
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Table 5.5. Linking shoulder ROM, muscles responsible for the action and SPADI items. 
Shoulder ROM and SPADI 
  Normal ROM women (°) 
(Barnes et al., 2001) 
 
Action Musculature Dominant Non-dominant SPADI items* 
Abduction Supraspinatus 
Deltoid 
187.6 ± 16.1 188.6 ± 15.4 Reaching high 
Touching back of neck 
Washing hair 
Putting on vest 
Placing an object on a high shelf# 
Extension Latissimus dorsi 
Posterior fibers  
Of deltoid 
Teres major 
67.3 ± 8.7 68.7 ± 9.3 Buttoning up shirt 





176.7 ± 5.5 176.2 ± 5.9 Reaching high 
Buttoning up shirt 
Putting on pants 






104.9 ± 12.0 97.3 ± 11.3 Touching back of neck 
Washing hair 
Putting on vest 









47.5 ± 11.2 54.5 ± 11.3 Lying on the involved side/ 
Reaching high 
Pushing with the involved side 
Washing back 
Buttoning up shirt 
Putting on pants 
Protraction Serratus anterior   Putting on pants 
* Both pain and disability items have been included to give a more complete picture of the involvement of the musculature 
# The item as well as item Ǯcarrying a heavy objectǯ involve muscle strength as well 
/ The item also involves tenderness of the involved area 
The items in red indicate the action that significantly improved after physiotherapy, muscles that were found to be directly 




Interestingly, on the unaffected side, abduction improved with a median 31% and external 
rotation with a median 21%. Other changes showed a very limited or a slight negative trend, but 
were within normal ROM (Table 5.5). Although there were no statistically significant changes, 
the trends highlighted possible changes occurring on the unaffected side as well, not previously 
discussed in the literature. Fourie & Robb (2009), for example, found that the opposite side was 
not affected. 
 
To explain the differences seen before and after physiotherapy and to link the movements with 
findings on imaging and SPADI, the theory around fascia will be described. 
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5.2.3.2.1. Fascial explanation for limited ROM 
Although Hase and colleagues (2006) reported no association between pain and RM upon 
improvement after physiotherapy, the current study showed a clear trend with significant 
improvement on both SPADI and ROM measures, even though a correlation between specific 
movements could not be obtained. Table 5.5 highlights the relationship between the muscles 
and their actions related to the different measures on the SPADI questionnaire. The movements 
in red highlight the actions that were significantly improved on the affected arm, the muscles 
which were shown on MRI to be connected to the fibrous cord mechanically linking the 
structures, and the items of SPADI that were found to be the most affected, highlighting a 
biomechanical relationship. As the MRI scans could not visualise the whole structure, and that 
the scans are from a single patient, limits the full extent of the descriptive correlation.  
 
A physical relationship to the muscles could explain the ROM limitations as found in the present 
study. Considering that the axilla is a functional assembly point of many different structures and 
independent movers that are all required to work synchronously, independently but also in a 
particular glenohumeral rhythm for proper functioning (Shamley et al., 2007), any physical 
limitations within the area could affect the ROM deficits.  
 
Adhesions between different tissues such as muscles, subcutis and axillary skin as a result of 
damage to the fat and loose connective tissue in the axilla have been suggested to be a cause of 
the mechanical limitation (Fourie & Robb, 2009) as visualised in the present study on MRI and 
US by linear fibrous connecting strands. OǯToole and colleagues ȋʹͲͳͷȌ also showed linear, 
continuous structures which extended into the biceps brachii muscle on US, supporting the idea. 
 
The development of the adhesions was discussed by Lauridsen and colleagues (2005). In a 
mastectomy patient, where the deep facia of the pectoralis major is removed, they suggest that 
a strong adhesion forms directly between muscle and skin, inhibiting a smooth gliding 
movement that allows for motions of abduction, flexion and external rotation, as observed in the 
current study. In axillary surgery and clearance, the pathological connection forms as a result of 
the removal of all fibrofatty tissue between the lateral side of pectoralis major and minor and 
muscles that line the chest wall and axilla and axillary skin (Lauridsen, Christiansen & Hessov, 
2005). The adhesions may then be further reinforced by adjuvant treatments, resulting in 
tougher adherences (Lauridsen, Christiansen & Hessov, 2005). The adhesions as a direct 
connection could explain the puckered appearance, the tightened feeling with which the patients 
presented, and the reduced active ROM as well as the tension that is put on the muscle via the 
adhesions to its deep fascia and muscle fascicles, preventing it from moving – and is visualised 
as difficult and sluggish movement on the dynamic US videos. Improved ROM after 
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physiotherapy could thus be explained by the breaking of these adhesions as a result of tissue 
stretching (Bouffard et al., 2008; Myers, 2012).   
 
The stiffness and slow motion could also be the result of the hypodermis, the ECM of the deep 
fascia and the hyaluronan becoming more rigid in texture due to the densifying response 
increasing the viscosity of fascial layers as described by Stecco (2015) and causing friction 
between tissue plains with reduced gliding potential on the dynamic scans. Langevin and 
colleagues (2011) describe similar results with decreased trunk range of motion and functional 
ability as a result of reduced gliding in lower back pain patients, with statistically significant 
reduced shear between the layers. In patients with myofascial neck pain, sternocleidomastoid 
and scalene fasciae showed a significant increase in the thickness and density correlating to 
limited neck ROM and pain (Stecco et al., 2014). The latter study also showed reduced fascial 
thickness with significant restoration of the ROM and reduction in pain after physiotherapy, also 
demonstrated in the current study. The findings could be explained by the remodelling 
stimulated and guided by physiotherapy (Fourie, 2014). 
 
Local adhesions can affect tissues at a distance, further contributing to movement limitation, as 
a result of myofascial continuity (Gautschi, 2012) and highlighted by the concept of biotensegrity 
(Schleip, 2012). Due to the fascial continuity between the deep fascia of the muscles of the arm 
and the pectoralis major fascia, which is continuous with the brachial fascia in multiple ways and 
connects to the axillary fascia which connects to the fascia of the back (Stecco, 2015), any 
damage to the network can disrupt independent muscular movement along the chain. 
Biotensegrity may thus explain why the unaffected arm also changed post-physiotherapy as was 
shown in the percentage improvement after physiotherapy seen in abduction particularly 
(Figure 4.2). Shamley and colleagues (2012) found a similar phenomenon in their EMG study, 
showing that there is bilateral morbidity in the shoulder after breast cancer treatment due to 
reduced muscle activation. The phenomenon was suggested to be as a result of systemic effects 
of breast cancer treatments but could also be explained by the disruption of the myofascial 
proprioceptive feedback system as highlighted by Stecco (2009a) in conjunction with the 
biotensegrity model.  Reduced tightness and adhesions after physiotherapy could thus partly 
explain the improvements seen on both affected as well as unaffected arms. 
 
Another factor to consider, in order to explain movement limitation, is the fibrosis that was 
visualised within the muscles, as focal fascial thickening of the fascia and as general dense 
echotexture on the US scans. Table 5.6 highlights the anatomical areas where radiotherapy 
treatment of the patients took place. The areas overlap with the area of US examination and 
hence the changes seen can have been as a result of radiotherapy on the muscles caught in the 
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radiation field. Although skeletal muscle is usually radio-resistant, therapeutic doses can affect 
the muscle and can affect the connective and vascular tissues, explaining the inflammatory and 
fibrotic response seen in and around the muscular tissue (Jurdana, 2008). Improvements in 
tissue healing by increased perfusion via deep friction and removing inflammatory cytokines 
from the tissue may explain the improvements seen in muscles on imaging and improved ROM 
after physiotherapy (Van den Berg, 2010; Schleip, 2012; Meert, 2013). 
 
Table 5.6. The anatomical locations of the area of treatment for radiotherapy for the different patients. 
Radiotherapy area 
Participant # Anatomical area of treatment 
FS/2013/02 Medial axilla, chest wall 
FS/2013/03 Medial axilla, chest wall, supraclavicular triangle / Superior half axilla, 
supraclavicular triangle 
FS/2013/04 Medial axilla, chest wall, supraclavicular triangle 
FS/2013/06 Medial axilla, chest wall, supraclavicular triangle / Superior half axilla 
FS/2013/07 Medial axilla, chest wall, supraclavicular triangle 
FS/2013/09 Medial axilla, chest wall, supraclavicular triangle 
FS/2013/10 Medial axilla, chest wall, supraclavicular triangle / Superior half axilla 
FS/2013/11 Medial axilla, chest wall 
 
 
Lastly, behavioural factors affecting the fasciae can also explain movement limitations as found 
in the current study. Women after breast cancer treatment often present with a protective 
posture with their arm and shoulder to prevent movement and pain (Shamley et al., 2007; 
Fourie, 2014). The abnormal posture may, however, lead to altered scapulothoracic movement 
and brings problems of impingement within the coracoacromial arch and reduced joint stability 
with subsequent inflammation of the tendons and capsules involved (Shamley et al., 2007; 
Stecco, 2015). Altered posture may also result in the shoulder muscles and fasciae to tense up in 
an unnatural position and can lead to movement imbalances (Shamley et al., 2007; Fourie, 2014; 
Stecco et al., 2014). Muscle weakness and shortening were also found by Shamley and colleagues 
(2007) and could also contribute to altered scapulothoracic movement and shoulder movement 
impairment via myofascial continuity. Reduced tissue tightness and pain, possibly as a result of 
physiotherapy, and the teaching of how to improve posture during physiotherapy sessions, may 
explain improvements in ROM as well.   
 
The abovementioned explanations support the first and second hypotheses of the present study.  
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5.2.3.3. FACT-B and quality of life (Results Section 4.4.3.2. + 4.4.4. + 4.5.4.) 
The FACT-B questionnaire, which is specifically aimed at patients with breast cancer, has been 
used in several studies to identify the impact of treatments and interventions on quality of life, 
or QOL (Davies, Gibbons, Mackintosh & Fitzpatrick, 2009). In the present study it was used to 
observe whether the changes that occurred after physiotherapy with respect to cording, pain 
and disability had an impact on the patientǯs quality of life. No other study looking into AWS 
utilised the FACT-B questionnaire or rigorously evaluated QOL in the literature (Yeung, McPhail 
& Kuys, 2015). 
 
In the current study, the median score after physiotherapy showed no statistically significantly 
difference and was very similar descriptively. Analysing the scores separately did show 
improvements with a range from 3.3-12.8% with an exception of patient FS/2013/08 who had 
a reduction of -16.8%. The worsened score in the patient could be due to her comorbid condition 
of fibromyalgia and slipped disc in her back, and her inability to actively do the exercises to 
maintain the improvements as explained by the physiotherapist. 
 
As QOL is very dependent on functioning (Fourie, 2014), the improvement in patientǯs quality of 
life in the present study could be explained by the corresponding improvements on both ROM 
and SPADI score. Although there appeared to be a larger difference after physiotherapy that was 
statistically significant for both SPADI and ROM, the discrepancy in FACT-B score may be 
explained by FACT-B measuring not only functional scores, but also other domains that may not 
be changing in the patientǯs life, reducing the overall effect of the physiotherapy. Further analysis 
indeed did not show any clear differences between the different contributions of each different 
domain to the total score. 
 
When comparing the FACT-B scores to other research findings in the local context, the results 
were consistent with the bigger breast cancer patient cohort as evidenced by statistical analysis, 
indicating the QOL measure was similar in patients after breast cancer treatment. As FACT-B is 
a general measure for breast cancer patientǯs QOL, that it is representative of a larger cohort 
indicates that dysfunction in AWS patients measured in the FACT-B in the current study may not 
be significantly different from general functional deficits after breast cancer treatment in the 
bigger population, which implies substantial morbidity to be present generally and needs 
addressing in a larger cohort as previously discussed. The dysfunctions as a result of general 
breast cancer treatment may be understood by the fascial explanations described in the 
respective pain and ROM sections above (Section 5.2.3.1. + 5.2.3.2.).  
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5.3. Physiotherapy (Chapter 7 + Appendix G + J) 
The current study adds to the existing evidence that physiotherapy is useful in aiding symptom 
resolution and improvement, as all patients who received physiotherapy showed improvement 
after the treatment in our study and three patients experienced full relief of all self-reported 
symptoms – supporting the second hypothesis of the present study. The extent of the 
improvement, however, was dependent on person-specific factors including (neo)adjuvant 
treatments, lifestyle changes and adherence to homework exercises and was difficult to quantify 
as attempted using a ranking system (see Appendix J).  
 
Although physiotherapy was successfully utilised in a number of case and small group studies, 
there appears to be a limit to its ability to restore the patient to pre-operation levels of 
functioning. Besides that damaged tissue does not fully regain its original structure and function 
(Guimberteau & Armstrong, 2015), longstanding chronic tight scars as evidenced in some 
patients may not regain their functioning at all, even with physiotherapy, and being so fixed that 
surgery is the only option to release the tissues (Fourie, 2014), explaining retention of the cords 
in at least two of the patients post-physiotherapy who had surgery longer than a year before 
physiotherapy. 
 
In the present study, the main technique used by the physiotherapist was myofascial release, 
stretching and scar tissue massage to release the cord, to reduce tightening and to improve ROM. 
On US afterwards, these patients presented decreased adhesions, reduced thickening and 
increased multilinearity of the superficial fasciae. Myofascial release aims at the different fascial 
planes and the intersections of muscle and fascia and, once again, highlights the possible fascial 
contribution to the AWS (Fourie, 2014). Several studies have indicated that myofascial release 
or similar techniques aid in the resolution of the cord, the relief of pain and improvement in 
movement (Kepics, 2007; Moreau et al., 2010; Fourie & Robb, 2009; Tilley, Thomas-MacLean & 
Kwan, 2009). A study by Stecco and colleagues ȋʹͲͳͶȌ supports the current studyǯs US findings, 
i.e. a reduction of fascial thickness to normal levels and a concomitant reduction in pain and 
disability using a different myofascial technique called Fascial Manipulation that focuses on the 
deep fasciae. In other studies, myofascial release was shown to improve independent muscle 
gliding as well as coordination between adjacent myofascial structures (Fourie & Robb, 2009), 
and was able to remove tissue adherences by stretching adherent layers independently 
(Bouffard et al., 2008; Myers, 2012).  
 
Although there is very limited research to provide evidence-based recommended treatment 
(Fourie, 2014), there are some suggestions in the literature as to how physiotherapy aids in 
improving tissue adherences and fibrotic scar tissues which were seen in the current study and 
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were highlighted in the previous sections. Stretching the fascia has been hypothesised to 
contribute to functionally changing the fibrotic tissue by encouraging remodelling of collagen to 
new demands (Myers & Frederick, 2012; Bouffard et al., 2008). Furthermore, it has been thought 
to eliminate water and inflammatory cytokines from the tissue, mitigating the inflammatory 
response and improve healing (Schleip, 2012; Meert, 2012). Stretching was also suggested to 
relieve pain by releasing receptors which are activated by being confined to fibrotic tissue and ǲre-educatingǳ them with skilled stimulation (Schleip, 2003). Deep friction is thought to help in 
tissue perfusion and subsequent healing (Van den Berg, 2012).  
 
In our study, the majority of the patients improved post-physiotherapy in all domains of pain 
and disability and reduced functioning on both ROM and SPADI scores. The improvements 
indicate that myofascial release physiotherapy may be useful in treating the participating 
patients and relieving their symptomology. However, due to limited availability with the 
physiotherapist, patients may not have received all the treatments that they would have 
required for full relief of symptoms. Although the majority of patients who received 
physiotherapy have improved over time, the current study did not attempt to evaluate 
physiotherapy and thus the observed changes could possibly be attributed to the normal healing 
process. Physiotherapy was used in the present study as it was previously found to be beneficial 
for AWS patients, improving their range of movement and hastening cord resolution. No 
randomised clinical trials have, however, been done to show the effect of physiotherapy alone 
on cord resolution. Physiotherapy thus cannot be concluded to be the sole contributor to the 
improvements. Although some cords may resolve spontaneously as suggested in the literature, 
a number of patients in the current study presented with cords years after the original surgical 
treatment. Their improvement with physiotherapy suggests that physiotherapy may aid in 
improving their outcome. Furthermore, fascial observations and changes on US may be able to 
guide future treatment. More research including randomised clinical trials is needed to verify 
the efficacy of myofascial treatment in AWS. Lastly, no research has been done to evaluate 
whether physiotherapy may aid in preventing AWS from developing e.g. by stretching in the direction of the Langerǯs lines previously described. More research is needed in this domain as 
well. 
 
5.4. Limitations of the study 
The present study as a pilot and proof-of-concept study to evaluate the involvement of the fascial 
system in AWS using US was able to present several findings in support of the hypotheses set 
out in the introductory chapter. There were, however, a number of limiting factors that need to 
be taken into account and which affected the studyǯs statistical power.  
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The major limitation of the study was the low sample size of the patients (in keeping with proof-
of-concept studies), which affected the ability to perform more powerful statistical analyses and 
to allow evaluation of different relationships. We were therefore restricted to using non-
parametric tests and to describing general trends in order to compare patients. However, 
comparing SPADI and FACT-B measures to findings in several other studies done in the local 
context allowed us to make some inferences about a wider cohort. 
 
Although the current study was predominantly descriptive, the few statistical tests used to 
support the descriptive findings also have limitations. Use was made of the non-parametric 
Spearman rank correlation and Kruskal-Wallis tests. While the tests are less strict and can be 
applied to categorical data as was done in the present study, the tests reduce the data to a 
qualitative form (ranks) which lessens the power of the tests and causes Ǯexactǯ information loss 
(Triola, 2006). Furthermore, the tests are less efficient and require a larger data sample or 
increased differences (e.g. in the Kruskall-Wallis test) between the comparison groups to be able 
to reject a null hypothesis (Triola, 2006). The small sample size of the study could then have 
compromised the testsǯ abilities.  
 
The Spearman rank correlation tests a monotonic relationship present in the data which was not 
specifically analysed for the current studyǯs data, affecting the statistical strength of the test 
(Triola, 2006). To address the multiple comparisons problem, a Bonferroni correction was 
applied to each section but, given the number of comparisons, the correction could have 
increased the number of Type II errors occurring, possibly masking any real correlations, and 
limiting the statistical power of the tests (Peres-Neto, 1999). A larger sample would aid in 
addressing the abovementioned concerns in the future. 
 
The limited sample size was partly due to time constraints with respect to data collection and 
the difficulty in finding patients with cording which, as the quintessential symptom of AWS, is 
often not discovered due it sometimes being a very subtle structure, as exemplified in the current 
study as well. Also, the result that pain and disability as well as quality of life might not be very 
different in AWS patients from the general breast cancer-treated patient population could 
contribute to not easily being able to differentiate AWS patients in the present study. Patients 
may also not have understood the severity or extent of their symptoms, possibly as they had 
been downplayed or dismissed by previous health professionals and thus would not mention 
the symptoms when asked. The current study also lost patients during physiotherapy and for 
follow-up after physiotherapy due to patient-related variables such as the cost, time and 
transport to the study settings due to resource constraints (even though the study would 
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reimburse them for transport costs), and patient health factors such as progressive cancer or 
comorbid disease which could also have affected the studies trends (Harris et al., 2011). 
 
Future studies could look into using a FASTRAK protocol, for example, to improve ROM 
measures (Shamley et al., 2012), to use a radiographer to take US quality scans, or use MRI only 
instead to visualise the involved tissues. Furthermore, we were only able to provide patients 
with a maximum of six physiotherapy session due to the limited time and availability of the 
physiotherapist which may have hindered the patients in their recovery potential. 
 
The absence of blinding could have affected and biased the results, especially considering that 
US is dependent on the skill of the ultrasonographer. The researcher has done US before in an 
unpublished mini-dissertation showing that US is able to visualise fascia clearly (Paulssen & 
Shamley, 2012 [unpublished academic mini-dissertation]). The same researcher performed all 
of the scans to improve consistency and several blinded, independent radiologists observed the 
ultrasonographs to gain a professional opinion. Although the research took a different approach – observing the connective tissues by US alignment – the radiologists seemed not to focus on the 
differences and changes in the fascia. The author therefore used his prior knowledge, anatomical 
knowledge of the area via dissection and from the limited available literature and used 
terminology by Stecco (2015), to describe the visualised fascia with assistance from the 
supervisors as anatomists.  
 
To be able to compare the present studyǯs findings with previous studies by Leduc et al. (2014) 
and Koehler (2013), similar US and cord terminology was utilised in the written analysis of the 
scans. The limited two-dimensional view of the US scans did affect our ability to make 
suggestions about a three-dimensional structure; the alignment of the longitudinal scans, 
however, provided a view on fascial continuity which aided in describing the fasciae better. The 
method could nevertheless be better standardised in future studies. Due to the quality of the US 
scans, greyscale analysis (as performed by Zaidman and colleagues, 2008) to quantify the 
fibrotic content, although attempted, could not be executed. For future research, a more 
experienced radiologist could perform the US scans in three dimensions for both qualitative and 
quantitative analysis.  
 
The limited time available to obtain information during the observation point appointments, due 
to patient pain and disability, meant that we were not able to secure all the scans for each patient, 
which is why certain scans are missing from the patient plates. For example, the patients could 
not always remain in the ABER position required for US, or achieve the same position as other 
patients. The discrepancy might have influenced the ability to compare between patients. 
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Similarly, repeat measurements were not able to be obtained due to the patients experiencing 
pain and discomfort during the ROM measurements and not being comfortable repeating the 
same movements, possibly having led to measurement errors as reliability tests could not be 
performed.  
 Since the study observed active range of movement as representative of the patientǯs ability to function, the patientǯs motivational aspects related to, for example, trying to do what the 
researcher wants to see, might have changed the patientǯs ROM. A way to prevent the limitation 
in a future study is to measure passive ROM where a physiotherapist would take the measures 
to measure the anatomical limitations of the movements (Clarkson & Gilewich, 1989). Measuring 
passive ROM could also aid in determining the pathological barrier, where there is a premature 
end to the passive range of movement (Clarkson & Gilewich, 1989). The restriction indicates an 
impairment in the soft tissue structures which affects the quality of movement between the 
tissues. 
  
Lastly, the present study focused on the adhesions being the result of the fibrotic changes 
occurring after invasive treatments. However, (remaining) malignant cells could also possibly 
contribute to increased TGF-B production, increased fibrosis and possibly tethered tissues, but 
these were not considered in the present study. To avoid complications of tumour seeding and 
spread with physiotherapy, also highlighted in the literature (Langevin et al., 2016), future 
research should consider the possibility in the differential diagnosis of the tethering tissues. 
More research is needed to look into the contribution of malignant tissues to adhesions and 
axillary web syndrome in general. 
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Chapter 6: Conclusions 
 
The current observational, pilot, proof-of-concept study explored the relationship between 
outcome measures relating to the symptomology of patients with axillary web syndrome (AWS) 
and clinical and imaging data to elucidate the involvement of the fascial web and its contribution 
to the symptom complex presented by AWS patients. The study used a case-series design with n 
= 11 patients and addressed two different hypotheses: (1) altered fascia plays a role in the 
restriction of upper limb movement, the perpetuation of pain and the fibrosis and formation of 
the cord in AWS; and (2) changes on US images of the cord, fascia and surrounding structures 
will be evident when the cord resolves or symptoms improve.  
 
To address the first hypothesis, the role of risk factors found in the AWS literature with findings 
in the present sample and in relation to the facial literature were explored. A younger age as a 
risk factor for AWS showed similar findings in the current study and was explained by a reduced 
healing response in the older patients. Increased invasive treatment could be explained to lead 
to worsened cording using fascial fibrosis, and cord resolution could be explained using the 
timing of the wound healing cascade but could be complicated by factors such as movement too 
soon after injury, and abnormal posture. Due to the small sample size, only limited statistical 
analyses could be performed between different variables, reducing generalisability. The limited 
statistical power led to uncertainty regarding the contribution of certain factors such as the 
involvement of (neo)adjuvant treatments in AWS. There is a plausibility, however, that the 
treatments may be involved in the syndrome as they have been found to be implicated in fibrosis 
in the literature. Future studies should aim to include larger patient samples to improve their 
generalisability to the larger cohort. 
 
Other risk factors in the AWS literature appear to contradict the present studyǯs findings. For 
example, the suggestion that the symptom complex was self-limiting and would disappear 
within three months post-surgery was shown to be invalid in the current sample as there were 
women who had experienced relevant symptoms for multiple years. The number of nodes as a 
measure of extent of invasive treatment may not be a good measure due to the dependency on 
correct evaluation by the pathologist. Furthermore, the relationship between lower BMI and 
cording, as found in the literature, may possibly be skewed due to the difficulty of observing the 
cord in people with increased BMI in the current study. The definition of what the cord is also 
made comparisons difficult, as some studies considered the cord to be just its original fibrosed 
vasculature structure, rather than the full fibrotic extent which was regarded as being the cord 
in the present study. The difference in cord definition also affected measures of cord length 
which may thus not be a good indication of the full extent of the affected tissue. 
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Anatomical evidence to answer the first hypothesis was attempted to be provided with imaging. 
Ultrasonography (US) was utilised as a means to determine any visual fascial abnormalities 
comparing affected and unaffected arms and descriptively relating the information to the 
outcome measures of range of movement (ROM), pain and disability as represented by the SPADI questionnaire, and quality of life scores to show how the syndrome affected the patientsǯ daily 
lives using the FACT-B questionnaire and comparing findings to MRI scans of a single patient.  
 
Ultrasonography, as a cost-effective modality, was found to give a good continuous and dynamic 
view of the fasciae, their structure and biomechanical functioning, especially using aligned scans. 
Findings on US scans in n = 11 AWS patients before physiotherapy demonstrated reduced 
continuity, increased thickening of the longitudinal superficial fasciae bands, decreased gliding 
potential and increased adherence of fascial layers to each other and the skin. The findings were 
explained by appreciating the activated and prolonged wound-healing cascade due to invasive 
and continuous treatment, possible behavioural and movement changes and the role 
inflammatory cytokines such as TGF-B play in stimulating fibroblasts to produce collagen which 
may induce subsequent fibrosis and fascial densification.  
 
The US findings corresponded to the surface anatomy in terms of skin puckering, cord 
appearance and the reduced measures of ROM, and increased pain and disability. The symptoms 
could be explained theoretically by consulting the fascial literature. Increased adhesions 
between surfaces, a thick adhesive cord and reduced gliding between muscles as visualised on 
dynamic US may explain the ROM and disability measures before physiotherapy. Pain could be 
explained by the development of myofascial trigger points due to local injury and fascial 
thickening, restrictions and adhesions causing increased traction on the fascia as a result of 
biomechanical limitations causing nociceptor activation. Quality of life measures did not appear 
to change very much after treatment, indicating that it might not be a sensitive enough measure 
in the current cohort of patients, or other factors such as socioeconomic status may be at play. 
 
In the present study, US imaging was unable to visualise the vessel origin leading to the cord, 
which corroborates most of the studies that have attempted to image the cord. MRI scans, on the 
contrary, may be a better alternative to US imaging as, in the current study, MRI was clear in 
being able to show a fibrous band that connected to many different tissues, but MR might not be 
able to provide enough detail regarding fascial continuity. Future studies could consider using a 
three-dimensional US to evaluate the fascia from a multidirectional view, but for clinical 
observation and treatment of AWS, US may be sufficient. In line of the findings discussed 
regarding the risk factors and imaging, hypothesis (1) was supported. 
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To address hypothesis (2), we compared changes on US within the fasciae after physiotherapy 
that focused on treating the myofasciae with aforementioned outcome measures.  
 
Physiotherapy treatment using the myofascial release technique, in particular, appeared to aid 
in improving the patientsǯ ROM and pain to better states than before. In addition, the majority of 
patients in the current study resolved their cords or had their cord length much reduced. 
Improvements on ROM, SPADI and cord measures mirrored observed changes in the US scans 
such as reduced adhesions between tissue planes, increased tissue gliding and tissue restoration 
which resembled the fasciae seen in the unaffected arm. US may thus be a feasible outcome 
measure to evaluate fascia and fibrosis and understand the mechanism by which physiotherapy 
may be effective as well as guide physiotherapy treatment in the future. Hypothesis (2) was thus 
also accepted.  
 
Overall, irrespective of the limitations, the present study was able to show that fascial disruption 
and fibrosis are present in the axilla of patients with AWS. It also provided an overview of how 
the fasciae – and injury to the connective tissues – can aid in explaining the symptomology 
present in AWS patients before and after physiotherapy, supporting hypothesis (1) and (2). The 
symptoms of reduced ROM, pain and cording can be descriptively related to the findings as, upon 
their improvement, fascial changes were also visible on ultrasound. The findings in the present 
study were corroborated by the fascial literature that connected movement limitations and pain 
to similar findings. Additionally, by discussing the anatomical and physiological findings in the 
literature related to the fasciae, the symptoms were able to be explained which had not been 
done before. The explanations improve the understanding of the syndrome and can aid in 
developing new ways for future prevention of the development of cording and related morbidity. 
Furthermore, although the present study did not attempt to validate physiotherapy as a formal 
treatment for the participating patients, it is important to recognise that physiotherapy 
treatment probably has aided in their symptom improvement. 
 
Some recommendations can be made regarding the outcomes of the current study. Given the 
result that our wider cohort FACT-B and SPADI analyses showed a similar morbidity in patients 
after breast cancer treatment, there is a need for more recognition and treatment of symptoms 
to be able to prevent long term sequalae. It is important to challenge a dismissive attitude of – 
and to instruct – medical doctors to know about and recognise AWS, cording and accompanying 
symptoms after breast cancer treatment, and to be aware that early diagnosis may prevent long 
term morbidity. Physiotherapists should be up-to-date with current research regarding 
treatment of symptoms such as in AWS, and what the recommended treatment is. Patients to 
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receive axillary or breast operations should be made aware of AWS-like symptoms as a possible 
side-effect and be taught homework exercises and lifestyle modifications in accordance with 
current research to prevent debilitation. Society needs to be made aware that AWS and similar 
symptoms exist, how they come about and how they affect women which is important so that 
more resources can be made available for research to prevent and treat the symptoms. 
Furthermore, societal awareness could inform public policy to include compensatory measures 
for patients with breast cancer treatment sequalae in terms of employment, due to the 
debilitating symptoms.  
 
Future research should look into less invasive treatments for breast cancer to cause minimum 
morbidity. To understand more about AWS and the involvement of fascia in the syndrome, more 
imaging studies should be done in patients with cording and better definitions of cording should 
be developed. Furthermore, validation studies looking into the best treatment for AWS should 
be done to inform treatment and prevent long-term morbidity. Lastly, risk factors for AWS need 
to be verified so an early warning system for the sequalae of breast cancer as proposed by 
Shamley and Robb (2015) could be implemented in a local healthcare setting. A warning system 
would ensure that patients at risk are identified timeously and measures can be taken to 
minimise their risk of developing symptoms, that affected patients are recognised as soon as 
possible, and that they can receive the help they need to minimise the effect of the syndrome on 
their wellbeing in order to improve their quality of life.  
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Chapter 7: Supplementary Information – Patient Case Studies 
7.1. Patient FS/2013/01 
Table 7.1. Participant variables describing age, affected side, handedness and treatment details. 
Patient details  
Age 48 years 
Side affected Left and right 
Handedness Left 
Treatments Surgery Bilateral mastectomy and left SLND  
 Chemotherapy Gemcitabine (x2) and CEF (x4) 
 Radiotherapy - 
 Hormonal therapy - 
No. of days surgery until presentation 70 days 
Self-reported symptoms before Axillary tightness, pain and reduced range of movement 
Self-reported symptoms after None 
No. of physiotherapy treatments 5 
Physiotherapy focus Scar adherence release; myofascial release along chest wall, 
axilla, upper arm with a greater focus on the left arm; 








Figure 7.1. With the arm in the ABER position, showing the cord (arrows) and scar area for patient 
FS/2013/01 before physiotherapy. The third photograph (c) illustrates the extension of a web of smaller cords 
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7.1.1. Patient description 
A 48-year-old woman presented 70 days post-surgery with bilateral cording, tightness on the 
chest wall and in the axilla, limited shoulder movement and pain upon movement (Table 7.1, 
Figure 7.1).  
 
The patient was treated with a left mastectomy and sentinel lymph node dissection on the left 
for breast carcinoma and a right prophylactic mastectomy with no axillary surgery on the right 
side. The patient was being treated with two cycles of gemcitabine and was due to receive four 
cycles of the CEF regimen which she finished during the course of her physiotherapy treatment. 
No other adjuvant treatments were prescribed during the study.  
 
The physiotherapist reported more puckering, tightness and impairment on the left side and 
therefore focused on the left, but treated both arms with myofascial release into the chest wall, 
axilla and upper arm, the muscles pectoralis major and minor and serratus anterior and 
posterior, and by mobilisation of shoulder and scapula to improve scapulothoracic movement. 
 
7.1.2. Surface anatomy 
Figure 7.1 shows that the cord on the left side is more prominently bulging outwards and 
seemingly thicker (b) extending branches down towards the cubital fossa (c), whereas the cord 
on the right is more guitar-string like with the skin being pulled inwards (a). Both appear to lie 
between coracobrachialis and teres major muscles.  
 




Figure 7.2. With the arm in the ABER position, showing the cord and scar area for patient FS/2013/01 
after physiotherapy. L=left, R=right. 
 
L R 
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7.1.3. Measurements  
At the first measurement cycle, the axillary cords measured 100.43 mm on the left (with a web 
extending further down) and 100.11 mm on the right which were completely resolved after the 
five physiotherapy treatments at the second measurement cycle.  
 The patientǯs SPADI score mirrored the cord size difference as she reported a higher pain and 
disability score on the left compared to the right (L: 78 versus R: 70; Table 7.2). With a similar 
score for lying on the involved side (9/10) bilaterally, reaching high (9 versus to 7) and putting 
an object on a high shelf (9 versus 6) proved more painful and difficult on the left. The total 
scores decreased by 88% on the left and by 66% on the right, possibly due to the physiotherapy 
focus on her left arm. The right showed the highest score for pushing with the involved arm and 
carrying a heavy object (4/10), both scores being related to muscle strength. 
 The patientǯs FACT-B score showed relatively low scores for the physical subsection (10/28), 
where she scored herself as very much having (4/4) pain, feeling ill and being nauseous, and in 
the additional concerns subsection (16/36) in which she indicated she was worried about the 
effect of stress on her illness and she had lots of places in her body where she felt pain. The 
responses linked to the SPADI with a (±35/50=) 70% pain score. After physiotherapy her overall 
score improved very little with only a 5% increase to 84.4/144, even though the SPADI 
decreased and range of movement increased.  
 
Table 7.2. Percentage change of cord length, SPADI and Fact-B scores after physiotherapy. L=left, R=right. 
Changes after physiotherapy 
Outcome measure Before After Change (%) 
Cord length (mm) L: 100.43/ R: 100.11 L/R: 0 L/R: -100  
SPADI (pain) L: 39/ R: 35 L: 6/ R: 14 L: -84.6/R: -60 
SPADI (disability) L: 39/ R: 35 L: 3/ R: 10 L: -92.3/R: -71.4 
SPADI (total) L: 78/ R: 70 L: 9/ R: 24 L: -88.4/ R: -65.7 
FACT-B (physical) 10 9 -10 
FACT-B (social) 15,2 23,3 +53.3 
FACT-B (emotional) 21 21 0 
FACT-B (functional) 18 18 0 
FACT-B (additional concerns) 16 13 -18.8 
FACT-B (total) 80.2 84,3 +5.1 
 The patientǯs ROM before and after physiotherapy is depicted in Figure 7.3. Comparing the 
before and after data it can be observed that all the actions improved with more than 25% after 
physiotherapy. The most improved and thus affected actions are extension on both sides (L: 
133.3%/R: 150%) and abduction on the right (130%). Except for internal rotation, the 
difference between both arms reduced after physiotherapy in all other actions and thus the ROM 
of both arms became more similar. 
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Although the cord and SPADI were worse on the left side, it did not necessarily reflect in the 
range of movement, apart from forward flexion where there was a difference before 
physiotherapy of 25% compared to the right side. A link with the 20% difference in SPADI scores 
between left and right after physiotherapy was not clearly observable from the change in ROM 
values, but perhaps related to her being left-handed.  
 
Figure 7.3. The difference between left and right arms and improvement on range of movements for 
patient FS/2013/01 after physiotherapy. The left side is highlighted in blue and the right side in red, with 
both lighter colours depicting the ROM after physiotherapy. The red bolded percentage indicates the 
percentage difference between left and right with the lowest value being the reference. The percentages 








































































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/01 before (top) and after (bottom) physiotherapy as indicated by the torso pictograms. 
Each torso pictogram denotes the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with 
the longitudinal scans at the top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. 
Orientation indicators: S=superior, I=inferior, L=lateral, M=medial. Within the scans: D=dermis, SF=superficial fascia, DF=deep fascia, CB=coracobrachialis muscle, 
HH=humeral head. 
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7.1.4. Ultrasonography Plate 1 
7.1.4.1. Static 
7.1.4.1.1. Left 
A variable layer of between 1-1.5 cm of adipose tissue was visible on the longitudinal ultrasound 
scans before physiotherapy. The superficial fascia layer (SF) which was closely related to the 
skin, appeared more thickened and hyperechoic, expecially in the middle and close to the deep 
fascia (DF), throughout the superficial adipose tissue and irregular, broken strands appeared to 
originate from it. It had a coarse but dense area of homogeneity in echotexture closer to the skin 
on the right. The DF showed some continuation with the SF, showed much thickened but 
appeared ill-defined on the transverse scan. The CB showed slight increased echotexture within 
it. The transverse scan further showed an irregular heterogeneity with hyperechoic strands in 
the adipose tissue within which vessels openings were noted.  
 
After physiotherapy, although still slightly thickened there were more defined multiple 
continuous striae of superficial fascia compared to before physiotherapy on the longitudinal 
scans or compared to the right side after treatment. On the transverse scan the superficial fascial 
layer was more continuous than before and was clearly separated from the DF by the deep 
adipose tissue and its retinacula cutis profundus. 
 
7.1.4.1.2. Right 
Comparable to the left, on the pre-physiotherapy longitudinal scans of the right side there was 
approximately 1 cm of adipose tissue visible at the location of the cord. There was increased 
echogenicity with thickened, irregular fascial bands in the superficial adipose tissue. It also had 
a honeycomb appearance. The deep fascia (DF) over the coracobrachialis muscle was 
hyperechoic and had a width of approximately 0.35 cm. There seemed to be increased 
homogenous echotexture within the coracobrachialis muscle itself, which was also visible on the 
transverse scans. On the transverse scan, taken mid-cord, there were fossae for vessels present 
within the adipose tissue as well as a thickened coracobrachialis fascia.  
 
Post-treatment, the longitudinal scans on the right side showed more regular linear bands of 
superficial fascia within the hypodermis with a thinner coracobrachialis muscular fascia. There 
was still some increased echogenicity, but the echogenicity was much decreased after cord 
resolution and there was little difference in echotexture.  
 
 
- 115 - 
 
7.1.4.2. Dynamic 
On the left one could see tightening of all the fascial layers in conjunction when attempting to 
move the arm (Video 1.1). More fluid movement and more gliding potential between the deep 
fascia and the muscle was visible in video 1.2 after physiotherapy. 
 
In Video 1.3 on the right the adipose tissue was observed to be restricted in movement whilst 
the patient was moving her arm in the ABER position. There also seemed to be very little gliding 
between the SF, DF and muscle. After physiotherapy, some gliding between the layers seemed 
to have been restored though the video is unclear (Video 1.4).  
 
7.1.4.3. Links between outcome measures 
Although no definite cord structure appeared on the ultrasonographs, there were distinct fascial 
differences before and after physiotherapy and between left and right sides. A thicker and more 
dense homogeneous SF on the left side may have correlated to the thicker more invasive axillary 
cord as observed on surface anatomy, compared to the thinner SF more honeycombed structure 
on the right with the less obvious cord. There also seemed to be more regularity and more fluid, 
independent movement with fascial gliding between the separate layers after physiotherapy, 
more on the left than on the right, on the dynamic videos. The findings corresponded to the 
reduced pain and disability scores as well as to the much improved ROM and side differences, 
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7.2. Patient FS/2013/02 
Table 7.3. Participant variables describing age, affected side, handedness and treatment details. 
Patient details  
Age 38 years 
Side affected Right 
Handedness Right 
Treatments Surgery Right mastectomy + right ANC 
 Chemotherapy CEF (3x) + paclitaxel (4x) 
 Radiotherapy 41.6 Gy (3.2 Gy/frac) chest wall + 
medial axilla; 38.4 Gy (3.2 Gy/frac) 
supraclavicular area + superior half 
of axilla 
 Hormonal therapy - 
No. of days surgery until presentation 149 
Self-reported symptoms before Cording and limited range of movement 
Self-reported symptoms after Cording 
No. of physiotherapy treatments 8 
Physiotherapy focus Scar tissue massage; myofascial release over chest wall, axilla, 
upper and forearm; adherent superficial and deep fascia; 





Figure 7.4. With the arm in the ABER position, showing the cord and scar area for patient FS/2013/02 before 
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7.2.1. Patient description 
A 38-year-old woman presented 149 days post-surgery with cording in the right axilla, a very 
adherent scar and reduced shoulder movement that left her unable to continue her work as a 
nursing aid (Table 7.3, Figure 7.4). 
 The patientǯs breast cancer treatment consisted of a right mastectomy with axillary node 
clearance on the same side. The patient had received her first three CEF chemotherapy courses 
and continued with four paclitaxel courses and 41.6 Gy radiotherapy to the chest wall (3.2 
Gy/frac) and 38.4 Gy to the supraclavicular area (3.2 Gy/frac) during the course of her 
physiotherapy treatment.  
 
The physiotherapist focused her treatment on the scar area and myofascial release over 
pectoralis major and minor, coracobrachialis, short head of biceps, serratus anterior, 
infraspinatus, latissimus dorsi, rhomboid major and minor, levator scapulae and trapezius. The patientǯs physiotherapy treatment had to be discontinued for a month for the tissues to recuperate before commencing again and the patientǯs treatment was extended with three more treatments to recover the patientǯs achieved range of movement and reduce the redeveloped 
tightness across the chest wall after radiotherapy.  
 
7.2.2. Surface anatomy 
Figure 7.4a showed the finger-thick cord on the right side extending from the chest wall over the 
axillary fossa into the antero-medial aspect of the upper arm and the limitation of the arm. The 
cord appeared more medially lying between coracobrachialis and teres major muscles and was 
bulging out in the ABER position. On Figure 7.4c the improvement after four physiotherapy 
treatments was noted and showed much improved range of motion and a remnant of the cord. 
 
  
Figure 7.5. With the arm in the ABER position, showing the cord and scar area for patient FS/2013/02 
after physiotherapy with the arm in the ABER position. Arrow indicates the cord position. L=left, R=right. 
L R 
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On Figure 7.5, three physiotherapy treatments after RT, it was noted that the skin looked 
darkened, the range of movement was reduced and the unresolved cord indented into the 
axillary fossa.  
 
7.2.3. Measurements  
At the first measurement cycle, the cord length was measured to be 98.6 mm. It showed an 
improvement of 34% after physiotherapy with a cord that subsequently measured 64.5 mm in 
length (Table 7.4).  
 
Even though the cord did not resolve, a vast improvement in both SPADI pain and disability 
scores was observed with an overall reduction of 75% to 26 out of 130 for the total SPADI score. 
Especially items where she scored high before such as Ǯreaching highǯ and Ǯputting an object on a high shelfǯ, Ǯtouching the back of the neckǯ, Ǯwashing her backǯ and Ǯputting a pants onǯ showed 
marked improvements from generally 10 to 2. The scores correlated with the patient feeling 
better, more active and feeling that her arm was less tight, as reported by the physiotherapist.  
 
Her Fact-B score improved only slightly with 9.5%, even though her physical and functional 
scores improved, potentially due to extraneous factors. 
 
Table 7.4 Percentage change of cord length, SPADI and Fact-B scores after physiotherapy. 
L=left, R=right. 
Changes after physiotherapy 
Outcome measure Before After Change (%) 
Cord length (mm) 98.61 64.46 -34.6 
SPADI (pain) 33 4 -87.9 
SPADI (disability) 71 22 -69 
SPADI (total) 104 26 -75 
FACT-B (physical) 5 12 +40 
FACT-B (social) 26 20 -23.1 
FACT-B (emotional) 24 20 -16.7 
FACT-B (functional) 13 18 +38.5 
FACT-B (additional concerns) 18 24 +33.3 
FACT-B (total) 85.7 93.8 +9.5 
 
 
The ROM measurements in Figure 7.6 showed a continued difference between affected and 
unaffected arms even after physiotherapy, with differences of over 15% for abduction, forward 
flexion and external rotation. Although abduction improved with approximately 50% for each 
side, only minor improvements or decreases (of up to 33% in external rotation) were seen on 
the affected side for other movements. The reduced changes could be due to the remnant cord 
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and retightening of the tissues after radiotherapy even though functionally she felt better as 
shown by the SPADI score. 
 
Figure 7.6. The difference between left and right arms and improvement on range of movements for 
patient FS/2013/02 after physiotherapy. The left side is highlighted in blue and the right side in red, with 
both lighter colours depicting the ROM after physiotherapy. The red bolded percentage indicates the 
percentage difference between left and right with the lowest value being the reference. The percentages 

























































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/02 before (top) and after (bottom) physiotherapy as indicated by the torso pictograms. 
Each torso pictogram denotes the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with 
the longitudinal scans at the top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. 
Orientation indicators: S=superior, I=inferior, L=lateral, M=medial. Within the scans: D=dermis, SF=superficial fascia, DF=deep fascia, CB=coracobrachialis muscle, 
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7.2.4. Ultrasonography Plate 2 
7.2.4.1. Static 
7.2.4.1.1 Left 
On the left side the different compartments were very clearly defined. An adipose tissue layer of 
approximately 1-2 cm was noted on the longitudinal scans with a superficial fascia that was 
continuous and consisted of multiple converging layers. It was connected to the dermis and to 
the deep fascia. The deep fascia lines extended into the coracobrachialis muscle in which we 
could clearly see the individual muscle fascicles demarcated. There was little difference on the 
post-physiotherapy scans, showing fascial continuity and vessel lumen in a honeycomb fashion 
on the transverse scan.  
 
7.2.4.1.2. Right 
On the pre-treatment longitudinal scans, a very heterogeneous echotexture throughout the 
different tissue compartments without clear distinction between them, was observed. The 
superficial fascia (SF) seemed thickened (±0.5 cm) and consisted of densely packed hyperechoic 
bands extending to the dermis of the skin with an unclearly appearing deep fascia (DF). Post-
physiotherapy the hypodermis showed a more homogenous but coarse echotexture. The 
superficial fascia appeared hyperechoic with unclear layering. On the transverse scan after 
physiotherapy there was an arch-like structure causing a shadow which was closely related to 
the SF and could have been the remnant of the cord.  
 
7.2.4.2. Dynamic 
On the left, post-physiotherapy, clear muscle gliding appeared on Video 2.1 between the deep 
fascia and the muscle and more independent of the more superficial structures. More 
independent movement was seen after physiotherapy on the right between the fascial layers 
and the muscle (Video 2.3). The continued adherence of the different layers was, however, 
visualised in Video 2.4 with a fibrotic structure pulling on the various tissues when moving the 
arm.  
 
7.2.4.3. Links between outcome measures 
Although no clear improvement was visualised post-physiotherapy on the ultrasound scans, 
possibly due to the radiotherapy, there was a difference in the connection of the superficial fascia 
to the skin with fewer clear connections and a coarser appearance on the longitudinal scans after 
the treatment. The findings could be related to the part-resolution of the cord, the slightly 
reduced tightening and adherence of the skin and improved range of motion and pain scores. 
Also, a clear difference was noted between affected and unaffected sides with the left, more able 
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side, appearing more continuous and the tissue layers moving independently from another. The 
finding correlated with the better range of movement of the left side before and after 
physiotherapy compared to the affected side.  
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7.3. Patient FS/2013/03 
 
Table 7.5. Participant variables describing age, affected side, handedness and treatment details. 
Patient details  
Age 48 years 
Side affected Left 
Handedness Right  
Treatments Surgery Left mastectomy + left ANC 
 Chemotherapy CAF (x6) + Paclitaxel (x6) 
 Radiotherapy 42.7 Gy (2.67 Gy/frac) chest wall, 
medial + superior half axilla of axilla, 
supraclavicular area 
 Hormonal therapy - 
No. of days surgery until presentation 132 
Self-reported symptoms  Pain, cording and reduced range of movement 





Figure 7.7. With the arm in the ABER position, showing the cord (arrow) for patient FS/2013/03 after 
physiotherapy. L=left, R=right. 
 
7.3.1. Patient description 
A 48-year-old woman presented with left cording, tightness and pulling in the axilla and onto 
the chest wall, pain and limited shoulder movement (Table 7.5, Figure 7.7). 
 
The patient was treated with a left mastectomy and left axillary node clearance for breast 
carcinoma. Her treatment included neoadjuvant 42.7 Gy radiotherapy to her chest wall, medial 
+ superior half axilla of axilla, supraclavicular area (2.67 Gy/frac) and six courses of CAF and an 
adjuvant six courses of Paclitaxel which finished on the day of the first measurement cycle. 
 
Due to personal issues she had to drop out of the study subsequent to the first measurement 
cycle.  
L R 
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7.3.2. Surface anatomy 
An obvious finger-thick cord extended over the whole medial axilla from the chest wall into the 
lateral aspect of the left upper arm when having the arm in the ABER position (Figure 7.7L). It 
was located over the coracobrachialis muscle. No axillary irregularities were found on the right 
side.  
 
7.3.3 Measurements  
At the first measurement cycle the cord length spanned 100.18 mm in the axilla (Table 7.6). The 
patient reported high levels of pain (42/50) and moderate disability (65/80) for the SPADI 
scores which were connected to the cording and tightness of axilla and the inability of the patient to move her arm, scoring ͻ/ͳͲ for most items except for Ǯwashing hairǯ and Ǯtaking something from back pocketǯ. Although her functional Fact-B score was higher (20/28), her physical score 
was very low with 8/28 where she indicated she was out of energy, nauseous and had pain (4/4), 
corresponding to the SPADI findings.  
 
Table 7.6. The different scores for the outcome measures of cord length, SPADI and FACT-B. 
Values at first measurement cycle 
Outcome measure Before 
Cord length (mm) 100.18 
SPADI (pain) 42 
SPADI (disability) 65 
SPADI (total) 107 
FACT-B (physical) 8 
FACT-B (social) 28 
FACT-B (emotional) 22 
FACT-B (functional) 20 
FACT-B (additional concerns) 17 
FACT-B (total) 95 
 
 The patientǯs range of movement measurements ȋFigure Ͷ.͵ͺȌ showed limited differences 
between extension, external and internal rotation but very high differences of 89% for abduction 
and 157% for forward flexion between affected and unaffected sides. Abduction and forward flexion were therefore the most affected movements, with the unaffected sideǯs ROM falling in 
the normal range. It correlated with the symptoms of cording, pain and disability in the left arm. 



















Figure 7.8. The difference between left and right arms on range of movements for patient FS/2013/03. The 
left side is highlighted in blue and the right side in red. The red bolded percentage indicates the percentage 










































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/03 before physiotherapy as indicated by the torso pictogram. The torso pictogram denotes 
the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with the longitudinal scans at the 
top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. Orientation indicators: S=superior, 
I=inferior, L=lateral, M=medial. Within the scans: D=dermis, SF=superficial fascia, DF=deep fascia, CB=coracobrachialis muscle, HH=humeral head. 
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7.3.4. Ultrasonography Plate 3 
7.3.4.1. Static 
7.3.4.1.1. Left 
On the left longitudinal scans it was noted that an adipose layer of approximately 1 cm with 
disrupted and unclearly defined fibres in it that extended towards the skin (D). Herein, the 
superficial fascia (SF) was showing coarse homogeneity, hyperechogenicity and thickening, 
relating closely to an even hyperechoic deep fascia (DF) of the coracobrachialis (CB) muscle. The 
heterogeneous echogenicity of the muscle showed coarse. On the transverse scan there was a 
shadow of a structure seen below the superficial fascia that extended between 1-2 cm, connected 
to SF and DF and appeared to arch the skin at the level of the D-marker. 
 
7.3.4.1.2. Right 
On the right side with 0.5 cm hypodermis, there was more clearly defined fibre continuity within 
the adipose tissue layers visible on both the longitudinal as well as the transverse scans. The 
homogenous echogenicity appeared more diffuse of the muscle. The SF and DF were also more 
hypoechoic than on the left side.  
 
7.3.4.2. Dynamic 
The left (Video 3.1) shows clear hyperechoic strands and increased traction on the skin when 
moving the arm in the ABER position. There was more independent gliding superficially on the 
right side (Video 3.2). 
 
7.3.4.3. Links between outcome measures 
The disrupted adipose mesh and hyperechoic appearance that was visible on the affected left 
side seemed related to the surgical disruption which occurred there. The thickened and 
hyperechoic SF could be indicative of the cord presence as well as the shadowing artefact. The 
increased traction on the SF and the adherence of the tissue layers when moving were linked to 
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7.4. Patient FS/2013/04 
Table 7.7. Participant variables describing age, affected side, handedness and treatment details. 
Patient details  
Age 69 years 
Side affected Right 
Handedness Right 
Treatments Surgery Right mastectomy + right ANC 
 Chemotherapy CEF (x6) 
 Radiotherapy 42.7 (2.67 Gy/frac) chest wall, 
medial and superior half axilla of 
axilla, supraclavicular area 
 Hormonal therapy Tamoxifen + Arimidex 
No. of days surgery until presentation 368 
Self-reported symptoms before Pain, cording and reduced range of movement 
Self-reported symptoms after - 
No. of physiotherapy treatments 6 
Physiotherapy focus Scar massage; scapular mobilisations; myofascial release 
into the axilla, chest wall and upper arm; cord release; 
homework stretches  




Figure 7.9. With the arm in the ABER position, showing the cord area for patient FS/2013/04 before 
physiotherapy. L=left, R=right. 
7.4.1. Patient description 
A 69-year-old woman presented 368 days post-surgery with axillary cording, pain and limited 
range of movement (Table 7.7, Figure 7.9).  
 
The patient was treated with a right breast mastectomy and right axillary node clearance for 
breast carcinoma. The patient received an adjuvant six course CEF regimen of chemotherapy, 
adjuvant Tamoxifen after which she switched to Arimidex due to the side-effects of Tamoxifen, 
and 42.7 Gy adjuvant radiotherapy to the chest wall, medial and superior half axilla of axilla, 
supraclavicular area (2.67 Gy/frac).  
 
L R 
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The physiotherapist reported a very tight scar on the right chest wall with puckering and 
increased adherence to the chest wall. She focused on the scar initially to remove the dead skin 
that was left after radiotherapy and after that she focused on the very rigid scapular movements 
and myofascial releasing of the chest wall, axilla and upper arm to pectoralis major and minor, 
coracobrachialis, serratus anterior, upper trapezius and infraspinatus. The patient also 
presented with a thoracic kyphosis which affected her shoulder movements adversely. 
7.4.2. Surface anatomy 
Figure 7.9 showed the right tightened axillary fossa with a slight indenting cord more medially 
(poorly visible on the photographs). It was overlying the coracobrachialis muscle.  
 
After physiotherapy, the cord was resolved at the time of the second measurement cycle, visible 
in Figure 7.10, where the right arm was less restricted and the axilla less tightened. The 
physiotherapist mentioned, however, that she still observed a cord remnant at full elevation a 




Figure 7.10. With the arm in the ABER position, showing the cord and scar area for patient FS/2013/04 
after physiotherapy. L=left, R=right.  
7.4.3. Measurements  
At the first measurement cycle, the axillary cord measured a length of 92.64 mm on the right 
side, which had (according to our measurements) fully resolved after physiotherapy (Table 7.8).  
 
The patient reported much less pain (-67.7%) at the second measurement cycle with the biggest improvement on the item Ǯreaching highǯ ȋͺ to ͳȌ. Her SPADI disability score, however, remained the same with no improvement on items ǲputting an object on a high shelfǳ and slightly more difficulty with Ǯcarrying heavy objectsǯ ȋʹ to ͵ Ȍ or Ǯwashing her backǯ ȋʹ to ͶȌ. The disability score 
findings could perhaps be explained by the physical sub-domain Fact-B score where she 
indicated that she had less energy and was more bedridden at the time of the second 
L R 
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measurement cycle. Her overall FACT-B score was also only slightly improved even though she 
had much less pain with her movements. 
 
Table 7.8. Percentage change of cord length, SPADI and FACT-B scores after physiotherapy. 
Changes after physiotherapy 
Outcome measure Before After Change (%) 
Cord length (mm) 92.64 0 -100 
SPADI (pain) 21 7 -66.7 
SPADI (disability) 17 17 0 
SPADI (total) 38 24 -36.8 
FACT-B (physical) 20 17 -15 
FACT-B (social) 28 25 -10,7 
FACT-B (emotional) 14 15 +7.1 
FACT-B (functional) 22 25 +13.6 
FACT-B (additional concerns) 23 29 +26.1 
FACT-B (total) 107 110.5 +3.3 
 
 The patientǯs range of movement ȋFigure 7.11), like her pain score, also showed improvements 
after physiotherapy for all movements except internal rotation on the affected arm, with only a 
couple degrees difference. Her biggest improvement was in abduction on the affected arm with 
a 48.9% increase, although her unaffected arm also increased by almost 40%. 
 
Interestingly, her extension and internal rotation measurements on the affected side were 
higher than on the unaffected arm. The ROM measures changed around after physiotherapy for 
extension, but for external rotation there was still a 35.6% difference between affected and 
unaffected with a higher range of movement for the affected arm.  
 
Apart from extension, the differences between each movement was reduced, indicating both 
arms were more similar. The differences still presented and her disability could be due to some 
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Figure 7.11. The difference between left and right arms and improvement on range of movements for 
patient FS/2013/04 after physiotherapy. The left side is highlighted in blue and the right side in red, with 
both lighter colours depicting the ROM after physiotherapy. The red bolded percentage indicates the 
percentage difference between left and right with the lowest value being the reference. The percentages 















































































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/04 before (top) and after (bottom) physiotherapy as indicated by the torso pictograms. 
Each torso pictogram denotes the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with 
the longitudinal scans at the top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. 
Orientation indicators: S=superior, I=inferior, L=lateral, M=medial. Within the scans: D=dermis, SF=superficial fascia, DF=deep fascia, CB=coracobrachialis muscle, 
HH=humeral head. 
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7.4.4. Ultrasonography Plate 4 
7.4.4.1. Static 
7.4.4.1.1. Left  
On the left longitudinal ultrasonograph there was an adipose tissue layer of approximately 2 cm 
present. The superficial fascia (SF) was clearly defined and multi-layered, continuing throughout 
the scans. It was connected to the deep fascia (DF) and to the dermis (D). The strands were 
clearly visible although there was some coarse heterogeneous echotexture visible. Post-
physiotherapy there was little difference, portraying similar organisation as before on both 
longitudinal as well as the transverse scan, although more defined.  
 
7.4.4.1.2. Right  
On the right longitudinal scans there was a lot more disruption visible in the fascial layers of the 
hypodermis (± 2 cm) and the SF was scarce. A couple of thickened SF fibres floated in between 
a dotted coarse homogenous echotexture. There appeared to be very close association with the 
dermis on the transverse scan with the superficial fascia extending around a shadowy artefact. 
The DF also seemed increased in thickness on both scans. After physiotherapy there appeared 
some more regularity and organisation in fascial layering on especially the transverse scan, but 
there still seemed to be increased coarse homogenous echotexture on the affected side 
compared to the unaffected side. 
 
7.4.4.2. Dynamic  
On the left side there was linearity within the hypodermal fascial layers and independent 
movement of the coracobrachialis muscle before and after physiotherapy but more clearly seen 
after physiotherapy (Video 4.1 before, Video 4.2 after). On the right, however, before 
physiotherapy there appeared to be much more connectivity between the different tissue layers 
which moved as one when the arm was in motion (Video 4.1). After physiotherapy there was 
more independent muscle gliding although the hypodermis still appeared disrupted (Video 4.2). 
 
4.11.4.4.3. Links between outcome measures 
The affected side showed no cord structure on the ultrasound scans but disrupted fascial 
layering within the hypodermis, thickening of the SF and DF and increased connections between 
the layers that were possibly associated with restricted movement or pain, as experienced by 
the patient. After physiotherapy movement improved with increased muscle gliding correlating 
to the improvements in the shoulder range of movement.  
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7.5. Patient FS/2013/05 
Table 7.9. Participant variables describing age, affected side, handedness and treatment details.  
Patient details  
Age 35 years 
Side affected Left and right 
Handedness Right 
Treatments Surgery Bilateral mastectomy + bilateral ANC 
 Chemotherapy CAF (x6) + CMF (x6) 
 Radiotherapy - 
 Hormonal therapy Tamoxifen + Arimidex 
No. of days surgery until presentation 201 
Self-reported symptoms before Cording and pain 
Drop-out Possible cord resolution but socioeconomic and personal 
factors prevented the patient from participating in the 
present study 




Figure 7.12. With the arm in the ABER position, showing the indistinct cords (arrow) for patient 
FS/2013/05. L=left, R=right. 
 
7.5.1. Patient description 
A 35-year-old patient presented 201 days post-surgery with tightness in the axilla and taut 
bands of tissue that caused pain upon movement of the arm. The patient did not complain about 
limited range of movement (Table 7.9, Figure 7.12). 
 
The patient was treated with a bilateral mastectomy and bilateral axillary node clearance for 
breast carcinoma. She received neoadjuvant chemotherapy of six CAF and six CMF regimens and 
after that neoadjuvant Tamoxifen. Post-surgery she started with Arimidex. 
 
When seen by the physiotherapist a few days later, no clear cording was identified on either arm, 
although tightness and pulling were observed more on the left than on the right side. Also, there 
were some problems filling in the questionnaires due to a language barrier even though she 
spoke English and her questionnaire was translated into isiXhosa. 
L R 
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7.5.2. Surface anatomy 
Figure 7.12 showed a taut band or cord extending on the left (L) from the axillary fossa retracting 
the skin inwards through the vascular groove and fanning out towards the biceps brachii and 
medial side of the arm. On the right (R) it was more indistinct and thinner, causing not as much 
traction on the skin in the ABER position, but lying in the same area of the axilla. 
 
7.5.3 Measurements  At the first measurement cycle, the patientǯs cord/taut band measured ͳ͵͵.ʹ͵ mm on the left 
and 72.51 mm on the right arm. Although the patientǯs cord length was longer and tightness 
seemed to be located more on the left than the right, she reported the same amount of pain on 
the right as on the left arm and limited disability on both sides (Table 7.10). She seemed to have more problems with Ǯreaching highǯ in terms of pain on the left ȋͳͲ/ͳͲȌ compared to the right ȋͲ/ͳͲȌ, but had trouble for both arms when asked to Ǯput an object on a high shelfǯ ȋͳͲ/ͳͲȌ. 
 The patientǯs FACT-B score showed a reduced physical domain with high scores for lack of 
energy and having pain (4/4), but higher functional domain score which mirrored her own 
functional ability.  
 
Table 7.10. The different scores for the outcome measures of cord length, SPADI and FACT-B. 
Values at first measurement cycle 
Outcome measure Before 
Cord length (mm) L: 133.23/ R: 72.51 
SPADI (pain) L: 30 / R: 30 
SPADI (disability) L: 20 / R: 20 
SPADI (total) L: 40 / R: 50 
FACT-B (physical) 16 
FACT-B (social) 20 
FACT-B (emotional) 16 
FACT-B (functional) 21 
FACT-B (additional concerns) 18 
FACT-B (total) 90.8 
 
 
There was little difference in abduction, forward flexion and internal rotation, although the 
forward flexion was more limited compared to normal ranges (120 versus 180) (Figure 7.13). 
Although there was a 10% difference in extension, the actual degree difference was only 5% and 
thus very small. External rotation, however, showed a more substantial difference with a 23% 
higher score on the right compared to the left. The ROM difference between arms was in 
agreement with the longer cord and increased tightness observations for the left side. 




















Figure 7.13. The difference between left and right arms of movements for patient FS/2013/05. The left side 
is highlighted in blue and the right side in red. The red bolded percentage indicates the percentage 










































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/05 before physiotherapy as indicated by the torso pictogram. The torso pictogram denotes 
the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with the longitudinal scans at the 
top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. Orientation indicators: S=superior, 
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7.5.4. Ultrasonography Plate 5 
7.5.4.1. Static 
7.5.4.1.1.Left 
The left adipose layer was very limited to 0.1-0.5 cm on the selected scans and showed as patches 
of tightly packed coarse hyperechoic, homogenous echotexture near the dermis. Within the 
superficial adipose tissue there was no completely clearly defined superficial fascia (SF) layering 
present. There was a haphazard meshwork of hyperechoic connective tissue strands between 
the muscles (coracobrachialis=CB, pectoralis major=PM) and lining them (deep fascia=DF). The 
PM showed increased connectivity and connective tissue. On the transverse scan there was a 
stellate-shaped conglomeration of hyperechoic connective tissue found at the meeting point of 
the SF and DF which connected strongly to the skin and muscular fascia. 
  
7.5.4.1.2. Right 
On the right there was greater definition of the coracobrachialis muscle. The adipose tissue of 
similar thickness as the left, also showed patches of coarse hyperechoic, homogenous 
echotexture as seen on the left but there seemed to be more definition of layering in the SF. There 
was similar disruption of the tissue layering as on the left but there seemed to be greater 
organisation in the central image with multiple hyperechoic strands deriving from the DF into 
the PM. On the transverse scans there was once again a thickened fibrotic scar seen as 
continuation of the deep DF but with less connection to the SF.  
 
7.5.4.2. Dynamic 
On Video 4.5.1 showing the movement into the ABER position on the left, there was not very 
much gliding potential between the different tissue layers, although difficult to observe from the 
video. A hyperechoic strand deriving from a thickening near the humeral head was exerting 
traction on the dermis with the action of moving the arm in the ABER position.  
 
On the right (Video 5.2) there was more gliding between the pectoralis major muscle, the skin 
and underlying tissue layers.  
 
7.5.4.3. Links between outcome measures 
Although it was unclear whether there was clear cording present in the patient, there were 
differences found between the left and right. As shown in Figure 7.12, there was increased 
tightness and a band of tissue which was measured to be longer than a similar, although less 
distinct one, on the right. The patient reported, for both left and right side, more pain than 
disability, showing as very little differences on the ROM measures, but relating to the tightness 
in the axillae. 
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On the US scans it was noted that there was a strong hyperechoic connection from the DF to the 
skin on the left and more disrupted SF on the left with limited gliding potential compared to the 
right. The restricted gliding correlated to the tightness, skin adherence and limited external 
rotation movement as part of the ABER position, although no cord was visible on the scans. 
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7.6. Patient FS/2013/06 
Table 7.11. Participant variables describing age, affected side, handedness and treatment details. 
Patient details  
Age 55 years 
Side affected Right 
Handedness Right 
Treatments Surgery Right mastectomy + right ANC 
 Chemotherapy CAF (x6) + Vinorelbine (x6) 
 Radiotherapy 47 Gy (2.35 Gy/frac) chest wall, 
medial and superior half axilla of 
axilla, supraclavicular area; 20 Gy (4 
Gy/Frac) superior half axilla of 
axilla, supraclavicular area 
 Hormonal therapy Tamoxifen + Exemestane + Arimidex 
+ Provera 
No. of days surgery until presentation 57 days 
Self-reported symptoms before Cording, pain and limited range of movement 
Drop-out Commenced physiotherapy but was too ill to continue due 
to progressive disease 




Figure 7.14. With the arm in the ABER position, showing the cord (arrow) for patient FS/2013/06. L=left, 
R=right. 
7.6.1 Patient description 
A 55-year-old woman presented 57 days after surgery with reduced range of movement, axillary 
webbing and pain when moving the right arm (Table 7.11, Figure 7.14). 
 
The patient was treated with a right mastectomy and right axillary node clearance for breast 
carcinoma. The patient also received neoadjuvant six courses of CAF and changed from 
Tamoxifen to Exemestane. She received 47 Gy radiotherapy to the chest wall, medial and 
superior half axilla of axilla (2.35 Gy/frac). She then started on Arimidex, had 20 Gy radiotherapy 
to the supraclavicular area and superior half axilla of axilla (4 Gy/Frac). Subsequently, she had 
six courses of Vinorelbine (which she continued during the physiotherapy treatment) and had 
adjuvant Provera for hormonal treatment.  
L R 
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Even though she had started receiving physiotherapy treatment under the auspices of the study, 
she could not continue due to progressing cancer. 
 
7.6.2. Surface anatomy 
A web of skin folds was observed on the right arm with one finger-thick taut cord bulging out at 
the level of the axillary vascular groove (Figure 7.14). The thickness of the cord was exaggerated 
due to the higher amount of adipose tissue in the hypodermis. The indenting skin forming the 
separate skin folds was adherent to the underlying tissue. 
 
7.6.3 Measurements  
At the first measurement cycle the cord measured 71.19 mm and the patient experienced 
moderate amounts of pain and high levels of disability according to her SPADI answers (Table 
7.12), reporting the highest amount of pain when reaching for something high (8/10). Her disability was exemplified by the high difficulty experienced when Ǯwashing her backǯ, Ǯreaching for an object on a high shelfǯ and Ǯcarrying heavy objectsǯ ȋͳͲ/ͳͲȌ.  
 
The patient had a very low FACT-B physical score of 8/24 indicating low energy levels (3/4) and 
feeling ill (4/4).  
 
Table 7.12. Percentage change of cord length, SPADI and Fact-B scores after physiotherapy. 
Changes after physiotherapy 
Outcome measure Before 
Cord length (mm) 71.19 
SPADI (pain) 33 
SPADI (disability) 61 
SPADI (total) 94 
FACT-B (physical) 8 
FACT-B (social) 28 
FACT-B (emotional) 20 
FACT-B (functional) 18 
FACT-B (additional concerns) 19 
FACT-B (total) 93 
 
 
Figure 7.15 showed that all movements on the affected side were lower than on the unaffected 
side except for a minor difference in abduction. Apart from extension, all unaffected movements 
were also lower than the expected normal range. The most affected action seemed to be internal 
rotation where the unaffected side was 425% higher than the affected side. The reduction 
related to the presence of the web of tight tissue and cord in her axilla, preventing her from 
normal arm functioning and was linked to the pain and disability as identified by SPADI. 
 





















Figure 7.15. The difference between left and right arms and improvement on range of movements for 
patient FS/2013/06 after physiotherapy. The left side is highlighted in blue and the right side in red. The 
red bolded percentage indicates the percentage difference between left and right with the lowest value 









































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/06 before physiotherapy as indicated by the torso pictogram. The torso pictogram denotes 
the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with the longitudinal scans at the 
top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. Orientation indicators: S=superior, 
I=inferior, L=lateral, M=medial. Within the scans: D=dermis, SF=superficial fascia, DF=deep fascia, CB=coracobrachialis muscle, HH=humeral head. 
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7.6.4. Ultrasonography Plate 6 
7.6.4.1. Static 
7.6.4.1.1. Left 
On the left longitudinal ultrasound scans an adipose tissue layer of approximately 1.5-2 cm was 
noted. The superficial fascia (SF) planes were more defined and continuous, extending 
superficially and to the deep fascia (DF). There was no complete homogenous echogenicity 
within the muscle (CB) and no linearity of the endomysial fascia surrounding the fascicles either. 
The transverse scan showed an unbroken SF and a slightly unclear DF overlying the CB.  
 
7.6.4.1.2. Right  
On the right, a more disrupted but similar thickness hypodermis with a meshwork of thickened 
fibres and unclear SF, that was in many places connected to the dermis and DF, was observed. 
The muscle fascicles within the muscles were also not arranged perpendicularly. On the 
transverse scan less organisation was observed compared to the left, where there was no 
distinctive DF and the SF was surrounding another such lesion and connecting to the dermis.  
 
7.6.4.2. Dynamic 
On Video 6.1 the left side showed regularity and continuity of the fascial layers that was clearer 
than the static scans. During movement there also appeared to be more independence with 
muscle gliding although it was not very clear on the video. Video 6.2, on the contrary, showed 
more adherence of all layers to one another and the dermis when the arm was moved. There 
were also disrupted fibrotic strands within the SF which seemed to extend through to the DF. 
 
7.6.4.3. Links between outcome measures 
The disarrangement as seen on the surface of the right axilla with the skin folds continued into 
the hypodermis on the ultrasonographs where the superficial fascial layers were discontinuous 
and showed adherence of the deeper fascia and muscle to the skin. Potential muscle and other 
tissue gliding loss as seen on the Video was furthermore associated with the limited movement, 
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7.7. Patient FS/2013/07 
Table 7.13. Participant variables describing age, affected side, handedness and treatment details. 
Patient details  
Age 63 years 
Side affected Right 
Handedness Right 
Treatments Surgery Right mastectomy + right ANC 
 Chemotherapy CAF (x6) 
 Radiotherapy 47 Gy (2.35 Gy/frac) chest wall, 
medial and superior half axilla of 
axilla, supraclavicular area 
 Hormonal therapy Tamoxifen 
No. of days surgery until presentation 798 days 
Self-reported symptoms before Pain, cording, reduced range of movement 
Self-reported symptoms after - 
No. of physiotherapy treatments 5 
Physiotherapy focus Tightness in axilla; myofascial release of chest wall, scar, 
axilla and upper arm; scapula mobilisation 




Figure 7.16. With the arm in the ABER position, showing the cord area (arrow) for patient FS/2013/07 
before physiotherapy. L=left, R=right. 
 
7.7.1 Patient description 
A 63-year-old patient presented 798 days post-surgery with a cord on the right side, pain upon 
movement and limited shoulder range of movement (Table 7.13, Figure 7.16). 
  
The patient was treated with a right breast mastectomy and right axillary node clearance for 
breast carcinoma. Adjuvant treatment included six courses of the CAF regimen, tamoxifen and 
47 Gy radiotherapy to the chest wall, medial and superior half axilla of axilla, supraclavicular 
area (2.35 Gy/frac).  
 
The physiotherapist reported an increased tightness in the axilla and a taut band of tissue in the 
affected axilla. The patient also felt a pull further down the upper arm across the cubital fossa 
although no superficial sign was observed, and a pain inside the arm towards the thumb. The 
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patient was very anxious not to use the affected arm and guarded it beyond 90° elevation. Furthermore, the patient had a Ǯhunchbackǯ, thoracic kyphosis, which limited her shoulder 
movement. 
 
The focus of the physiotherapy treatment was to release the tightness in the axilla, in the upper 
arm and on the chest wall via myofascial release of pectoralis major and minor, serratus anterior 
and extended down the forearm to the flexor retinaculum, and improved scapula mobilisation. 
 
7.7.2. Surface anatomy 
Figure 7.16 showed a very tight axilla with a taut band retracting the skin inwards extending 
from the medial axilla inferiorly into the medial aspect of the upper arm superiorly. The band 
overlaid the coracobrachialis muscle.  
 
After physiotherapy the cord resolved upon measurement, although the physiotherapist 
reported a small remnant still visible days before (Figure 4.47). Also noticed was the shoulder 
asymmetry on Figure 7.17c and 7.17d where a clearly hypertrophied trapezius was visible on the left side, and the patientǯs left range of movement appeared more restricted on the left side 





Figure 7.17. With the arm in the ABER position, showing the cord and scar area for patient FS/2013/07 
after physiotherapy (a,b) and in abduction her asymmetrical shoulder range of movement, possibly due to 
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At the first measurement cycle her cord measured 70.17 mm in length across the axilla, which 
completely resolved after physiotherapy treatment (Table 7.14).  
 
An improvement was also noticed in the SPADI pain and disability scores, where, on the affected 
arm, the patient showed a reduction of approximately 40% in both scores. She still had pain Ǯwhen lying on the involved sideǯ and had difficulty Ǯputting an object on a high shelfǯ or Ǯcarrying a heavy objectǯ, but the item scores reduced to 2 or 3/10, possibly related to some tenderness 
and tightness still present within the axilla. 
 The patientǯs quality of life score also improved with ͳʹ.ͺ% as indicated by the total Fact-B score 
with the improvements in especially the additional concerns section where she indicated less 
anxiety and less tenderness or swelling in the arm and more energy but still reported having 
pain in the physical subsection. 
 
Table 7.14. Percentage change of cord length, SPADI and FACT-B scores after physiotherapy.  
Changes after physiotherapy 
Outcome measure Before After Change (%) 
Cord length (mm) 70.17 0 -100 
SPADI (pain) 21 12 -42.9 
SPADI (disability) 13 8 -38.5 
SPADI (total) 34 20 -41.2 
FACT-B (physical) 21 25 +19 
FACT-B (social) 28 28 0 
FACT-B (emotional) 22 24 +9.1 
FACT-B (functional) 27 28 +3.7 
FACT-B (additional concerns) 19 27 +42.1 
FACT-B (total) 117 132 +12.8 
 
 The patientǯs ROM of both shoulders also improved after physiotherapy, but the affected arm in 
every action improved more than the unaffected arm and resulted in a higher range of movement 
(Figure 7.18). The improvement was especially clear in abduction where the affected arm 
improved with 97% and there was a difference of 67.1% between both arms after 
physiotherapy. The difference correlated with the reduced pain and disability and the unaffected 
shoulder being restricted due to the thoracic kyphosis. 
 
After physiotherapy all actions were still below the normal range of movement (Clarkson & 
Gilewich, 1989). 
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Figure 7.18. The difference between left and right arms and improvement on range of movements for 
patient FS/2013/07 after physiotherapy. The left side is highlighted in blue and the right side in red, with 
both lighter colours depicting the ROM after physiotherapy. The red bolded percentage indicates the 
percentage difference between left and right with the lowest value being the reference. The percentages 









































































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/07 before (top) and after (bottom) physiotherapy as indicated by the torso pictograms. 
Each torso pictogram denotes the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with 
the longitudinal scans at the top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. 
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7.7.4. Ultrasonography Plate 7 
7.7.4.1. Static  
7.7.4.1.1. Left 
On the left longitudinal ultrasound scan there was approximately 0.5-1 cm of adipose tissue 
present. Within the adipose tissue the superficial fascia (SF) was clearly defined with a multi-
layered continuous appearance and had a homogenous echotexture throughout. The deep fascia 
(DF) was also continuous and closely associated with the SF and the coracobrachialis muscle 
(CB) showed linearly arranged muscular fibres, although some patches of increased connective 
tissue were present. On the transverse scan the SF was organised like a honeycomb structure 
surrounding the vessels with continuity. There was little change post-physiotherapy with 
reduced echogenicity of the SF and reduced thickness.  
 
7.7.4.1.2 Right 
On the right longitudinal scans there was decreased continuity with the SF but it appeared 
thicker and had increased connectivity with the dermis. The echotexture also appeared 
homogenous but coarser compared to the left. The muscle fibres were also not as clearly defined 
with shadowy artefacts, possibly due to scanning error, present. On the transverse scan there 
was similarly less organisation compared to the left. The organisation appeared to improve post-




On the affected arm the videos mirrored the findings above with increased connectivity before 
the physiotherapy treatment, with thicker superficial fascial strands and reduced gliding of the 
muscle (Video 7.1) and after physiotherapy, more organisation and layering, less adhesions of 
the SF and some improved muscle gliding (Video 7.2). On the unaffected arm there was slightly 
more fluid muscle movement and increased gliding potential but less coarse homogenicity 
within the CB with more linear epimysial fascia compared to before (Video 7.3 before, Video 7.4 
after).  
 
7.7.4.3. Links between outcome measures 
As the cord resolved, pain and disability measures as well as the ROM improved on the affected 
side as well as improved regularity and continuity of the SF, decreased adhesions to the dermis 
and improved muscle gliding. The unaffected arm also showed some reduced thickening of the 
fascial fibres and less coarseness correlating with improved functioning but the remaining 
limitation in ROM on the unaffected side was not visible on the ultrasound scans as it was most 
likely caused by the thoracic kyphosis and muscular problems around the site of investigation. 
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7.8. Patient FS/2013/08 
Table 7.15. Participant variables describing age, affected side, handedness and treatment details. 
Patient details  
Age 68 years 
Side affected Right 
Handedness Right 
Treatments Surgery Right mastectomy + right ANC 
 Chemotherapy CEF (x3) + Taxotere (x3) 
 Radiotherapy NA 
 Hormonal therapy Tamoxifen + Arimidex 
No. of days surgery until presentation 1455 days 
Self-reported symptoms before Cording and pain 
Self-reported symptoms after Cording and pain 
No. of physiotherapy treatments 6 
Physiotherapy focus Altered scapulothoracic movement; deep scar massage; 
myofascial release into axilla, upper arm, scar; homework 
exercises 
Confounding factors • Length of time since surgery so tissues not 




Figure 7.19. With the arm in the ABER position, showing the cord (arrow) and scar area for patient 
FS/2013/08 before physiotherapy. L=left, R=right. 
 
7.8.1. Patient description 
A 68-year-old patient presented 1455 days post-surgery with a cording on the right arm and 
pain upon movement (Table 7.15, Figure 7.19).  
 
The patient was treated with a right mastectomy and right axillary node clearance for breast 
carcinoma. Her adjuvant treatment included three courses of the CEF regimen and three courses 
of Taxotere, and hormonal drugs Tamoxifen and Arimidex. According to the physiotherapist the 
patient mentioned she had also received radiotherapy to the chest wall but which could not be 
verified from the patient folder. 
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The physiotherapist worked on the extensively adherent scar incision on the right medial chest 
wall that extended to the axilla and focused here with myofascial release as well as into the arm 
and on the cord. Although homework exercises were taught, the patient did not actively do the 
exercises to maintain the improvements. The physiotherapist mentioned the patient complained 
of bilateral shoulder pain that was worse on the right, had a slipped disc in her lower back which 
also caused pain, and suffered from fibromyalgia. 
 
Subtle changes were noticed post-physiotherapy by the physiotherapist across the axilla and 
marginal reduction of the skin fold thickenings superior to the incision, despite some 
confounding factors (Table 7.15).  
 
7.8.2 Surface anatomy 
In Figure 7.19 a finger-thick cord was visible on the right prominently bulging outwards 
extending from the scar incision into the medial aspect of the upper arm, lying in the mid-axillary 
line. The skin folds were the result of the adherent scar lines and the increased BMI. The scar 
was shown to indent the skin adhering closely to the chest wall.  
 
Post-physiotherapy the arm appeared to be freer in motion, but the cord did not improve and 
was still very visible and protruding out (Figure 7.20a) as also shown in the first and last 
physiotherapy comparison photographs (Figure 7.20c-d). 
 
7.8.3 Measurements  At the first measurement cycle the patientǯs cord measured ͸ͺ.ͳ͸ in the axilla which instead of 
increasing, measured 79.04 mm after physiotherapy (Table 7.16). The increased length may 
have been due to the cord becoming more exposed upon increased movement. 
 The patientǯs shoulder pain and disability scores improved over 70% after physiotherapy, with some residual pain when reaching high and still a lot of difficulty with Ǯcarrying heavy objectsǯ 
(10/10) with the affected arm. Her FACT-B score on the other hand decreased with 16.8%, which was especially evident in her physical score where she indicated that she had a Ǯlack of energyǯ, was Ǯworried about the needs of her familyǯ and she felt Ǯbedriddenǯ, and arguably being related 










Figure 7.20. With the arm in the ABER position, showing the cord (arrow) and scar area for patient 
FS/2013/08 after physiotherapy (a,b) and in abduction of the area at the first (c) and the last 
physiotherapy treatment (d). L=left, R=right. 
 
Table 7.16. Percentage change of cord length, SPADI and Fact-B scores after physiotherapy.  
L=left, R=right. 
Changes after physiotherapy 
Outcome measure Before After Change (%) 
Cord length (mm) 68,16 79,04 +16 
SPADI (pain) 33 4 -87.9 
SPADI (disability) 45 13 -71.1 
SPADI (total) 78 17 -78.2 
FACT-B (physical) 20 9 -55 
FACT-B (social) 28 25 -10.7 
FACT-B (emotional) 13 12 -7,7 
FACT-B (functional) 22 22 0 
FACT-B (additional concerns) 15 14 -6.7 
FACT-B (total) 98 81,5 -16.8 
 
 
All movements on both arms improved or stayed the same after physiotherapy, except for a 
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improvements were on internal rotation of the affected arm with a 500% increase post-
physiotherapy, abduction with 38.3% increase and forward flexion with 28.3% increase. The 
improvements mimicked the reduced difficulty she had in washing her hair and back. 
 
There was also a reduction in the difference between the two arms except for forward flexion, 
even though both arms improved. Abduction and forward flexion were not at full range of 
motion (Clarkson & Gilewich, 1989), which might be related to the persistence of the cord. 




Figure 7.21. The difference between left and right arms and improvement on range of movements for 
patient FS/2013/08 after physiotherapy. The left side is highlighted in blue and the right side in red, with 
both lighter colours depicting the ROM after physiotherapy. The red bolded percentage indicates the 
percentage difference between left and right with the lowest value being the reference. The percentages 








































































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/08 before (top) and after (bottom) physiotherapy as indicated by the torso pictograms. 
Each torso pictogram denotes the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with 
the longitudinal scans at the top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. 
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7.8.4. Ultrasonography Plate 8 
7.8.4.1. Static  
7.8.4.1.1. Left 
On the left longitudinal ultrasound scans there was an approximate 1.5-2 cm adipose tissue layer 
within regular, continuous strands of superficial fascia (SF) forming a honeycomb structure. The 
deep fascia (DF) was intact over the coracobrachialis muscle (CB) which showed its epimysial 
layers, although not very clearly, within it. On the transverse scan there appeared a similar 
organisation with clear fascial bands visible through the tissues. Post-physiotherapy there was 
increased contrast showing similar organisation but better definition of the structures. 
 
7.8.4.1.2. Right 
On the right longitudinal scans there seemed to be greater disruption in the superficial fascial 
layers with increased thickening at the dermal-hypodermal junction, strong connections 
between the SF and the dermis (D) and more coarse homogeneity throughout. On the transverse 
scan the SF showed slightly thickened with the DF forming a fibrous scar. After physiotherapy 
the disorganisation was still visible with thickened fascial planes but with slightly more 
regularity and less connection to the skin. 
 
7.8.4.2. Dynamic 
On the ultrasound videos there was slightly more regularity and less thickening of the superficial 
fascia and dermis on the unaffected arm (Video 8.1) compared to the affected arm (Video 8.3). 
After physiotherapy the abovementioned differences between affected and unaffected arms 
were shown again on Videos 8.2 and Video 8.4, but no other clear differences were detected. 
 
7.8.4.3. Links between outcome measures 
Although the cord remained visible on the surface, there were some fascial changes that could 
possibly be related to the ROM and pain improvements and differences. The fascial planes were 
less adhesive post-physiotherapy, although there was still thickening of the fascia close to the 
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7.9. Patient FS/2013/09 
Table 7.17. Participant variables describing age, affected side, handedness and treatment details. 
Patient details  
Age 53 years 
Side affected Left 
Handedness Right 
Treatments Surgery Left mastectomy + left ANC 
 Chemotherapy CAF (x6) 
 Radiotherapy 47 Gy (2.67 Gy/frac) chest wall, 
medial and superior half axilla of 
axilla, supraclavicular area 
 Hormonal therapy Tamoxifen 
No. of days surgery until presentation 1122 days 
Self-reported symptoms before Pain, cording and limited range of movement 
Drop-out Cord resolution but socioeconomic and personal problems 




Figure 7.22. With the arm in the ABER position, showing the cord (arrow) for patient FS/2013/09. L=left, 
R=right. 
7.9.1 Patient description 
A 53-year-old patient presented 1122 days after surgery with pain, cording and tightness in the 
axilla and limited range of movement (Table 7.17, Figure 7.22).  
 
The patient was treated with a left mastectomy and axillary node clearance for breast carcinoma. 
She received neoadjuvant six courses of CAF chemotherapy and started with Tamoxifen soon 
after her surgery. Two years later she received 47 Gy adjuvant radiotherapy to the chest wall, 
medial and superior half axilla of axilla and supraclavicular area (2.67 Gy/frac), approximately 
a year before she entered the study. 
 
Although the physiotherapist examined her and no clear cord was observed, she could not 
continue with the study due to personal problems. 
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7.9.2. Surface anatomy 
Figure 7.22 shows a taut band of tissue on the left arm that retracted the skin inwards within the 
axillary vessel groove between coracobrachialis and teres major and latissimus dorsi muscles. 
The cord started in the middle of the axilla and extended towards the lateral side of the upper 
limb.  
 
7.9.3. Measurements  
At the first measurement cycle the cord measured approximately 58.08 mm in length (Table 
7.18). The patient reported a high amount of pain (41/50) but a moderate amount of disability 
(56/80) when prompted with the SPADI questions. She experienced a lot of pain when Ǯreaching highǯ ȋͳͲ/ͳͲȌ or when Ǯlying on the involved sideǯ ȋͻ/ͳͲȌ and could not by herself Ǯput an object on a high shelfǯ, Ǯcarry a heavy objectǯ or Ǯwash her hair or backǯ with the affected arm (10/10). 
All her FACT-B scores were lower, giving a low total score of 77.2/144, indicating a low quality 
of life exacerbated by the pain and disability.  
 
Table 7.18. The different scores for the outcome measures of cord length, SPADI and FACT-B. 
Values at first measurement cycle 
Outcome measure Before 
Cord length (mm) 58.08 
SPADI (pain) 41 
SPADI (disability) 56 
SPADI (total) 97 
FACT-B (physical) 15 
FACT-B (social) 15 
FACT-B (emotional) 20 
FACT-B (functional) 17 
FACT-B (additional concerns) 10 
FACT-B (total) 77.2 
 
 
All ROM measures, except external rotation, on the affected side were lower than on the 
unaffected side (Figure 7.23). The external rotation measure could be explained as being due to her right handedness. The patientǯs most affected actions were abduction and forward flexion 
with a 51.2% and 67.6% difference, respectively, between the lower and the higher scores. The 
reduced actions in her affected arm correlated with the tightness in her axilla preventing her 



























Figure 7.23. The difference between left and right arms on range of movements for patient FS/2013/09. 
The left side is highlighted in blue and the right side in red. The red bolded percentage indicates the 







































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/09 before physiotherapy as indicated by the torso pictogram. The torso pictogram denotes 
the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with the longitudinal scans at the 
top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. Orientation indicators: S=superior, 
I=inferior, L=lateral, M=medial. Within the scans: D=dermis, SF=superficial fascia, DF=deep fascia, CB=coracobrachialis muscle, HH=humeral head. 
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7.9.4. Ultrasonography Plate 9 
7.9.4.1. Static  
7.9.4.1.1. Left 
On the affected side on the longitudinal scans there was approximately 1 cm of adipose tissue 
present. Within the hypodermis the superficial fascia (SF) was multi-layered and more densely 
packed on the far-most right image but more disrupted and thicker on the left, closer towards 
the area below the scar superficially. There were some shadowy artefacts within the muscle 
(CB). The unclear continuity was also visible on the transverse scan which had a coarse 
homogeneity and some hypoechoic shadows, probably from vessel lumen. On both the 
transverse and longitudinal scans the superficial fascia showed connections to the skin, but was 
more visible on the transverse ultrasonograph. 
 
7.9.4.1.2. Right 
On the right unaffected side, the hypodermal thickness was slightly less (0.5-1 cm) but the SF 
was showing more regular throughout, was more organised and more obvious surrounding the 
vasculature on the transverse scan. The deep fascia (DF) also seemed slightly thicker on the 
unaffected side, compared to the affected side.  
 
7.9.4.2. Dynamic 
On Video 9.1 of the left side there appeared to be more disrupted SF strands extending from the 
skin to the DF and muscle. On Video 9.2 independent muscle gliding was present and continuity 
and linearity of the SF fibres in the hypodermis was more obvious than in Video 9.1. The videos 
are, however, not very clear. 
 
7.9.4.3. Links between outcome measures 
Although there was a fibrous band and tightness in the axilla, no clear cord was observed by the 
physiotherapist or on the ultrasound scans. There were, however, close skin connections and 
less regularity found in the superficial fascia layers of the affected arm compared to the 
unaffected arm. The findings correlated with the tightness on the surface and could be associated 
with the low SPADI and FACT-B scores as experienced by the patient due to pain, discomfort and 
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7.10. Patient FS/2013/10 
Table 7.19. Participant variables describing age, affected side, handedness and treatment details. 
Patient details  
Age 48 years 
Side affected Left 
Handedness Right 
Treatments Surgery left mastectomy + left ANC 
 Chemotherapy CAF (x6) 
 Radiotherapy 42.7 Gy (2.67 Gy/frac) chest wall, 
medial and superior half axilla of 
axilla, supraclavicular area 
 Hormonal therapy Tamoxifen + Arimidex 
No. of days surgery until presentation 1133 days 
Self-reported symptoms before Cord, pain and limited range of movement 





Figure 7.24. With the arm in the ABER position, showing the cord (arrow) for patient FS/2013/10 with the 
arm in the ABER position. L=left, R=right. 
7.10.1. Patient description 
A 48-year-old woman presented 1 133 days post-surgery with a clear cord on the left side, 
puckering around the scar, pain and restriction upon movement of the arm and shoulder (Table 
7.19, Figure 7.24).  
 
The patient was treated with a left breast mastectomy and axillary node clearance for breast 
carcinoma. She received adjuvant six courses of CAF, was prescribed Tamoxifen and after that 
L R 
- 171 - 
 
Arimidex and received 42.7 Gy radiotherapy to the chest wall, medial and superior half axilla of 
axilla and supraclavicular area (2.67 Gy/frac). 
 
Although the patient expressed interest in being part of the study, the physiotherapist was 
unable to make an appointment with her for treatment after the first measurement cycle. 
  
7.10.2. Surface anatomy 
A clear double finger-thick cord was observed in the mid-axillary line extending inferiorly from 
the scar-line fanning superiorly towards the lateral upper arm (Figure 7.24). Clear puckering 
was noticed around the scar as well as around the root of the cord, showing slight retraction of 
the skin.  
 
7.10.3. Measurements  
At the first measurement cycle the cord measured 91.34 mm across the axilla (Table 7.20) which 
restricted some movements and caused pain. The patient, for example, reported increased pain Ǯreaching highǯ ȋͳͲ/ͳͲȌ or Ǯpushing with the involved armǯ ȋͳͲ/ͳͲȌ and disability when Ǯputting an object on a high shelfǯ ȋͳͲ/ͳͲȌ or ǯwashing her backǯ ȋ͹/ͳͲȌ, but little other difficulty as reflected in her SPADI scores ȋ͹ͳ/ͳ͵ͲȌ. The patientǯs FACT-B scores mirrored the item scores 
as she had a high quality of life score of 124.5/144.  
 
Table 7.20. The different scores for the outcome measures of cord length, SPADI and FACT-B. 
Values at first measurement cycle 
Outcome measure Before 
Cord length (mm) 91.34 
SPADI (pain) 26 
SPADI (disability) 45 
SPADI (total) 71 
FACT-B (physical) 21 
FACT-B (social) 25 
FACT-B (emotional) 20 
FACT-B (functional) 27 
FACT-B (additional concerns) 32 
FACT-B (total) 124.5 
 
 
The action that was most debilitated was abduction with the unaffected arm having a 133.8% 
higher ROM measure (Figure 7.25). Internal rotation showed a 56.9% difference between the 
unaffected and affected arms and forward flexion was affected on both sides but showing a 
18.9% higher score on the unaffected arm. Her disability in reaching high, putting something on 
a high shelf and washing her back reflected in the scores. 
 



















Figure 7.25. The difference between left and right arms on range of movements for patient FS/2013/10. 
The left side is highlighted in blue and the right side in red. The red bolded percentage indicates the 









































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/10 before physiotherapy as indicated by the torso pictogram. The torso pictogram denotes 
the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with the longitudinal scans at the 
top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. Orientation indicators: S=superior, 
I=inferior, L=lateral, M=medial. Within the scans: D=dermis, SF=superficial fascia, DF=deep fascia, CB=coracobrachialis muscle, HH=humeral head 
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7.10.4. Ultrasonography Plate 10 
7.10.4.1. Static 
7.10.4.1.1. Left  
On the longitudinal scans of the left affected side there was approximately 1-1.5 cm of adipose 
tissue. Within the adipose tissue there was scarce, thickened superficial fascia which had a 
diffuseness surrounding it and disappeared in an area of high coarse homogeneity on the left of 
the images. The coarseness was spread throughout the hypodermis and coracobrachialis muscle 
(CB). A shadowy artefact appeared near the CB marker. The superficial fascia seemed closely 
associated with the skin with which it connected on multiple points. On the transverse 
ultrasound scan the organisation of the SF was not regular, thinner and surrounded a hypoechoic 
lumen.  
 
7.10.4.1.2. Right  
On the right the adipose tissue was 1.5-2 cm with honeycomb-like organised superficial fascia 
throughout it. The deep fascia (DF) was unclearly defined on the ultrasound scan but appeared 
continuous over the CB, which itself appeared diffuse as well - possibly relating to a scanning 
artefact. On the transverse scan the SF appeared more linear and regular compared to the left 
but was not very clear. 
 
7.10.4.2. Dynamic  
There appeared more continuity and organisation and slightly better muscle gliding on the 
unaffected side (Video 10.2, Figure 7.26 (R)) compared to the affected side (Video 10.1, Figure 
7.26 (L)) Furthermore, the superficial fascia was very closely connected to the dermis on the 








Figure 7.26. Video stills showing the difference in relationship of the superficial fascia to the dermis, being 
thicker and more closely connected on the ultrasound scans of the affected (left) compared to the 
unaffected (right). L=left, R=right. 
R L 
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7.10.4.3 Links between outcome measures  
Although the patient had an obvious long and thick cord on the surface, which seemed to cause 
some pain and discomfort with particular movements and actions, a clear cord structure was 
not visible on the ultrasound scans. The puckering and close relationship of the SF with the 
dermis could explain the puckering and tightness, and perhaps the cord itself was obscured by 
the dense connective tissue in the hypodermis.  
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7.11. Patient FS/2013/11 
Table 7.21. Participant variables describing age, affected side, handedness and treatment details. 
Patient details  
Age 51 years 
Side affected Left 
Handedness Right 
Treatments Surgery Left mastectomy + left ANC 
 Chemotherapy CAF (x6) 
 Radiotherapy 42,7 Gy (2,67 Gy/frac) chest wall + 
medial axilla 
 Hormonal therapy Tamoxifen 
No. of days surgery until presentation 601 days 
Self-reported symptoms before Cording 
Self-reported symptoms after Cording 
No. of physiotherapy treatments 5 










Figure 7.27. With the arm in the ABER position, showing the cord (arrow) and scar area on the left side for 
patient FS/2013/11 before physiotherapy with the arm in the ABER position (a) compared to the right (b) 
and the patient standing with arm in abduction (c). On (c) a clear thickening is visible in the mid-axilla. 
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7.11.1. Patient description 
A 51-year-old patient presented 601 days post-surgery with a complaint of tightness and 
cording in the left axilla (Table 7.21, Figure 7.27).  
 
The patient was treated with a left breast mastectomy and left axillary node clearance for breast 
carcinoma. She received neoadjuvant six courses of the CAF regimen and adjuvant Tamoxifen 
and 42,7 Gy radiotherapy to the chest wall and medial axilla (2,67 Gy/frac). 
 
The physiotherapist noted a palpable but not tender lump mid-axilla – which was visible on 
Figure 7.27a. There was no puckering or excess tissue but slight adherence to the chest wall. 
Physiotherapy treatment was focused on the myofascial release of the cord, the lump in the axilla 
and the chest wall tightness and pectoralis major and minor, latissimus dorsi and the scapular 
muscles. 
 
As a result of an interest in comparing the cord on US and MRI, patient 11 was selected to 
undergo an MRI scan before undergoing physiotherapy treatment (Figure 7.28b), which was 




Figure 7.28. With the arm in abduction, showing the cord and scar area for patient FS/2013/11 at the 
time of the MRI scan. (a) - shows the cord similar to Figure 4.56c - and in the ABER position (b) shows the 
beads that are put on the cord area for the MRI scan. L=left, R=right. 
 
7.11.2. Surface anatomy 
A web of guitar string-like cords presented in the unusual lower aspect of the axilla in the axillary 
vessel groove, extending from the inferior portion of the scar line to the middle of the axilla. The 
first cord was visible in Figure 7.27, whereas the second cord was not visible on the photographs. 
A lump was visible over the cord (Figure 7.27c) when the patient was standing upright.  
b a 
L L 
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After physiotherapy the cord partly resolved showing a slight remnant of the structure still 




Figure 7.29. With the arm in the ABER position, showing the cord and scar area for patient FS/2013/11 
after physiotherapy with the arm in the ABER position. L=left, R=right. 
 
7.11.3. Measurements  
At the first measurement cycle the cords measured 139.52 mm and 57,96 mm. After 
physiotherapy, the second cord resolved completely, whereas the first cord reduced by 30.3% 
in length to 97, 19 mm (Table 7.22).  
 
Although the patient had some tightness in the axilla, she did not experience a lot of pain but some pain when Ǯlying on the involved sideǯ ȋͶ/ͳͲȌ or Ǯreaching highǯ ȋͷ/ͳͲȌ and had some difficulty with Ǯputting an object on a high shelfǯ ȋ͵/ͳͲȌ or Ǯwashing her hairǯ ȋ͵/ͳͲȌ. The item 
scores mirror what the physiotherapist found as the only areas the patient had difficulty with 
were the abovementioned, otherwise she could manage all the activities of daily living. Her 
SPADI scores corroborated that finding with relatively low scores for pain and disability (14/50 
and 8/80) which decreased even further to no pain and little disability (4/80) when placing 
objects high up, after physiotherapy. 
 
The abovementioned low scores for pain and disability were reflected in the Fact-B score where the patientǯs score improved but her initial score was higher, showing only a small Ͷ,ͳ% 
improvement overall. She had some anxiousness regarding the disease progression in the 
emotional subsection which improved after physiotherapy but otherwise the patient had no 
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Table 7.22. Percentage change of cord length, SPADI and FACT-B scores after physiotherapy. 
Changes after physiotherapy 
Outcome measure Before After Change (%) 
Cord length (mm) 139.52 (57.96) 97.19 -30.3 (-100) 
SPADI (pain) 14 0 -100 
SPADI (disability) 8 4 -50 
SPADI (total) 22 4 -81.8 
FACT-B (physical) 24 27 +12.5 
FACT-B (social) 28 26 -7.7 
FACT-B (emotional) 14 15 +7.1 
FACT-B (functional) 27 26 -3.7 
FACTFACT-B (additional concerns) 21 25 +19 
Fact-B (total) 114 118.7 +4.1 
 The patientǯs range of movement showed very little improvement, being 16.7% in forward 
flexion and 10.1% in abduction of the affected arms (Figure 7.30). Both unaffected arms seemed 
to improve for the actions as well and showed less difference between the arms after 
physiotherapy. The reduced difference between arms mirrored the results from the SPADI 
scores where there was improvement in functioning due to less pain and disability being 
experienced. 
 
Extension, external and internal rotation showed a decrease of up to 24% on both arms after 
physiotherapy but still remained in normal range of motion (Clarkson & Gilewich, 1989).  
 
Figure 7.30. The difference between left and right arms and improvement on range of movements for 
patient FS/2013/11 after physiotherapy. The left side is highlighted in blue and the right side in red, with 
both lighter colours depicting the ROM after physiotherapy. The red bolded percentage indicates the 
percentage difference between left and right with the lowest value being the reference. The percentages 








































































Overview of ultrasound scans of the cord in the axillary region of patient FS/2013/11 before (top) and after (bottom) physiotherapy as indicated by the torso pictograms. 
Each torso pictogram denotes the position and an indication of the length of the cord in red. The ultrasound scans for each side were placed at the side of the pictogram with 
the longitudinal scans at the top and the transverse scans at the bottom. The longitudinal scans are aligned along the cord length; the transverse scan taken mid-cord. 
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7.11.4. Ultrasonography Plate 11 
7.11.4.1. Static 
7.11.4.1.1. Left 
On the left longitudinal ultrasound scan there was an adipose tissue layer of approximately 0.5-1 
cm thickness present. Within the adipose tissue there was increased coarse homogeneity and a 
thickened superficial fascia (SF) present that was partly continuous. Numerous broken fibrous 
thinner strands with an increased connection to the dermis were shown with a particular 
densified patch close to the dermis (D) demarcation. The coracobrachialis (CB) muscle and its 
fascia (DF) was not very clearly as shown on the scan. On the transverse scan the SF appeared 
thickened again. Post-physiotherapy, there seemed to be more regularity of the SF and multi-
layering, with more space between the individual strands, and reduced coarse homogeneity. The 
transverse scan showed an artefact and the focal thickening of the SF was still present. 
 
7.11.4.1.2. Right  
On the right longitudinal scans there was a clearly defined multi-layered and regular SF that 
connected to the DF and D. There seemed to be more regularity in the CB with more perpendicular 
epimysial fascia layers present. The transverse scan showed a latticework organisation for 
vessels and nerves. Post-physiotherapy the layering was somewhat less clear on the ultrasound 
scans but was still multi-layered and structurally organised as before. Similarly, the transverse 
scan showed the honeycomb organisation as pre-physiotherapy and more organised on the right 
than on the left.  
 
7.11.4.2. Dynamic 
On the affected side on Video 11.1 there was increased thickness of the superficial fascial bands 
which were more disrupted compared to the more continuous planes in Video 11.3 on the 
unaffected side and more connected to the D. Post-physiotherapy increased muscle gliding on 
both scans was visible, but the disrupted superficial fascial layers were still evident on the 
affected side on Video 11.2 compared to the unaffected side on Video 11.4.  
 
7.11.4.3. Links between outcome measures 
Although the cord did not resolve fully, the improvements in both range of movement and pain 
showed as slight fascial reorganisation on the ultrasound scans. Increased multilayering of the 
superficial fascia, decreased connectivity to dermis and more independent tissue gliding 
appeared after the physiotherapy treatment, all of which can be associated with the reduced 
tightness in the axilla and on the chest wall and freer ROM.  
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7.11.4.4. MRI 
On the MRI scan it was noted that the axillary swelling was composed of multiple linear fibrotic 
bands superiorly that confluenced with the subcutaneous adipose tissue of the upper arm and 






















Figure 7.31. Long axis STIR PDFS T1 (a and b) and short axis STIR T1 (c and d) MRI images of the arm in 
the ABER position as shown in Figure 4.57b. Figures a and c are in parasaggital view; b and d in axial view. 
The red arrows indicate the fibrous bands. For orientation, the torso pictogram is placed at the top, 
indicating the direction of the unconventional MRI scanning of the cord (red line). Orientation indicators: 
S=superior, I=inferior, P=posterior, A=anterior, L=lateral, M=medial. Within the scans: HH=humeral head, 
BB=biceps brachii, Dt=deltoid, CB=coracobrachialis, TM=teres major, LD=latissimus dorsi, PM=pectoralis 
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The multiple thin fibrous bands at the site of the axillary web extended into the hypodermis at 
the junction of the upper arm and axilla. The bands lay superficial to the skin and had short axis 
dimensions of 2.6 x 8.2 mm with the whole fibrotic area measuring 6.5 cm. The fibrous tissue 
showed low signal on all the sequences.  
 
There was also prominent adipose tissue mixed with the fibrotic bands which accounted for the 
larger swelling evident clinically (Figure 7.31, see label fat admixture). No STIR hyperintensity 
within the bands or conglomerate cord indicated a vascular or lymphatic contribution. 
 
A distal clear fibrous band connected the conglomerate cord to the pectoralis major muscle 
postero-caudally (PM). A lesser band originated from the pectoralis minor (Pm) muscles and 
merged with the axillary cord. Proximally, inferiorly on the image, the cord continued to become 
inseparable with the anterior border of latissimus dorsi (LD) and its fascia. The most inferior 
extent of the lesion was not included.  
 
7.11.4.5. Links between ultrasound, MRI and outcome measures 
There were several agreements between our ultrasound and MRI finds which included an 
increased thickness of the multi-layered dense superficial fascia which had increased connection 
with the dermis and some musculature, which explained some difficulty in movement, and pain 
upon movement, which prevented independent muscle gliding. 
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Sensitivity and numbness due to severed 
peripheral nerves within the fascia (see I and II)
Damaged Fascia in AWS
Cord is venous or lymphatic in orgin: 
investing fascia guides blood- and 
lymphatic vessels that helps keep this 
structures patent (see V)
Moskovitz et al. 2001, AWS Symptoms:
I. ͞…visible web of axillary skin overlying 
palpable cords of tissue (typically, there 
are two or three taut, tender, 
nonerythematous Đords) ͞
II. ͞… are ŵade taut and painful by shoulder 
aďduĐtioŶ͟
III. ͞…is a ŵajor Đause of limitation in 
shoulder raŶge of ŵotioŶ” 
IV. ͞…cord is self-limiting. Resolves within 2 
months”
V. ͞… cord has a lymphovenous etiology͟
Fascia adapts to a new environment via 
force loads and nervous impulses
↑ fiďrosis/adhesioŶs ďetweeŶ fasĐial plaŶes





• Facilitate muscle glide: fascia allows for
muscular gliding because of its
production of a lubricant. Damaged
fascia causes restrictions in 
movements (see III) and stiffness of the 
tissues, muscles and skin (see I)
• Appropriately activate nociception: 
fascia contains many receptors (noci
and proprio) embedded in the matrix in 
a specific pattern. Damaged fascia 
inappropriately activates these with
normal movement which can lead to
pain (see I & II)
Cord formation due to fibrosed wall and 
fibrosed/adhesive surrounding tissue (see V)
Histological alterations to the fascia tissue 
matrix by ↑ deposition of collagen
Histological alterations to the fascia tissue 
matrix by ↑ deposition of collagen
Severed vessel leaks protein rich  fibrin 
into interstitium
Breast cancer treatment
Patients in current study shortest time  since 
surgery 2 months!  Longest 4 years! (see IV)
͞Popping͟ souŶd when cord resolves is the 
fascia releasing. ↑ ROM and ↓ pain is fascia 
resolving (see IV)
Appendix A: Scheme of
Argument AWS and
Fascia Involvement
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TITLE OF THE RESEARCH PROJECT: Axillary Web Syndrome (AWS) after treatment 
for breast cancer: comparing clinical variables with ultrasound imaging data focussing on 
anatomical changes before, during and after physiotherapy treatment. 
 
 
PRINCIPAL INVESTIGATOR: Dr Delva Shamley   021 406 6281 
 
CO-INVESTIGATORS:   Dr Charles Slater    
     Mr Willie Fourie 
      Dr Hannah Simonds   021 404 4267 
Mr Kyle Paulssen   079 091 6904 
 
 
ADDRESS: Department of Human Biology, Level 2, Anatomy Building, Faculty of Health 
Sciences, University of Cape Town, Observatory, 7925 
 
Invitation to participate: We are inviting you to take part in a research project in breast 
cancer because you have been treated for breast cancer in the past. The information in this 
letter explains the details of the project and how you could be involved. Please ask your 
doctor to explain anything that you do not understand.  Only you can decide if you want to 
take part and, if you choose to say no or to withdraw from the study at any time, it will not 
affect your medical treatment in any way, not now or in the future. 
 
What is the study about? Axillary web syndrome (AWS) is a disorder which may develop as 
a side effect of the treatment for breast cancer. It is characterised by a tight cord that runs 
over the inside of the arm from the armpit and can extend to the thumb. This cord will tighten 
and become more visible when lifting the arm, which can be painful and difficult. Not all 
Participant Information Leaflet  





















women treated for breast cancer develop the complications and we do not know why some 
women have problems and others do not.  
 
This study will be the one of the first that looks at how a cord responds to physiotherapy 
treatment. We would like to do this by viewing the cord before, during and after treatment 
using ultrasound images of your arm and shoulder. We hope this will assist us to learn more 
about the disorder and develop better treatment for patients like you. 
 
Ethical approval: This study has been approved by the University of Cape Town Human 
Research Ethics Committee which promotes respect for the research participants and 
protects their health and their rights.  
 
Who will be doing the research? All of the researchers and health professionals who will 
be involved are experts in their field and are based at the University of Cape Town or at the 
Groote Schuur Hospital. Younger scientists who become involved will be adequately trained 
and supervised by a senior staff member. 
  
Who is paying for this study? Who is paying for this study? This study is carried out on 
voluntary basis and is not paid for and forms part of a Masters degree.  
 
Can we trust that there is no conflict of interest? In other words, can we be sure that 
this study is for the benefit of breast cancer patients and not to promote a hidden 
agenda of a sponsor or a researcher? There are NO conflicts of interest. The findings of this 
study are for the benefit of breast cancer survivors and will add to our knowledge of the 
components of axillary web syndrome and how to manage it. 
  
What if something goes wrong during or after the study? The University of Cape Town 
(UCT) promises that in the event of you suffering in health or well-being caused by you taking 
part in the study, it will provide immediate medical care.  
 
Procedures and time involved:  
Once we receive your reply slip we will contact you about your possible inclusion in the study. 
If you are able to participate we will then make an appointment for you to attend the Groote 
Schuur Hospital Radiology Department in Cape Town. This appointment will require about 
one hour of your time. This will start with a 15 minute information session about the aim of 
the research project. We will read through the information sheet and answer your questions 
about the project. If you are interested in taking part in our research project you will be asked 
to read and sign a consent form. If you agree to take part we will continue as follows:  
 
1. A member of the research team will ask you a few questions regarding your 
symptoms, areas of tightness and pain and ability to move your arm and shoulder. 
2. You will then be asked to undress to your bra and lie down on a table with your arm 
raised. You will be asked to move your arm into different positions and the  range of 
movement (ROM) will be measured. We will do this for both arms. 
3. Then we will take measurements of the cord with a tape measure and photograph it. 
Your face will not be photographed only your arm and armpit will be in the 
photographs. 
4. A team member will then take ultrasound scans of your arm and armpit with some 
gel and ask you to hold your arm in specific positions but within your ability and level 
of pain. The gel can be washed off afterwards. We will also do this for both arms. 
5. Lastly, you will fill in a short questionnaire about your current level of pain and 
functional ability of the arm and shoulder. You may not be experiencing any difficulty, 
but we will still use your data to compare to those who are having difficulty. 
6. After this an appointment with the physiotherapist will be made for you to receive 
treatment. Subsequent sessions will be made with her. 
7. At the end of your last treatment the research team will go through one final 
measurement cycle with you. In total there are thus two measurement times. 
 
Will I get to see the results? This is a pilot study which may give us more information on 
the development of the disorder and hints of where to look next. We will not be sending out 
any results to participants but if you would like to see a summary of the study you may ask 
us. 
 
Who can take part: To take part in this study you must be a female and older than 18 years 
of age. You must have been treated for breast cancer, have clear evidence of cording and 
speak English or Afrikaans. For participating in the MRI procedure, you cannot have a 
pacemaker or have had a shoulder replacement. 
 
Who will know that I am taking part in this project: Your identity will be kept secret and 
your personal details will be safely stored in the office of the principal investigator, at the 
Department of Human Biology, University of Cape Town. The data will be coded with a 
reference number so that your name and other details cannot be matched with the other data 
and will not be used in any reports or publications written about this study.  
The only person who will know that you are taking part are your health professionals 
working with the research team. 
 
Will I get paid for taking part: You will not be paid to take part in the study. You will, 
however, be reimbursed for travelling to the venue where research data is collected. 
 
Are there any risks involved in taking part in the study: The MRI exam may be 
uncomfortable and unsettling because of the tunnel you are asked to lie in, the noise the 
machine makes and that you need to lie still for the duration of the scan. We will, however, 
work as fast as possible to limit the discomfort and give you earphones during the exam to 
block the noise as much as possible. You are unlikely to experience pain and discomfort 
during the physiotherapy treatment as treatment is done within your limits of pain. It is 
carried out by a professional physiotherapist and is a standard procedure. All research 
measurements taken will also be done within your level of pain and discomfort. 
 
What are the benefits are for me: The direct benefit from the study is that you will get 
professional physiotherapy treatment and medical attention for your problems. This study 
aims to observe changes in your symptoms during physiotherapy and may provide 
information that will be useful in the future to understand what causes the complications and 
how to improve treatment.  
 
Do I have to take part? NO. It is entirely up to you if you want to take part in this study. You 
may decide that you do not want to take part or decide to withdraw from the project at any 
time. This decision will not affect any current treatment you may be receiving. 
 
What if I have other questions now or later about the study or my rights: If you have 
questions about the study that are not answered in these Information Sheets please ask the 
interviewer to answer them. If you have any concerns related to this project in the future you 
may contact: 
• the study investigators at the telephone numbers given on the first page  
• Professor Marc Blockman, Chair, UCT Human Research Ethics Committee, Faculty of 
Health Sciences, may be contacted by research subjects to discuss their rights.  











PROJECT TITLE: Axillary Web Syndrome (AWS) after treatment for breast cancer: 
comparing clinical variables with ultrasound imaging data focussing on anatomical changes 
before, during and after physiotherapy treatment. I, …………………………………………………………………………., would like to take part in this study.  
 




We will contact you via these details and confirm your inclusion in the study. 
  
Reply Slip 
PROJECT TITLE: Axillary Web Syndrome (AWS) after treatment for breast cancer: 
comparing clinical variables with ultrasound imaging data focussing on anatomical changes 
before and after physiotherapy treatment. 
 
AGREEMENT TO PARTICIPATE 
 
I, ………………………………………., have read (or have had read to me) the Information Sheet for 
the study named ǮAxillary Web Syndrome (AWS) after treatment for breast cancer: 
comparing clinical variables with ultrasound imaging data focussing on anatomical changes 
before and after physiotherapy treatmentǯ. 
My role in the study is as a research volunteer to help the investigators collect information 
about the anatomical structures involved in the development of arm and shoulder 
complications after treatment for breast cancer. I understand that the purpose of this study 
is to observe symptom changes during physiotherapy treatment and the information may or 
may not be useful in designing better ways to treat these complications in the future. My 
questions have been answered to my satisfaction in a language that I understand. By signing 
this consent form I do not waive any of my rights.  
 I, ………………………………………., AGREE to take part in the study ǮAxillary Web Syndrome 
(AWS) after treatment for breast cancer: comparing clinical variables with ultrasound 




(initial boxes where appropriate) 
I authorise my doctor and other health care professionals to provide  
relevant clinical details to the research team of this study. 
 
I authorise photographs of my armpit and arm to be taken and  
used in publications. 
 
 




Date:           ………………………………………. Volunteer: Please sign both copies of this page 
 
Name:         ………………………………………. 








Date:          ……………………………………….  Interviewer: Please sign both copies of this. 
page and hand one copy back to the research  
Name:        ………………………………………. volunteer 




Date: 04-06-2013        Version: 02 
 
 
Participant #:  Dominant hand: Left Right 
Date:     Symptoms: Cording ↓ROM Pain 
Cord characteristics:  # of cords:  
Cord 1 side: Left Right Cord 2:  
Localisation (°):  Localisation (°):  
Width (cm):      Width (cm):      
Length (cm):      Length (cm):      
ROM measurements: Left Right   
Scaption (°):     SPADI score:  
Horizontal adduction (°):     Photograph #:  
Flexion (°):     Ultrasound Scan #:  
Extension (°):       
Internal rotation (°):      
External rotation (°):      
Treatment #:  
Date:  Symptoms: Cording ↓ROM Pain 
Cord characteristics:   # of cords:  
Cord 1 side: Left Right Cord 2:  
Localisation (°):  Localisation (°):  
Width (cm):      Width (cm):      
Length (cm):      Length (cm):      
ROM measurements: Left Right   
Scaption (°):     SPADI score:  
Horizontal adduction (°):     Photograph #:  
Flexion (°):     Ultrasound Scan #:  
Extension (°):       
Internal rotation (°):      
External rotation (°):      











Treatment #:  
Date:  
Participant #:  Operated side: Left Right 
Date:   Scar location:   



















Participant #:  Weight (kg):  
GSH file #:   Height (m):  
RT file #:  BMI (kg/m2):  







Stage: I II III IV 
Tumour type: Invasive ductal Tubulolobular Mucinous Comedo Lobular DCIS Tubular NOS 
Tumour size (mm):  
 Tumour 
Tumour: T1 T2 T3 T4 
 Lymph nodes: N1 N2 N3 
Metastasis: M0 M1 
If M1, to where:  
# Resected nodes:  
Type of nodes:  
Receptor status: ER: Positive Negative PR: Positive Negative 
 Surgery 
Surgery type:  
Tissues removed:  
Procedure date:  
 Radiotherapy Chemotherapy Hormonal therapy 
Dose intensity (Gy):    
# Fractions:    
Dose frequency:    
Total doses:    
Field of radiation:    
Start date:    
End date:    
 Physiotherapy 
Start date symptoms:  
Time since surgery:  
Time 1st treatment since 
surgery: 
 
Total treatments:  
Time to resolution:  
Symptom recurrence:  
Appendix E: Data Collection Sheet B: Clinical and Demographic 




Treatment #:  
Date:  
Treatment #:  
Date:  
Participant #:  
Date:  













   













   








Compensatory actions: Areas of pain and/or tightness: 
  





Treatment session 1 
Treatment session 2 
Treatment session 3 
Appendix G: Physiotherapist Notes 
Physiotherapy details     
 




having 3rd chemo on 
25/10/2013, does light chores, 
pulls++ on L chest wall with 
arm mvts 
bilat horizontal mastectomy 
incisions, more puckering on L  Elevation: L ͳͷͲ⁰   R ͳ͹Ͳ⁰ 
 
scar massage to release 
adherence areas L & R  
MFR across chest wall with arm 
in elevation L & R  
L – fascial releasing into axilla 
and upper arm on L with arm 
supported in elevation  
Taught mobilising and stretch 
exercises to do at home 
 
 
 2 6/11/2013 
felt good after Rx till chemo 
then tight again 
scarring tight, quite adherent to 
chest wall 
ROM L  - ͳ͸Ͳ⁰ 
 
focussed on releasing scar on L as 
well as tight fascia 
Exercises 
Breathing and relaxation 
 
 3 8/11/2013 easier since Rx  
MFR across chest wall in supine 
(pecs) and R side ly – serratus ant 
and post  
Passive scapular mobilisation and 
active retraction in side ly 
Side ly – progress to full elbow 
ext – neural stretch  
Exercises and breathing 
 
 4 13/11/2013 
feels tightness in L arm and into 
chest after doing housework 
minimal cording visible but 
restriction felt and seen with 
elevation + elbow ext 
strong stretches + fascial release 
of chest wall, into axilla and 
upper arm ՜ much freer still slight pull in 
upper arm with overpressure  
Exercises:  progressed to 
wt bearing in 4 Pt kneeling, alt 
arm and leg stretch, cat stretch, 
shell stretch and table top stretch 
in standing 
 5 11/12/2013 
feeling better, doing well with 
stretches, arm asymptomatic 
very little cording visible on full 
elevation with full elbow and wrist 
Ext. pull felt in upper inner arm 






pain in arm, sometimes down to 
wrist when has used arm. Is a 
nurse aid, unable to work at the 
moment but hopes to return to 
nursing once treatment over 
All sh mvts restricted   
Elevation through Fl - ͳͷͲ⁰,  HBH 
most limited functional mvt due to 
limited ext rot - Ͷͷ⁰ 
Palpation –scar very adherent on 
chest wall – restriction of skin and 
superficial fascia 
Cording ++ visible - tight band 
extends from chest wall above scar 
across axilla and into antero-medial aspect upper arm ՜ pulls ++ down 
towards elbow with elbow E with 
arm in elevation 
Scap mvts very restricted  
 
Scar tissue massage along length 
of scar 
Fascial release over chest wall – 
very adherent to ?? deep fascia  
MFR to pec maj and minor, 
coracobrachialis, short head of 
biceps  
Fascial release into axilla  











MFR – ant and posterior – 
serratus ant, infraspinatus, 
latissimus, rhomboids, lev scap 
and trapezius 
Trigger point release TPs in 
infraspinatus and   serratus ant. 
Neural mobilisation of median 
nerve Also MFR down upper arm 
and forearm Fascial release 
across chest and into axilla, upper 





feeling better – been 
more active 
Pulls medial aspect 
forearm with full 
elbow extension as 
when bending down 
to pick something 
up 
 
Elev - ͳ͸ͷ⁰ - tight across 
elbow and into med 
aspect forearm ՝ ROM 
elbow on full elev     -10⁰ 
elbow ext 
 
MFR ++ across chest wall over 
pec minor and long head of biceps
  
Side ly – scap mobs, activation of 
lower traps, rhomboids. Release 
of post axillary structures and 
triceps Exercises – progressed to 






Finished radiotherapy – caused 
tightness ++ across chest wall 
ROM - ͳ͸Ͳ⁰ 
gentle massage over chest due to skin still being Ǯsunburntǯ 
Side ly – scap mobs and MFR of 
scap/tx muscles   






feeling better again – being 
more active and arm less Ǯtightǯ 
 
ROM elev - ͳ͸ͷ⁰ restriction due to adherence on chest wall ՜ tight 
bands into axilla and upper arm. 
 






uses arm but is cautious Ǯdoes not know what she can/canǯt doǯ does not want to cause 
 harm 
 
ROM:  Elevation L – 160     R – 150 
but unable to extend elbow ՜- ͳͷ⁰ 
E Obs – very tight, ugly scar on R 
chest wall with puckering and 
adherence to chest wall 
 Has not touched or washed area 
since radiotherapy as was told not 
to. Thoracic kyphosis – restricts sh 
mvts 
Scar massage ++++   ՜  removal 
of dead and discoloured layers of 
skin  
Gentle fascial release over chest 
wall 
Stretching exs 
 2 13/11/2013 
very happy with the improved 
appearance – has made her feel 
better. 
no change in ROM – very Ǯstuckǯ Scapular mobilisations – very 
tight and stuck 
 3 20/11/2013 
feeling easier, using arm more 
freely 
ROM – no change 
Skin better and looser 
 
scar massage  
MFR – pecs, coracobr 
Fascial release over chest wall 
down onto attachments of 
diaphragm, extending into axilla 
and upper arm – pulls++ at limit 
of range  
Stretching exs 
 4 4/12/2013 doing well, feeling good 
no change in ROM 
Scap mvts very restricted 
 
Release of scap mǯs in side ly and 
activation of stabilisers 
 5 11/12/2013  No change 
MRF ++ also Serratus ant, upper 
traps, infrasp 
Fascial release – pec minor  




 6 5/02/2014 
has been fine, happy with what 
has been achieved with physio 
scapula mvts freer - has maintained 
the improved range and function 
cord still visible in axilla at full 
range 







R arm does not feel right – feels 
a pull down the upper arm and 
across elbow Also feels a pain Ǯinsideǯ arm and into thumb 
 
extremely anxious and guarded about using R arm beyond 9Ͳ⁰ elev 
ROM – Elev - free active 100,  active 
assisted – 150Tightness ++ in axilla 
and extends to med aspect upper 
arm – taught band Scar fairly tight 
at meduial end and puckered lat end ՛ thoracic kyphosis restricts sh 
range  
 
scar massage Fascial release front 
of chest wall MFR – pecs and into 
upper arm Exercises 
 
 2 5/12/2013 
feels much improved, arm feels 
normal, no longer anxious to 
use it. 
Active ROM – 150 
 
more vigorous scar massage and 
fascial release on chest wall 
above scar and towards axilla 
Scapular mobilisation in side 
lying + MFR serratus ant 
Exercises 
 3 15/01/2014 
feeling good, has managed well 
Had an episode of swelling R 
upper arm + pain med aspect 
towards elbow 1 week ago –
spontaneous resolution – has 
occurred before  ? related to 
bouts of overuse??  
 
maintained range well  
ROM  elev  160 = Full range 
due to tx kyphosis which limits full 
elev 
Abd  90 
HBB  L = R 
HBH L = R  (ie normal for the 
patient) but ?? L sh dysfunction)   
Scar massage 
 
Fascial release around scar to 
under lower ribs/diaphragm 
MFR –across chest to axilla + 
upper arm Stretch with arm in elevation  ՜  good release of cord in axilla  ՜   ՛ range  ՜ slight pull in upper arm on full 
elevation + wrist ext 
Stretching exs 
 
 4 22/01/2014 
inner upper arm & forearm feel 
tight 
pain on elbow ext, sh elevation  - 
appears neural (has been a bit 
stressed) 
extensive fascial release – chest 
wall, axilla and upper arm in 
supine with arm in elev. ՜  Neural mobs with sh in 
elev – some relief of upper arm Sx ՜ facial release down arm 
into flexor retinaculum forearm    ՜ improvement 
 Side ly – Cx Sp mobs  C2 - pain 
  Tx mobs – T8 very tight and 
painful Scap mobs and Ǯsettingǯ 










ROM elev 160 but mvt feels much 
freer and no pain/tightness 
Cord still visible in axilla on elev  
 
specific fascial relwease over 
incision & into axilla where cord 
is still visible with arm in elev- 
good response – tissues less 
taught & no pull in upper 
arm.MFR serr ant & rhomboids 
Scap mobilisation & scap setting 
Exs – stretches + wt bearing thru 





bilateral shoulder pain R > L x 1 
year 
 R knee osteoarthritis – 
waiting for a knee replacement  
 Also Ǯslipped discǯ – 
low back pain  
 
horizontal mastectomy incision, 
adherent to chest wall medially  
Skin very discoloured from 
radiotherapy, has not been washing 
the area so a lot of old dry skin and 
scabs along incision Active elevation in standing:  L ͳͷͲ⁰  R ͳʹͲ⁰ Active Abduction in stand L   
80 R   70 Altered scapulao –
thoracic rhythm noted with mvts in 
standing, poor control 
 
general massage with oil to clean 
up area of old skin etc 
Deep scar massage to release 
adherence medially as well as 
thickened area between scar and 
axilla where there is extensive 
adherence MFR across chest wall 
with arm in elevation R  
Taught mobilising and stretch 
exercises to do at home 
 
 2 9/04/2014 
recovering from gastic flu, has 
not done exs 
no change except in appearance of 
the area due to clearing of old skin 
etc 
focussed on releasing very tight 
areas along scar as well as tight 
areas above 
R – fascial releasing into axilla 
and upper arm on R with arm 
supported in elevation Taught 
shoulder mobilising exercises as 
well as stretches to maintain  
 
 3 23/04/2014 feeling easier since Rx 
slight improvement in elev R – 130, 
functional activities like dressing a 
bit easier. 
scar tissue release – area above 
and below scar are very 
thickened and adherent 
++ MFR across chest wall in 
supine (pecs) and L side ly – 
serratus ant and post  
Passive scapular mobilisation and 
active retraction in side ly 
MFR into axilla and upper arm + 
stretches ++ Exercises 
 
 4 14/05/2014 
has had a lot of fibromyalgia – 
not moving around much so has 
stiffened up   
 
pre treatment elevation in lying = 
150 Post treatment = 160 ( has 
difficulty maintaining this 
improvement week to week) 
Rx a/a – ++ MFR and stretching 
with arm in elevation - not much 
response by tissues to fascial 





finds cold weather affects her 
arthritis – stiff joints Elev in standing – 130 
Rx a/a  – extensive strong fascial 
releasing as well as passive 
stretching with arm in elevation 
as well as side lying with scapular 
protraction & retraction. 
---- Pulls down inner upper arm – 
range also restricted by shoulder 
pathology in supine ly  
Checked on exs and emphasised 
home exercises. 
 
     
Note: It has been difficult achieving significant objective changes 
with FS/2013/08 due to several factors:  
 
• Length of time since surgery so tissues not responsive 
to change 
• General OA and fibromyalgia 
• Increased BMI 
• Lack of motivation to do home exs or massage 
 
Subjectively, I felt there were subtle changes in the structures 
crossing the axilla and marginal reduction in the thickening of 







some difficulty reaching top 
shelf, drying hair, otherwise 
manages all ADL Does protect 
her L side  
 
Elev      R 180      L 160 
Ab      90        90 
Lat Rot      50        40 
HBB    115       100  (hand 
behind back)  
cord visible in lower aspect axilla 
on full elevation in lying (unusual 
as commonly higher up towards 
humerus) Palpable superficial lump 
in mid axilla – soft, not tender …??  
Low BMI so no puckering or 
thickening of excess tissue along 
scar area. Slightly tight and 
adherent to chest wall  
 
scar tissue massage  
MFR -  pec major,(supine) and lat 
dorsi and scapular muscles in 





Ǯfeels easierǯ, using arm more 
freely 
MFR +++ lat border of pec major,  
  pec minor(tender)  lat dorsi 
insertion   posterior axillary wall  
fascial release of cord in axilla and 
attachements to adipose tissue 
Full stretch into elevationwith 
fascial and neural releasing  
Pec and lat dorsi stretches 
elevation in lying – 170 – slight 








achieved full range of shoulder 
elevation, reduced pull into axilla 
with full range movements.  
 
Cording reduced visibly as well in 
axilla and the fat pad softened and 
became smaller and flatter. 
Good compliance with home 
exercises as well as her confidence 
in herself contributed to what I 
perceive to be a successful 















Did not want to continue with 
physio after measurement 
cycle due to socioeconomic 
and personal problems 
 
Cord resolution but 
socioeconomic and personal 
problems prevented her from 
continuing 
 
Too ill to continue with 
physiotherapy 
 
Cord resolution but 
socioeconomic and personal 
problems prevented her from 
continuing 
 
Did not respond to calls for 
physiotherapy 




Appendix H: Table US Analysis  
This table demonstrates the indicators used in ultrasound analysis of each patient. 
 
Affected Side versus Unaffected Side - Before Physiotherapy 
 Patient number 
Variable 1(L) 1(R) 2 3 4 5(L) 5(R) 6 7 8 9 10 11 
Thickened/ 
hyperechoic SF ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Thickened/ 
hyperechoic DF ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Coarse homogeneity AT 
 ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Muscle artefact 
 ✓ ✓  ✓    ✓  ✓ ✓ ✓ ✓ 
Increased connections 
dermo-hypodermic junction ✓             
Increased connections SF-
DF-muscle ✓             
Disorganisation in AT 
 ✓     ✓ ✓       
Decreased number of layers 
 ✓  ✓ ✓ ✓ ✓ ✓      ✓ 
Patch of (course) 
homogeneity ✓ ✓    ✓ ✓     ✓ ✓ 
Fibrous scar 
 
     ✓ ✓       
Arch during tensioning 
 
   ✓          
Honeycomb organisation SF 
 
             
Increased heterogeneity 
 
             
 
Appendix I: Most at Risk for Fibrosis Table 
A summary of the different treatments (radiotherapy, chemotherapy and hormonal therapy) and their contributing risk at developing fibrosis. The # = the rank attributed 
according to the number in the previous column with 1 attributed to the highest – 11 to the lowest. The accumulative risk is the term describing the final position of the risk 
on all the measures combined compared to the other participants and is dependent on the total rank: the lower the total rank, the more potential risk the patient has at 
developing fibrosis, the higher the accumulative risk. Although the author acknowledges the necessity of knowing the quantities of each drug taken, the treatment regimens 
were of similar dose and the ranking are more a relative indicator rather than absolute. 
*patient received two different doses of radiotherapy to two different areas during the physiotherapy treatment and had to stop the treatment for some time to recover. 
Although treatment regimens are dependent on the cancer type and severity, they have also been shown to pose a potential risk of developing fibrosis due to their destructive ability. The table is 
therefore not an absolute indicator of fibrosis development but ranks the patients according to who might be more at risk due to previous findings in the literature on the development of fibrous 
tissue. For example, when the radiation dose is higher and in the case of specific chemo- and hormonal therapy regimens. This might also give an indicator on the propensity of recovery after 
physiotherapy as less fibrotic tissue formed will require less effort to resolve and should be compared to the improvement table. This seems to mirror some of the information especially in the 
extreme cases – indicating some relationship trend between these values. Other factors such as the lifestyles of these individuals that may worsen their condition could not be evaluated and thus 
this table is not conclusive and only a guideline.  





dose (Gy) # 
Chemotherapy types 
of treatments 
Chemotherapy no. of 
treatments # 
Hormonal therapy 








FS/2013/01  5 Gemcitabine/ CEF 2/4 5  4 14 Best best/ best 
FS/2013/02 41,6 + 38,4* 1 CEF/ Paclitaxel 3/4 2  4 7 Worst Worst/ 5 
FS/2013/03 42,7 3 CAF/ Paclitaxel 6/6 1  4 8 Fifth  
FS/2013/04 42,72 4 CEF 6 7 Tamoxifen/ Arimidex 3 14 Best best /4 
FS/2013/05   6 CAF/CMF 6/6 3 Tamoxifen/ Arimidex 3 12 Third  
FS/2013/06 
47/ 20 2 CAF/ Vinorelbine 6/6 5 
Tamoxifen/ Exemestane/ 
Arimidex/ Provera 
1 8 Fifth 
 
FS/2013/07 47 3 CAF 6 6 Tamoxifen 2 11 Fourth 2 / 2 
FS/2013/08   6 CEF/ Taxotere 3/3 4 Tamoxifen/ Arimidex 3 13 Second 4 /3 
FS/2013/09 47 3 CAF 6 6 Tamoxifen 2 11 Fourth   
FS/2013/10 42,72 4 CAF 6 6 Tamoxifen/ Arimidex 3 13 Second  
FS/2013/11 42,72 4 CAF 6 6 Tamoxifen 2 12 Third 3 /worst 
Appendix J: Most Improved Ranking Table 
SPADI Pain and Disability (Dis.) scores on the affected arm. The # = the rank attributed according to the number in the previous column with 1 attributed to the 
highest – 7 to the lowest. The accumulative improvement is the term describing the final position of how the participant improved on all the measures combined 
compared to the other participants dependent on the total rank: the higher the total rank, the least the participant improved, the lower the accumulative 
improvement.  
*Patient FS/2013/01 had both left and right arms affected  
Number of physiotherapy treatment was approximately equal for all patients and were at the discretion of the physiotherapist on the team to decide whether more 
treatments would be beneficial to the patients. This is a relative ranking as the ranks do not take into account differences between the patients.  
































100,00 1 78,13 3 133,33 2 46,00 2 24,21 5 26,32 4 84,62 4 92,31 1 22 Second 
FS/2013/01* 
(right) 
100,00 1 130,14 1 150,00 1 29,60 3 30,95 4 36,94 3 60,00 6 71,43 2 21 Most 
FS/2013/02 34,63 2 47,83 6 8,16 4 -0,88 7 -33,33 7 -8,77 6 87,88 3 69,01 4 39 Sixth 
FS/2013/04 100,00 1 48,91 5 6,78 5 77,81 4 40,35 3 -5,88 5 66,67 5 0,00 7 35 Fifth 
FS/2013/07 100,00 1 97,01 2 106,25 3 18,00 1 44,32 2 53,27 2 42,86 7 38,46 6 24 Third 
FS/2013/08 -15,96 4 38,27 4 -14,06 7 6,31 6 109,80 1 500,00 1 87,88 2 71,11 3 28 Fourth 
FS/2013/11 30,35 3 10,07 7 -11,29 6 16,67 5 -24,24 6 -11,76 7 100,00 1 50,00 5 40 Least 
